text
stringlengths 65
123k
| url
stringlengths 25
420
| crawl_date
timestamp[us, tz=UTC]date 2022-04-01 01:00:57
2022-09-19 04:34:04
|
|---|---|---|
Supporting game-changing dialysis technology to transform therapy for kidney disease
SEATTLE, April 11, 2022 /PRNewswire/ -- Kuleana Technology, Inc. (Kuleana), a Seattle Washington-based company, received the National Kidney Foundation (NKF) Innovation Fund's first dialysis investment. Kuleana is developing a groundbreaking portable hemodialysis device that will not require connection to an external water source and will not require complex sorbents. This device will be more effective than current dialysis since it will allow patients to dialyze on the go - enabling whenever, wherever dialysis for millions of patients worldwide.
"The kidney health landscape is broken and lacks needed innovation," said Kevin Longino, chief executive officer of NKF and a kidney transplant recipient. "About 37 million Americans have kidney disease and many crash into kidney failure and require dialysis before ever being diagnosed. We need a fundamental change in how we deal with chronic kidney diseases. NKF's Innovation Fund will provide donors with a unique opportunity to see their dollars support companies pursuing the most promising therapies, treatments and prevention methods that offer the potential to transform kidney care."
Capitalizing on the prize-winning innovations and the extensive patent portfolio of the University of Washington's Center for Dialysis Innovation (CDI), Kuleana is revolutionizing treatment technologies aimed at improving patient outcomes and enabling patients with chronic kidney failure to live life to the fullest. "Using the most promising biomaterials and bioengineering technologies and leveraging the CDI's multi-disciplinary research teams and patient advisory board, Kuleana is transforming dialysis. Our solutions will keep dialysis patients healthier and productive, and they will lower costs to make sustainable dialysis accessible worldwide," according to Kuleana's Chief Technology Officer and CFO, Buddy D. Ratner, PhD.
NKF indicates that "10% of the population worldwide is affected by chronic kidney disease, and millions die each year because they do not have access to affordable treatment." In upper income countries, like the US, only 60% of people who need dialysis have access to it. In lower and lower-to-middle income countries dialysis is available to between 1% and 4% of people who need it.
"We're enthusiastic about the support NKF is providing Kuleana. Like NKF, we recognize that the unmet needs in hemodialysis are imperative – for the patient and for the economy. Progress over the last 62 years has been incremental and unimpressive. Patients want and deserve radically transformed treatment options that are safer, more effective, and that significantly improve their quality of life. Kuleana is a Hawaiian word conveying care, responsibility, accountability and reciprocity. These are the values that underpin everything we do", said Dr. Jonathan Himmelfarb, Kuleana's President and CEO.
About Kuleana Technology
Kuleana, a spinoff from the University of Washington, enjoys a close relationship with the Center for Dialysis Innovation , and with the Northwest Kidney Centers. These institutions pioneered dialysis technology and care, and with the support of investors like the NKF Foundation, they will continue to revolutionize it. For more information, visit kuleanatechnology.com.
View original content:
SOURCE Kuleana Technology
|
https://www.whsv.com/prnewswire/2022/04/11/kuleana-technology-receives-nkf-innovation-funds-first-dialysis-investment/
| 2022-04-11T12:24:17Z
|
HARRISBURG, Pa., April 11, 2022 /PRNewswire/ -- LINKBANCORP, Inc. (OTC Pink: LNKB) (the "Company"), the parent company for The Gratz Bank, today announced the closing of a $20.0 million private placement of Fixed-to-Floating Rate Subordinated Notes due 2032 (the "Notes"). The Company intends to contribute a significant portion of the proceeds to The Gratz Bank as additional capital to support continued growth.
The Notes have a maturity date of April 15, 2032 and will initially bear interest at a fixed rate of 4.50% until April 15, 2027. From April 15, 2027 to the stated maturity date or early redemption date, the interest rate will reset quarterly to an annual floating rate equal to the then-current three-month term Secured Overnight Financing Rate (SOFR) plus a spread of 203 basis points.
The Notes are redeemable by the Company, in whole or in part, on or after April 15, 2027 and at any time upon the occurrence of certain events. The Notes have been structured to qualify as Tier 2 capital for regulatory capital purposes.
Chief Executive Officer Andrew Samuel stated, "We are very pleased with the positive momentum we have experienced in recent periods, and are confident that our teams will quickly leverage this additional capital with further organic loan growth, supported by the recent expansion of our teams in the Delaware Valley, Lancaster and York markets."
LINKBANCORP, Inc. was formed in 2018 with a mission to positively impact lives through community banking. Its subsidiary bank, The Gratz Bank, is a Pennsylvania state-chartered bank serving individuals, families, nonprofits and business clients throughout Central and Southeastern Pennsylvania through 10 client solutions centers of The Gratz Bank and LINKBANK, a division of The Gratz Bank. LINKBANCORP, Inc. common stock is traded over the counter (OTC Pink) under the symbol "LNKB". For further company information, visit ir.linkbancorp.com.
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of current or historical fact and involve substantial risks and uncertainties. Words such as "anticipates," "believes," "estimates," "expects," "forecasts," "intends," "plans," "projects," "may," "will," "should," and other similar expressions can be used to identify forward-looking statements. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. Among the risks and uncertainties that could cause actual results to differ from those described in the forward-looking statements include, but are not limited to the following: costs or difficulties associated with newly developed or acquired operations; changes in general economic trends, including inflation and changes in interest rates; increased competition; changes in consumer demand for financial services; our ability to control costs and expenses; adverse developments in borrower industries and, in particular, declines in real estate values; changes in and compliance with federal and state laws that regulate our business and capital levels; our ability to raise capital as needed; and the effects of the COVID-19 pandemic and actions taken by governments, businesses and individuals in response. The Company does not undertake, and specifically disclaims, any obligation to publicly revise any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements, except as required by law. Accordingly, you should not place undue reliance on forward-looking statements.
# # #
CONTACT
Nicole Ulmer
(717) 803-8895
nulmer@linkbancorp.com
View original content to download multimedia:
SOURCE LINKBANCORP, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/linkbancorp-inc-announces-completion-20-million-subordinated-notes-offering/
| 2022-04-11T12:24:23Z
|
Industry veterans Jill M. Jene, Ph.D. and Spyros Papapetropoulos M.D. Ph.D. appointed to Board
SALT LAKE CITY, April 11, 2022 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on neuroendocrine and metabolic disorders, announced today the appointment of Jill M. Jene, Ph.D. and Spyros Papapetropoulos, M.D., Ph.D. to its board of directors.
"We are very pleased to welcome Jill Jene and Spyros Papapetropoulos to our board of directors. Each of them brings a wealth of relevant expertise," said Mahesh V. Patel, Ph.D., Chairman and CEO of Lipocine. "Jill brings extensive experience in corporate development and portfolio strategy with a strong track record in creating value through successful licensing and M&A transactions. Spyros has a broad spectrum of medical and development experience with specific expertise in neuroscience, which we believe will be invaluable as we advance our innovative programs, especially the neuroactive steroid ("NAS") programs. We are confident that the insights and contributions of Jill and Spyros will strengthen the Board and we are enthusiastic about the role they can play in helping Lipocine succeed."
Jill M Jene, Ph.D. brings more than 20 years of biopharmaceutical strategy, leadership and deal making experience to the Company's Board of Directors. She has amassed a deal sheet of over $6 billion of closed transactions and she is currently the Founder and Principal of Jene Advisors, a Biopharmaceutical advisory firm. Dr. Jene was the Vice President and Head of Corporate Development, Strategy, Portfolio Planning and Alliance Management at Adamas until the company was sold to Supernus in November of 2021. Before joining Adamas, Dr. Jene was Vice President of Business Development for PDL, a publicly traded biotechnology company where she was responsible for executing deal-making to maximize value for shareholders. Before PDL, Dr. Jene led Business Development at twoXAR pharmaceuticals where she led deal-making, resulting in closing 6 new partnerships and securing Series A funding from Softbank and A16z. Prior to twoXAR, Dr. Jene was at Depomed (now Assertio), where she led over 36 transactions including licensing and M&A deals including acquiring 4 commercial franchises. Earlier in her career, she held positions of increasing responsibility at Baxter International, the 3M Company (Pharmaceutical Division now part of Valeant) and Cell Genesys (acquired by Biosante). Dr. Jene earned a B.S. from Bradley, a M.S. and Ph.D. in Chemistry from Northwestern University, and an M.B.A. in strategic management from DePaul University.
Spyros Papapetropoulos, M.D., Ph.D. is an experienced biopharmaceutical executive, recognized neuroscientist and neurodegenerative disease clinician. He is currently Chief Medical Officer at Vigil Neurosciences Inc. where he oversees all the clinical development and medical functions. Prior to Vigil, Dr. Papapetropoulos served as SVP, Head of Development (CDO) at Acadia Pharmaceuticals Inc., CEO at SwanBio Therapeutics, and Head of Research & Development and Chief Medical Officer at Cavion. Before Cavion, he held senior/executive positions at Biogen Inc., Allergan plc, Pfizer Inc., and Teva Pharmaceuticals Inc. Dr. Papapetropoulos has overseen a broad spectrum of biopharmaceutical development programs including small molecules, biologics, and gene therapy leading to successful regulatory filings and new product launches worldwide. He holds an appointment as consultant with Massachusetts General Hospital and has been involved in groundbreaking research that led to the characterization of genetic forms of Parkinson's disease and development of methodologies that revolutionized the quantification of neuromotor function in clinical research settings. Dr. Papapetropoulos has published more than 170 peer reviewed articles and authored several book chapters and patents. He received an M.D. from Semmelweis University in Budapest, Hungary and an M.D., Ph.D. from the University of Patras in Greece.
Lipocine Inc. is a biopharmaceutical company focused on neuroendocrine and metabolic disorders using its proprietary drug delivery technologies. Lipocine's clinical development pipeline includes: LPCN 1148, LPCN 1144, LPCN 1111, LPCN 1107 and oral neuroactive steroids including LPCN 1154 and LPCN 2101. TLANDO, a novel oral prodrug of testosterone containing testosterone undecanoate, is approved by the FDA for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism, in adult males. LPCN 1148 is an oral prodrug of bioidentical testosterone targeted for the management of symptoms associated with liver cirrhosis. LPCN 1144, an oral prodrug of bioidentical testosterone, recently completed a Phase 2 clinical study demonstrating potential utility in the treatment of non-cirrhotic NASH. LPCN 1111, a novel oral prodrug of testosterone, originated and is being developed by Lipocine as a next-generation oral testosterone product with potential for once-daily dosing. In a phase 2 clinical evaluation when administered as once or twice daily, LPCN 1111 met primary and secondary endpoints. LPCN 1107 is potentially the first oral hydroxyprogesterone caproate product candidate indicated for the prevention of recurrent preterm birth and has been granted orphan drug designation by the FDA. Neuroactive steroids are currently being evaluated including LPCN 1154 for the potential treatment of postpartum depression and LPCN 2101 for the potential treatment of epilepsy. For more information, please visit www.lipocine.com.
This release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include statements that are not historical facts regarding Lipocine's product candidates and related clinical trials, the timing of completion of clinical trials, the timing and completion of regulatory reviews, outcomes of clinical trials of our product candidates, the potential uses and benefits of our product candidates, and our product development efforts. Investors are cautioned that all such forward-looking statements involve risks and uncertainties, including, without limitation, the risks that the FDA will not approve any of our products, risks related to our products, expected product benefits not being realized, clinical and regulatory expectations and plans not being realized, new regulatory developments and requirements, risks related to the FDA approval process including the receipt of regulatory approvals, the results and timing of clinical trials, patient acceptance of Lipocine's products, the manufacturing and commercialization of Lipocine's products, and other risks detailed in Lipocine's filings with the SEC, including, without limitation, its Form 10-K and other reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC website at www.sec.gov. Lipocine assumes no obligation to update or revise publicly any forward-looking statements contained in this release, except as required by law.
View original content to download multimedia:
SOURCE Lipocine Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/lipocine-announces-board-director-appointments/
| 2022-04-11T12:24:29Z
|
MGIC MI Rate Quotes Now Available Through Industry Standard JSON API
MILWAUKEE, April 11, 2022 /PRNewswire/ -- Mortgage Guaranty Insurance Corporation (MGIC), the principal subsidiary of MGIC Investment Corporation (NYSE: MTG) and the nation's first private mortgage insurer, announced today that it is fully enabled to integrate with lenders and technology partners wanting to utilize the recently announced industry standard MISMO JSON API for mortgage insurance estimated rate quotes.1 The MISMO API will access MGIC's risk based MiQ pricing ensuring accuracy and consistency throughout the mortgage origination lifecycle.
"Our dedication to leading and fulfilling efforts to bring JSON API integrations and standards to market stems from listening to the requests and needs from our lending customers and technology partners," said Leslie Malicki, Director of Product Development at MGIC. "Our REST based API is lighter weight and higher performing than traditional implementations and intended to be one of our best-in-class solutions for the industry."
1 The press release from MBA announcing the MISMO JSON API for Estimated MI Rate Quotes can be found here. MISMO Members can access the MI Rate Quote API in the Resource Library housed on MISMO's Collaboration Site (MISMO Connect) here. Non-Members can access the MI Rate Quote API here.
Mortgage Guaranty Insurance Corporation ("MGIC") (www.mgic.com), the principal subsidiary of MGIC Investment Corporation, serves lenders throughout the United States, Puerto Rico, and other locations helping families achieve homeownership sooner by making affordable low-down-payment mortgages a reality through the use of private mortgage insurance.
From time to time MGIC Investment Corporation releases important information via postings on its corporate website, and via postings on MGIC's website for information related to underwriting and pricing, and intends to continue to do so in the future. Such postings include corrections of previous disclosures and may be made without any other disclosure. Investors and other interested parties are encouraged to enroll to receive automatic email alerts and Really Simple Syndication (RSS) feeds regarding new postings. Enrollment information for MGIC Investment Corporation alerts can be found at https://mtg.mgic.com/shareholder-services/email-alerts. For information about our underwriting and rates, see https://www.mgic.com/underwriting.
View original content:
SOURCE MGIC Investment Corporation
|
https://www.whsv.com/prnewswire/2022/04/11/mgic-announces-support-mismo-json-api-rate-estimate/
| 2022-04-11T12:24:35Z
|
DUBLIN, April 11, 2022 /PRNewswire/ -- EnigmaSoft Limited's SpyHunter 5 includes the HelpDesk – a one-on-one personalized technical support service. Sometimes users encounter unique problems related to stubborn malware infections that traditional anti-malware software may not fully detect or remove. SpyHunter 5's HelpDesk connects users directly to our SpyHunter 5 technicians who can create custom malware fixes to address unique malware issues where needed. SpyHunter 5's HelpDesk is completely integrated within SpyHunter 5; when a technician creates a custom malware fix, SpyHunter 5 automatically receives the fix. In just a few clicks, the fix can be easily and effectively applied.
How Does SpyHunter 5's HelpDesk Work?
1. Go to the "HelpDesk" menu and click the "Diagnostic Report" icon.
2. Generate a "Diagnostic Report" and submit it to SpyHunter 5's technical team.
3. The team will review your "Diagnostic Report" and will create a unique custom fix for you. Fixes are transmitted directly to SpyHunter 5.
4. When a fix is received by SpyHunter 5, you will receive a notification that it is ready to be applied. Applying the fix is as simple as clicking the "Apply Fix" button. SpyHunter 5 will take care of the rest.
To download SpyHunter 5 and try its HelpDesk along with its other anti-malware features, visit https://www.enigmasoftware.com/products/spyware-helpdesk/.
How to Easily Remove Hard-to-Remove Malware with SpyHunter 5's HelpDesk?
SpyHunter 5's HelpDesk offers:
- A custom fix feature designed to repair your system from persistent malware infections.
- Direct access to SpyHunter 5's technical support team.
- Generate diagnostic reports that provide our technical support team insights into subscribers' unique system problems to develop custom fixes.
About EnigmaSoft Limited
EnigmaSoft Limited is a privately held Irish company with offices and global headquarters in Dublin, Ireland. EnigmaSoft is best known for developing and distributing SpyHunter 5 and SpyHunter for Mac, advanced anti-malware apps. SpyHunter detects and removes malware, enhances Internet privacy, and eliminates security threats – addressing issues such as malware and other security threats affecting millions of PC and Mac® computer users on the web. SpyHunter 5 has scored top grades in comparative testing by independent third-party testing labs such as AV-TEST. SpyHunter 5 has also been certified by AppEsteem, Checkmark Certified and TRUSTe.
Connect with EnigmaSoft: Twitter | Facebook | LinkedIn | YouTube
View original content to download multimedia:
SOURCE EnigmaSoft Limited
|
https://www.whsv.com/prnewswire/2022/04/11/need-help-removing-stubborn-malware-other-antivirus-apps-dont-fix-spyhunter-5s-helpdesk-generates-custom-malware-fixes-you/
| 2022-04-11T12:24:41Z
|
SAN DIEGO, April 11, 2022 /PRNewswire/ -- NEUVOGEN, an immunoncology company, announced today that Peter Watler, PhD has been appointed Head, Manufacturing Operations. He will lead NEUVOGEN's clinical and commercial manufacturing strategy, oversee production of NEUVOGEN's cancer vaccines and manage relationships with contract manufacturing organizations.
"We are thrilled that Dr. Watler has agreed to join our team and lead NEUVOGEN's manufacturing operations" said Todd Binder, Chief Executive Officer, NEUVOGEN. "Peter has an extensive track record of delivering both biologic and vaccine clinical and commercial supply on time and on budget. I am confident that at NEUVOGEN he will build on his track record."
Dr. Peter Watler has over three decades of vaccine and biopharmaceutical development and manufacturing experience including a deep knowledge of clinical and commercial manufacturing and partnering with contract manufacturing organizations. He has authored several IND and BLA submissions with participation in FDA inspections and cGMP audits. During his twelve years at Amgen, Dr. Watler led teams responsible for the technology transfer and commercial manufacturing support of Neupogen®, Stemgen®, Kepivance® and Infergen®. He most recently served as Chief Technical Officer of Coherus BioSciences where he established partnerships with leading contract manufacturers and was responsible for the clinical supply chain management and establishing the commercial manufacture of Udenyca®. Dr. Watler also served as Chief Technology Officer at Hyde Engineering where he oversaw the process design of biopharmaceutical manufacturing facilities including a modern modular facility recently built and commissioned in China. Prior to that, he was Vice-President of Manufacturing at Vaxgen, and led the team responsible for the design, build and validation of a vaccine production facility. He also provided design input for Celltrion's first South Korea manufacturing plant. He received his PhD in chemical engineering from Yamaguchi University, Japan and holds bachelor's and master's degrees in chemical engineering from the University of Toronto.
"I look forward to working together with the team to develop the manufacturing strategy and building relationships with our contract manufacturing partners to generate clinical vaccine supplies and eventual commercial products." said Dr. Watler. "NEUVOGEN has the potential to generate substantial clinical benefit for patients with solid tumors. I am excited to be part of an effort that can be transformational for cancer patients."
A link to comprehensive biographies can be found at www.neuvogen.com/about-us/.
About NEUVOGEN
NEUVOGEN, Inc. is an immunoncology company focused on whole cell cancer vaccine therapies. NEUVOGEN believes its cancer vaccines have the broadest combination of tumor associated antigens and tumor specific antigens ever delivered in a cancer vaccine and as a result can directly target a greater percentage of cancer cells in a solid tumor than any previous cancer vaccine. Based in San Diego, California, NEUVOGEN's goal is to develop therapeutic cancer vaccines that activate the body's immune system to eradicate solid tumors and meaningfully extend the lives of patients while limiting side effects. To learn more, visit www.neuvogen.com.
View original content:
SOURCE NEUVOGEN
|
https://www.whsv.com/prnewswire/2022/04/11/neuvogen-appoints-vaccine-manufacturing-expert-peter-watler-phd-head-manufacturing-operations/
| 2022-04-11T12:24:48Z
|
VANCOUVER, BC, April 11, 2022 /PRNewswire/ - Northstar Clean Technologies Inc. (TSXV: ROOF), (OTCQB: ROOOF) ("Northstar" or the "Company") has announced that it will be presenting at the 2022 Asphalt Roofing Manufacturers Association ("ARMA") Spring Committee & Board Meeting Series. The Company's presentation "Repurposing Asphalt Roofing Materials" will highlight the Company's important contribution to the fight against landfill waste. The presentation is scheduled for April 26, 2022 at 8:30 am Central Time. Speaking at this event from Northstar will be the following:
- Aidan Mills, President & CEO, Director
- Gord Johnson, Co-Founder, Director, President of Empower
- Kellie Johnston, Chief Sustainability Officer
The 2022 ARMA meetings are being held in person in Kansas City, Missouri, from April 25-28, 2022, and will also be made available virtually for those who are unable to attend in person.
The Asphalt Roofing Manufacturers Association (ARMA) is a trade association representing North America's asphalt roofing manufacturing companies and their raw material suppliers. The association includes the majority of North American manufacturers of asphalt shingles and asphalt low slope roof membrane systems. Information that ARMA gathers on modern asphalt roofing materials and practices is provided to building and code officials, as well as regulatory agencies and allied trade groups. Committed to advances in the asphalt roofing industry, ARMA is proud of the role it plays in promoting asphalt roofing to those in the building industry and to the public.
For more information about ARMA and the 2022 Spring Committee & Board Meeting Series, visit www.asphaltroofing.org.
Northstar Clean Technologies Inc. is a Vancouver-based clean technology company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar has developed a proprietary design process for taking discarded asphalt shingles, otherwise destined for already over-crowded landfills, and extracting the liquid asphalt, aggregate and fiber for usage in new hot mix asphalt, construction products and other industrial applications. Focused on the circular economy, Northstar plans to reprocess used or defective asphalt shingle waste back into its three primary components for reuse/resale at its Empower Pilot Facility in Delta, British Columbia. As an emerging innovator in sustainable processing, Northstar's mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America, extracting the recovered components from asphalt shingles that would otherwise be sent to landfill.
For further information about Northstar, please visit www.northstarcleantech.com.
On Behalf of the Board of Directors,
Aidan Mills
President & CEO, Director
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. The TSXV has neither approved nor disapproved the contents of this press release.
View original content to download multimedia:
SOURCE Northstar Clean Technologies Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/northstar-present-2022-asphalt-roofing-manufacturers-association-spring-committee-amp-board-meeting-series-kansas-city/
| 2022-04-11T12:24:54Z
|
HONG KONG and SHANGHAI, April 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEx:2318; SSE:601318) has published its 2021 Sustainability Report. The sustainability report, the 13th from Ping An, highlights the Group's achievements in sustainability strategy, management, and operations as well as its milestones in environmental, social and governance performance.
Advancing green finance to achieve operational carbon neutrality in 2030
In 2021, Ping An announced its green finance development goals and plan to achieve operational carbon neutrality by 2030 for the first time. Ping An supports the efforts to reduce the risks and impacts of climate change outlined in the Paris Agreement, and China's goals to achieve a carbon peak by 2030 and carbon neutrality by 2060. By 2025, Ping An aims to achieve its overall targets with investment and credit of RMB400 billion and total green insurance premiums of RMB250 billion. As of December 31, 2021, Ping An's green investment and financing totaled RMB224.6 billion, green banking business totaled RMB89.8 billion, and environmentally sustainable insurance premium income totaled RMB44.57 billion.
To achieve operational carbon neutrality by 2030, Ping An has adopted a carbon neutral strategy in line with international best practices. It has prioritized internal measures to reduce emissions, and is also looking at external ways to further reduce emissions, including purchasing external green power. After all emission reduction measures are implemented, Ping An will achieve carbon neutrality through multiple approaches, including buying carbon credits.
In 2021, Ping An focused on reducing the impact of its operations on the environment through energy-saving transformation, smart office features and digitalization to reduce energy consumption and carbon emissions. Ping An's total carbon emissions decreased by 19% year-on-year to 429,000 tons; the electricity consumption of Ping An's own workplaces and leased workplaces was 513,946,880 kilowatt hours, down 2.65% year-on-year; and the total paper consumption at Ping An's operating sites and workplaces was 1,631 tons, down 75.89% year-on-year. Ping An also applied green and environmental technologies to construct green buildings. As of December 31, 2021, more than 10 of Ping An's green building projects, including the Ping An Financial Center in Shenzhen and the Ping An National Customer Service and Support Technology Center in Shanghai have obtained green building certifications at home and abroad, including the US Leadership in Energy and Environmental Design (LEED) Platinum Certification for Buildings Operations and Maintenance.
Focusing on rural revitalization for sustainable development
Ping An promotes rural revitalization by supporting the development of industries, healthcare and education and advancing its Ping An Rural Communities Support programs. In 2021, Ping An provided RMB12 billion for industrial revitalization. Leveraging the Group' s premium medical resources, Ping An also trained village doctors, upgraded village clinics and provided free health checkups and medical consultations for rural residents from its mobile Ping An Healthcare Diagnostics Center vehicle. During the year, Ping An held 69 events for mobile health checkups and medical consultations in rural areas, providing charitable healthcare services to 9,483 people. Ping An also recruited 875 volunteers in 2021, who provided over 20,000 hours of online and offline teaching services at 127 Ping An Hope Primary Schools. As of December 31, 2021, Ping An cumulatively provided approximately RMB41.9 billion for poverty alleviation and industrial revitalization, funded 119 Ping An Hope Primary Schools, and recruited nearly 10,000 volunteer teachers who served approximately 370,000 hours.
Improving corporate governance and shareholder returns
In 2021, Ping An paid an annual dividend of RMB2.38 per share in cash, up 8.2% year-on-year. The Group also started a new round of share repurchase. As of December 31, 2021, Ping An repurchased 77.77 million A shares, worth RMB3.9 billion. In order to retain key employees and establish long-term incentive and restraint mechanisms, Ping An has implemented the Key Employee Share Purchase Plan and the Long-term Service Plan, with 89,304 employees participating in the plans as of December 31, 2021. The Group has had stable and healthy operations since the implementation of the plans. The Group, shareholders, and employees have shared benefits and risks, providing a strong foundation to continue to improve the Company's governance structure, and facilitate the long-term, sustainable and healthy development of the Company.
Promoting responsible investment and sustainable insurance
Ping An believes that responsible investment helps to manage risk and contributes to long-term stable returns. In 2021, Ping An updated its Policy Statement on Responsible Investment and Policy Statement on Coal Related Business of Ping An Group. They set strict standards for monitoring the investments in high pollution and high emission industries. In addition, Ping An is committed to incorporating environmental, social and corporate governance (ESG) concepts into insurance business development and insurance product design. In 2021, Ping An updated the Group's Policy Statement on Sustainable Insurance based on the Principles for Sustainable Insurance (PSI) from the United Nations Environment Programme Finance Initiative (UNEP FI). As of December 2021, the scale of Ping An's responsible investment and financing reached nearly RMB1.22 trillion, of which Ping An's green investment and financing was nearly RMB 224.58 billion. Inclusive investment and financing was nearly RMB 68.467 billion, and social investment and financing was nearly RMB 926.860 billion, with 2,303 sustainable insurance products offered.
ESG practices and achievements with international recognition
In 2021, Ping An became a constituent of the FTSE Russell Sustainability Index (FTSE4Good), the Hang Seng ESG 50 Index, and the Hang Seng China Enterprises Index (HSCEI) ESG Index. Ping An was rated as low risk in Sustainalytics' ESG risk rating and BBB in MSCI's ESG rating, indicating a leading position in China's insurance industry. It was rated A- in the Carbon Disclosure Project, the highest rating obtained by a mainland China-based financial company. Ping An is dedicated to participating in global sustainable development initiatives. Ping An was the first asset owner signatory from China that joined UN-supported Principles for Responsible Investment network and Climate Action 100. It was also the first company in mainland China to sign up for the UNEP FI Principles for Sustainable Insurance.
Ping An said: "Driven by sustainable development strategies, Ping An integrates ESG core concepts and standards into enterprise management in all respects, striving to promote 'integrated finance + healthcare' services, and to create value for shareholders, customers, employees, partners, the community and the environment. In 2022, focusing on 'Integrated finance' and 'healthcare', Ping An will continue to build upon the strategy of 'finance + technology' and 'finance + ecosystem' to become a world-leading integrated financial and healthcare services provider."
The Sustainability Report was compiled in accordance with the Environmental, Social and Governance Reporting Guide of the Stock Exchange of Hong Kong Limited and by reference to Global Reporting Initiative Sustainability Reporting Standards, as well as the Sustainability Accounting Standards Board standards on Commercial Banks, Insurance and Asset Management & Custody Activities.
Click here for the Ping An 2021 Sustainability Report
About Ping An Group
Ping An Insurance (Group) Company of China, Ltd. ("Ping An") strives to become a world-leading retail financial services. With over 227 million retail customers and nearly 647 million internet users, Ping An is one of the largest financial services companies in the world. Ping An focuses on two over-arching domains of activity, "integrated finance" and "healthcare", covering the provision of financial and health care services through its integrated financial services platform and ecosystems in financial services, healthcare, auto services and smart city services. The "finance + technology" and "finance + ecosystem" strategies aim to provide customers and internet users with innovative and simple products and services using technology. As China's first joint stock insurance company, Ping An is committed to upholding the highest standards of corporate reporting and corporate governance. The Group is listed on the stock exchanges in Hong Kong and Shanghai. Ping An ranked 6th in the Forbes Global 2000 list in 2021 and ranked 16th in the Fortune Global 500 list in 2021. Ping An also ranked 49th in the 2021 WPP Kantar Millward Brown BrandZTM Top 100 Most Valuable Global Brands list.
For more information, please visit www.group.pingan.com and follow us on LinkedIn - PING AN.
View original content:
SOURCE Ping An Insurance (Group) Company of China, Ltd.
|
https://www.whsv.com/prnewswire/2022/04/11/ping-an-releases-2021-sustainability-report/
| 2022-04-11T12:25:00Z
|
MINNEAPOLIS, April 11, 2022 /PRNewswire/ - RBC Global Asset Management (U.S.) Inc. ("RBC GAM") today announced the launch of the RBC China Equity Fund ("the Fund") for U.S. investors looking for investment opportunities in China.
The RBC China Equity Fund aims to invest in businesses across a full spectrum of industries and sectors in China. The Fund is actively managed by Siguo Chen, Portfolio Manager, and Mayur Nallamala, Senior Portfolio Manager & Head of Asian Equities, both of whom are members of the RBC GAM's Asian Equity team in Hong Kong and employees of RBC Global Asset Management (Asia) Limited.
The Fund's investment team looks to invest in Chinese companies with reliable management and track records in risk management and capital allocation. The Fund is expected to invest primarily in common stocks, but may also invest in depositary receipts. This may include securities that trade in local Chinese, Hong Kong, or other exchanges and securities that trade in Renminbi ("RMB"), the official currency of China.
RBC's Asian Equity team has launched a total of 16 new funds across the globe from 2019-2021, and the RBC China Equity Fund will be the team's first mutual fund available to U.S. investors.
"We are excited to launch RBC GAM's first mutual fund that provides U.S. investors with the ability to invest in some of the most attractive companies in China," said Ms. Chen, who is lead manager of the Fund. "This strategy draws on the track record and expertise of our Asian Equity team as we aim to deliver positive outcomes to our clients."
The investment process of the RBC China Equity Fund is primarily based on fundamental research and RBC GAM's fund managers will assess the economic outlook for China and relevant markets, including expected growth, market valuations and economic trends, to position the fund. As part of the investment process, RBC GAM takes environmental, social and governance ("ESG") factors into account through an integrated approach within the investment team's fundamental investment analysis framework.
The RBC China Equity Fund is available in Class I, Class A, and Class R6 shares. The identifiers for the shares are listed below.
More information about RBC GAM's U.S. mutual funds can be found at https://us.rbcgam.com/mutual-funds/default.fs
Royal Bank of Canada is a global financial institution with a purpose-driven, principles-led approach to delivering leading performance. Our success comes from the 88,000+ employees who leverage their imaginations and insights to bring our vision, values and strategy to life so we can help our clients thrive and communities prosper. As Canada's biggest bank, and one of the largest in the world based on market capitalization, we have a diversified business model with a focus on innovation and providing exceptional experiences to our 17 million clients in Canada, the U.S. and 27 other countries. Learn more at rbc.com.
We are proud to support a broad range of community initiatives through donations, community investments and employee volunteer activities. See how at rbc.com/community-social-impact.
RBC Global Asset Management (RBC GAM) is the asset management division of Royal Bank of Canada (RBC) and includes money managers BlueBay Asset Management and Phillips, Hager & North Investment Management. RBC GAM is a provider of global investment management services and solutions to institutional, high-net-worth and individual investors through separate accounts, pooled funds, mutual funds, hedge funds, exchange-traded funds and specialty investment strategies. The RBC GAM group of companies manage approximately $580 billion in assets and have approximately 1,500 employees located across Canada, the United States, Europe and Asia.
BEFORE INVESTING, YOU SHOULD CAREFULLY CONSIDER A FUND's INVESTMENT OBJECTIVES, RISKS, CHARGES, AND EXPENSES. THIS AND OTHER INFORMATION IS IN THE PROSPECTUS, WHICH YOU CAN VIEW HERE: https://www.sec.gov/Archives/edgar/data/1272950/000119312522012493/d200657d485apos.htm. PLEASE READ THE PROSPECTUS CAREFULLY BEFORE INVESTING.
INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS COMMUNICATION SHALL NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER SECURITIES LAWS OF ANY SUCH STATE.
AN INDICATION OF INTEREST IN RESPONSE TO THIS ADVERTISEMENT WILL INVOLVE NO OBLIGATION OR COMMITMENT OF ANY KIND.
Mutual fund investing involves risk. Principal loss is possible. China Risk. Investing in securities economically tied to China may subject the Fund to a higher degree of risk of loss than investing in other countries or groups of countries because of the risks associated with, among other things, adverse securities markets, negative foreign currency rate fluctuations and social, political, regulatory, economic or environmental instabilities and natural disasters. The economy, industries, and securities and currency markets of China are particularly vulnerable to the region's dependence on exports and international trade and increasing competition from Asia's other low-cost emerging economies. Political, diplomatic, or regional conflicts, including the imposition of tariffs or other trade barriers by the U.S. or foreign governments on exports from China, may also have an adverse impact on Chinese issuers. In addition, currency fluctuations, currency convertibility, interest rate fluctuations and higher rates of inflation as a result of internal social unrest or conflicts with other countries have had, and may continue to have, negative effects on the economies and securities markets of Greater China. The government of the People's Republic of China ("PRC") exercises significant regulatory control over the economy in Mainland China, and may at any time alter or discontinue economic reforms. Taiwan and Hong Kong do not exercise the same level of control over their economies as does the PRC with respect to Mainland China, but changes to their political and economic relationships with the PRC could adversely impact the Fund's investments in Taiwan and Hong Kong. Investing Through Stock Connect Risk. Investing in China A Shares through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect ("Stock Connect") program is subject to trading, clearance, settlement, and other procedures, which could pose risks to the Fund. Trading through Stock Connect is subject to market-wide trading volume and market cap quota limitations, each of which may restrict or preclude the Fund's ability to invest in A Shares through Stock Connect. A primary feature of Stock Connect is the application of the home market's laws and rules applicable to investors in A Shares. Therefore, the Fund's investments in Stock Connect A Shares are generally subject to PRC securities regulations and listing rules, among other restrictions. Additionally, restrictions on the timing of permitted trading activity in A Shares, including the imposition of local holidays in either Hong Kong or Mainland China and restrictions on purchasing and selling the same security on the same day, may subject the Fund to the risk of price fluctuations of China A Shares at times when the Fund is unable to add to or exit its position. RMB Risk. The Fund may be subject to the risk of insufficient amounts of RMBs for the Fund to remain fully invested in Chinese equities. The Chinese government heavily regulates the domestic exchange of foreign currencies and RMB exchange rates in China, which may adversely affect the operations and financial results of the Fund's investments in China. Foreign and Emerging Markets Risk. The Fund invests in foreign securities, which involve greater volatility and political, economic, and currency risks, and differences in accounting methods. These risks may be greater in emerging markets. Non-Diversified Fund Risk. The Fund is non-diversified, which means it may concentrate its assets in fewer individual holdings than a diversified fund. Therefore, the Fund is more exposed to individual security volatility than a diversified fund. ESG Strategy Risk. The Fund's consideration of ESG factors could cause it to perform differently compared to funds that do not take ESG factors into account. These risks are described more fully in the prospectus.
RBC Global Asset Management (U.S.) Inc. is the Adviser for the RBC Funds. The Fund is sub-advised by RBC Global Asset Management (UK) Limited. The RBC Funds are distributed by Quasar Distributors, LLC. Securities are offered through RBC Wealth Management, a division of RBC Capital Markets, LLC, member NYSE/FINRA/SIPC.
NOT FDIC INSURED. NO BANK GUARANTEE. MAY LOSE VALUE.
RBC Global Asset Management (U.S.) Inc. is a federally registered investment adviser founded in 1983. RBC Global Asset Management is the asset management division of Royal Bank of Canada (RBC) and comprises the following affiliates, all of which are indirect wholly owned subsidiaries of RBC: RBC Global Asset Management (U.S.) Inc., RBC Global Asset Management Inc., RBC Global Asset Management (UK) Limited, RBC Global Asset Management (Asia) Limited, and BlueBay Asset Management LLP.
View original content to download multimedia:
SOURCE RBC Global Asset Management (U.S.)
|
https://www.whsv.com/prnewswire/2022/04/11/rbc-global-asset-management-launches-china-equity-fund/
| 2022-04-11T12:25:06Z
|
SALT LAKE CITY, April 11, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP) in patients who have previously undergone a colectomy/proctocolectomy. REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule inhibitor of MEK1 and MEK2 being developed to reduce polyp burden and progression to adenocarcinoma in FAP patients.
"The Fast Track designation for REC-4881 is an important addition to our work to rapidly develop this potential medicine to treat patients with FAP, for which there is significant unmet need," said Recursion Chief Medical Officer Ramona Doyle, M.D. "I am pleased that the team continues to advance this drug candidate towards a Phase 2 study to evaluate safety, pharmacokinetics and efficacy in FAP patients, for which we expect to begin enrolling patients in the third quarter of this year."
The FDA's Fast Track designation was established to expedite the review of investigational drugs to treat serious conditions and address unmet medical needs by enabling important drugs to get to patients earlier if approved. Fast Track designation can lead to more frequent interactions with the FDA, as well as Accelerated Approval and/or Priority Review eligibility if certain criteria are met.
Learn more about Recursion and view its pipeline at Recursion.com/pipeline.
REC-4881 is an orally bioavailable, non-ATP-competitive allosteric small molecule inhibitor of MEK1 and MEK2 being developed to reduce polyp burden and progression to adenocarcinoma in FAP patients. REC-4881 has been well tolerated in prior clinical studies, consistent with the intended use, and has a gut-localized PK-profile that may be advantageous for FAP, and potentially other APC-driven gastrointestinal tumors. REC-4881 has been granted Orphan Drug designation for FAP by the FDA. We expect to enroll the first patient in a Phase 2, double-blind, randomized, placebo-controlled basket trial in the third quarter of 2022.
FAP is a rare tumor syndrome with no approved therapies. In the US, France, Germany, Italy, Spain and the UK alone the disease affects approximately 50,000 patients. FAP is caused by autosomal dominant inactivating mutations in the tumor suppressor gene APC. FAP patients develop polyps in the gastrointestinal tract throughout their lives. These growths have a high risk of malignant transformation and can give rise to invasive cancers of the colon, stomach, duodenum, rectum, and other tissues. Standard of care for patients with FAP is colectomy, and without surgical intervention, affected patients will progress to colorectal cancer in adulthood. Even after colectomy, patients receive endoscopic surveillance every 6-12 months to monitor disease progression. While surgical management and surveillance have improved the prognosis for FAP patients, duodenal and desmoid tumors remain major causes of death following colectomy in patients with FAP.
Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion Operating System, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
The Company is proudly headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on Twitter and LinkedIn.
This press release contains information that includes or is based upon "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements provide our expectations or forecasts regarding future events. You can identify these statements by the fact they do not relate strictly to historical or current facts. They may use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, forward-looking statements include statements relating to intended future actions; plans with respect to clinical trials and preclinical activities; prospective products or product approvals; future performance or results of anticipated products or technology; expenses; our ability to obtain, maintain and enforce intellectual property protections; and financial results, in addition to other topics. Any or all of our forward-looking statements here and elsewhere may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements and from expected or historical results. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed. In particular, you should read the discussion in the "Risk Factors" section in our Prospectus filed with the U.S. Securities and Exchange Commission (SEC) on April 16, 2021 as well as in our Form 10-K filed with the SEC on March 23, 2022 and our other periodic filings with the SEC. Other factors besides those listed could also adversely affect the company. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future developments or otherwise, except to the extent required by applicable law. These forward-looking statements (except as may be otherwise noted) speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You are advised to consult any further disclosures we make on related subjects in our reports to the SEC.
View original content to download multimedia:
SOURCE Recursion
|
https://www.whsv.com/prnewswire/2022/04/11/recursion-is-granted-fast-track-designation-rec-4881-potential-treatment-familial-adenomatous-polyposis/
| 2022-04-11T12:25:12Z
|
Extensive portfolio enables Ribbon partners to deliver secure cloud migrations to rapidly growing UC platforms like Microsoft Teams and Zoom, while mitigating fraud and robocalls
PLANO, Texas, April 11, 2022 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software and IP Optical networking solutions to service providers, enterprises, and critical infrastructure sectors, today announced that it will be demonstrating key solutions at the Channel Partners Conference & Expo, April 11-14, in Las Vegas.
"Hybrid work is completely changing the basic tenets of business communications, and that will be on full display during this year's Channel Partners Conference," said Dave Hogan, Vice President Growth Segments at Ribbon. "Across the globe, Ribbon's channel partners are helping businesses facilitate the transition to hybrid work environments by making it easier for organizations to securely migrate to cloud-based communications for unified communications (UC) and contact centers."
Ribbon will be demonstrating its carrier-grade solutions that enable migrations to Microsoft Teams, Zoom Phone, and other leading cloud UC services globally. Additionally, Ribbon will highlight its ability to migrate and protect some of the world's largest contact center deployments. Ribbon's Session Border Controllers (SBCs) provide contact centers with multiple layers of security including against advanced denial-of-service attacks, which have become a major concern for contact centers.
In addition, Ribbon will highlight its Analytics solutions, which provide an enterprise-wide view of network performance and threats. As the number and sophistication of attacks on communications systems rise, Ribbon offers advanced protection from fraud and robocalls via its Voice Threat Prevention portfolio.
Hogan added, "We are working closely with our channel partners to help our customers across all industries, especially in regulated sectors like financial services and health care transition and secure their communications environments. Our partners are experts at delivering enterprise-wide our voice, security and analytics solutions to national and multi-national organizations, allowing them to gradually and seamlessly migrate legacy assets to secure cloud-based communications technology."
Ribbon is working with large Systems Integrators and Channel Partners in every global region to deliver these solutions including:
- Infosys – Ribbon and Infosys, a global leader in next-generation digital services and consulting, recently announced that the two companies are collaborating to deliver an integrated IT Managed Services offering to global enterprises. The integrated solution, which enables global enterprises to seamlessly migrate from legacy on-premise PBX communications systems to Microsoft Teams Phone System Direct Routing, has already been deployed by one of the world's largest automobile brands as part of their worldwide communications upgrade.
- TD Synnex – Ribbon recently expanded its relationship with TD Synnex, a Fortune 200 corporation and a leading provider of a comprehensive range of distribution, logistics and integration services for the technology industry, to add support for a wide range of enterprises, into the Caribbean and Latin America (CALA). TD Synnex is reselling Ribbon's Cloud and Edge portfolio of products. In addition to Ribbon's Microsoft-certified SBCs, the portfolio includes analytics, media gateways, policy and routing capabilities and an advanced application server platform.
- Westcon Comstor – Ribbon recently expanded its distribution agreement with Westcon-Comstor, to expand beyond covering Australia and New Zealand (ANZ) to several additional countries in the Asia-Pacific (APAC) region including Hong Kong, India, Indonesia, Japan, Malaysia, the Philippines, the PRC, Singapore, South Korea, Taiwan, Thailand, and Vietnam.
Visit Ribbon at Channel Partners at booth 2019.
About Ribbon
Ribbon Communications (Nasdaq: RBBN) delivers communications software, IP and optical networking solutions to service providers, enterprises and critical infrastructure sectors globally. We engage deeply with our customers, helping them modernize their networks for improved competitive positioning and business outcomes in today's smart, always-on and data-hungry world. Our innovative, end-to-end solutions portfolio delivers unparalleled scale, performance, and agility, including core to edge software-centric solutions, cloud-native offers, leading-edge security and analytics tools, along with IP and optical networking solutions for 5G. To learn more about Ribbon visit rbbn.com.
Important Information Regarding Forward-Looking Statements
The information in this release contains forward-looking statements regarding future events that involve risks and uncertainties. All statements other than statements of historical facts contained in this release, including those regarding the expected benefits of Ribbon's products and services, are forward-looking statements. The actual results of Ribbon Communications may differ materially from those contemplated by the forward-looking statements. For further information regarding risks and uncertainties associated with Ribbon Communications' business, please refer to the "Risk Factors" section of Ribbon Communications' most recent annual or quarterly report filed with the SEC. Any forward-looking statements represent Ribbon Communications' views only as of the date on which such statement is made and should not be relied upon as representing Ribbon Communications' views as of any subsequent date. While Ribbon Communications may elect to update forward-looking statements, Ribbon Communications specifically disclaims any obligation to do so.
View original content to download multimedia:
SOURCE Ribbon Communications Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/ribbon-showcases-comprehensive-solutions-portfolio-enabling-secure-hybrid-work-environments-channel-partners-conference-amp-expo/
| 2022-04-11T12:25:19Z
|
- Law firm launches associate firm in George Town, Grand Cayman – names it ChanceryESG
- Will focus on three pillars of the future economy: ESG, digital asset transactions and sanctions
LONDON, April 11, 2022 /PRNewswire/ -- Chancery Advisors Ltd (Chancery), the London-based go-to law firm for many of the world's leading hedge funds and investment banks, has today announced the launch of ChanceryESG, based in the Cayman Islands.
Dan Harris, a founding partner of Chancery Advisors who counsels many of the world's hedge fund billionaires, believes the time is right to offer joined-up thinking on ESG, digital asset transactions and sanctions. He commented:
"The siloed nature of most law firms prevents them from making the connection between ESG, digital asset transactions and sanctions. In practical terms, all three impact what, with whom, and how clients do business in the real economy and in the financial markets. They are increasingly part of the same conversation."
The question of what makes Cayman especially relevant to the future economy is interesting. Chancery believes that the constant framing of Cayman in tax terms, both by politicians scapegoating it and those defending its tax neutrality, is a tired war of attrition. While increasing fragmentation in the global economy is fast becoming a reality, ESG, digital asset transactions and sanctions seek to buck this trend. Important financial centres are already showing that these are now the three pillars of the future economy.
Harris continued: "We see Cayman through a different lens – as the clock ticks down on climate change, ESG needs capital with a short investment horizon. Digital assets need trading, not investment capital, to achieve sustained liquidity. Investment vehicles domiciled in Cayman, in contrast to many long only funds onshore, have the right kind of capital. Similarly, this capital is high quality capital. There is no sanctions arbitrage. Cayman tracks UK sanctions. This all means that Cayman will be front and centre in the future economy. ChanceryESG will be uniquely positioned to be the leading firm in this space"
Winston Connolly, a leading attorney in the Cayman Islands, will be senior partner of ChanceryESG. Connolly said: "The firm has the advantage of being able to build out a practice with the new economy in mind and be attuned to the needs of clients from day one. We are very excited by what the future holds for the firm."
View original content:
SOURCE Chancery Advisors
|
https://www.whsv.com/prnewswire/2022/04/11/sanctions-esg-digital-assets-cayman-islands-central-future-economy-says-chancery-advisors/
| 2022-04-11T12:25:25Z
|
NEW YORK, April 11, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today an amendment of the agreement with Phoenixus AG, formerly known as Vyera Pharmaceuticals AG ("Vyera"), for the development of SLS-002 (intranasal racemic ketamine) to repurchase in cash and stock the remaining royalties payable on any future net sales of SLS-002, all future success and commercial based milestones and the change of control fee in the event SLS-002 is acquired.
On March 6, 2018, Seelos entered into an asset purchase agreement (the "Purchase Agreement") with Vyera, currently known as Phoenixus AG, to acquire the assets and liabilities of Vyera's intranasal racemic ketamine program, which Seelos now calls SLS-002. As additional consideration to certain upfront cash and equity payments and success-based milestone payments contemplated under the prior agreement, Seelos agreed to pay a mid-teens percentage royalty on any future net sales of SLS-002. In February 2021, Seelos amended the asset purchase agreement, for three additional cash payments, agreeing to repurchase 9% of the future royalties and reduce its royalty obligations to a mid-single digit percentage on any future net sales of SLS-002. Seelos completed those payments in February, June, and September of 2021. Under the amendment entered into on April 8, 2022, for additional cash and stock payments due by April 2022, July 2022 and January 2023, the parties have agreed to terminate in full all contingent payment obligations to Vyera and its related entities under the Purchase Agreement, effective upon the payment and issuance of all cash and stock payments.
"We believe this repurchase of the remaining financial obligations owed or that may become payable on SLS-002 has the potential to return meaningful future value to Seelos' stockholders, assuming we are successful in the clinical development, regulatory approval processes, and commercialization of the intranasal ketamine program," said Raj Mehra, Ph.D., Chairman and CEO of Seelos.
"This amendment removes all future royalties due to Vyera, nearly $100 million of potential future milestones and a change of control fee in the event this program were to be acquired as a standalone transaction or as part of a larger transaction," said Michael Golembiewski, CFO of Seelos.
About SLS-002
SLS-002 is intranasal racemic ketamine with two investigational new drug applications for the treatment of Acute Suicidal Ideation and Behavior in Major Depressive Disorder or Post-Traumatic Stress Disorder. SLS-002 was originally derived from a Javelin Pharmaceuticals, Inc./Hospira, Inc. program with 16 clinical studies involving approximately 500 subjects. SLS-002 looks to address an unmet need for a therapy to treat suicidality in the U.S. Traditionally, anti-depressants have been used in this setting but many of the existing treatments are known to contribute to an increased risk of suicidal thoughts in some circumstances, and if they are effective, it often takes weeks for the full therapeutic effect to be manifested. The clinical development program for SLS-002 included two parallel healthy volunteer studies (Phase I) and is being followed by pivotal registration studies after meeting with the FDA. Based on information gathered from the databases of the Agency for Healthcare Research and Quality, there were more than 1,000,000 visits to emergency rooms for suicide attempts in 2019 in the U.S. alone. Experimental studies suggest ketamine has the potential to be a rapid, effective treatment for depression and suicidality.
About Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare diseases. The Company's robust portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior (ASIB) in Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD), amyotrophic lateral sclerosis (ALS), spinocerebellar ataxia (SCA), Sanfilippo syndrome, Parkinson's Disease, other psychiatric and movement disorders plus orphan diseases.
For more information, please visit our website: http://seelostherapeutics.com, the content of which is not incorporated herein by reference.
Forward Looking Statements
Statements made in this press release, which are not historical in nature, constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements include, among others, those regarding the ability of the royalty repurchase to return meaningful future value to Seelos stockholders, and Seelos' ability to succeed in the clinical development, regulatory approval processes and commercialization of its intranasal ketamine program (SLS-002). These statements are based on Seelos' current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks associated to Seelos' business include, but are not limited to, the risk of not successfully executing its preclinical and clinical studies, and not gaining marketing approvals for its product candidates, the risk that prior clinical results may not be replicated in future studies and trials, the risks that clinical study results may not meet any or all endpoints of a clinical study and that any data generated from such studies may not support a regulatory submission or approval, the risks associated with the implementation of a new business strategy, the risks related to raising capital to fund its development plans and ongoing operations, risks related to Seelos' current stock price, risks related to the global impact of COVID-19, as well as other factors expressed in Seelos' periodic filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise. We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Contact Information
Anthony Marciano
Chief Communications Officer
Seelos Therapeutics, Inc. (Nasdaq: SEEL)
300 Park Avenue, 2nd Floor
New York, NY 10022
(646) 293-2136
anthony.marciano@seelostx.com
www.seelostherapeutics.com
https://twitter.com/seelostx
https://www.linkedin.com/company/seelos
Mike Moyer
Managing Director
LifeSci Advisors, LLC
250 West 55th St., Suite 3401
New York, NY 10019
(617) 308-4306
mmoyer@lifesciadvisors.com
View original content to download multimedia:
SOURCE Seelos Therapeutics, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/seelos-therapeutics-announces-amendment-sls-002-agreement-repurchase-remaining-royalties-payable-phoenixus-ag-sls-002-intranasal-racemic-ketamine-program-all-future-success-commercial-based-milestones-change-control-fee/
| 2022-04-11T12:25:31Z
|
NEW YORK, April 11, 2022 /PRNewswire/ -- SportsGrid, the nation's first and only 24-hour streaming video network serving the massive sports wagering audience, announced today the debut of the NewsWire weekday news program on Tuesday, April 12th streaming live from 2-3 PM ET. NewsWire is a sixty-minute live sports wagering news program anchored by journalist and longtime broadcast TV veteran Craig Mish. NewsWire will feature the most important headlines, events, and storylines of the day providing comprehensive reporting on matters pertaining to sports betting. The weekday news program will have exclusive access to breaking news, sports betting legislation, sportsbook operator news, technology, and actionable insights from The Sporting News and Legal Sports Report's world-class editorial teams.
"NewsWire is based on two tenets —perspective and authority. Both tenets are supported by the strategic content alliance between SportsGrid, The Sporting News, and Legal Sports Report delivering the relevant daily news with insightful and authentic analysis to the sports betting audience base across the nation," said Jason Sukhraj, GM of Audience & Syndication at SportsGrid.
The SportsGrid strategic content alliance with The Sporting News and Legal Sports Report is a collaborative initiative bringing together the strategy, reporting, and editorial resources of each media organization. The SportsGrid content alliance integrates The Sporting News and Legal Sports Report's journalists and reporters contributing to NewsWire to develop a reputable world-class editorial platform. Digital technologies have fundamentally changed how SportsGrid's video content is created, presented, and distributed across multimedia platforms. Through the editorial management of effective collaboration and workflow coordination, the SportsGrid strategic content alliance will break news with deep editorial insights, analysis, and perspective.
"The Sporting News is thrilled to partner with SportsGrid on the launch of the NewsWire. The Sporting News has a strong heritage of going beyond the score to deliver insight, analysis, and context on the biggest stories in sports. We're excited for the opportunity for our award-winning journalists to offer their perspective to the NewsWire audience, and to be a part of SportsGrid's broad multimedia platforms," said Benson Taylor, global Editor-in-Chief for The Sporting News.
"The Legal Sports Report team is excited to collaborate with SportsGrid on a program focused on the business of sports betting in North America," said Dustin Gouker, Publisher for Legal Sports Report. "LSR's journalists will provide viewers with valuable insight into the ins and outs of the sports gambling industry as it expands across the US and Canada."
ABOUT SPORTSGRID INC.
SportsGrid, Inc. is
multimedia content and technology company providing digital innovative solutions for the convergence of sports content, gaming, and NextGen interactive video technology. The SportsGrid multimedia destinations include SportsGrid Streaming Video Network, SportsGrid Radio, SportsGrid.com, DailyRoto, and SportsGrid Studios. SportsGrid intelligence and data are provided by Sportradar featuring the seamless integration of their real-time comprehensive data feeds and content solutions. For more information, please visit sportsgrid.com.
ABOUT THE SPORTING NEWS
One of world's most iconic sports brands, The Sporting News was founded in 1886 and is the oldest sporting publication in the United States. Today, the brand is a dynamic digital publisher offering a trusted perspective across multiple sports all over the world leveraging a global network that understands local nuance. The Sporting News now features localized editions in the U.S., Canada, Mexico, Argentina, U.K., Spain, India, Malaysia, Singapore, Hong Kong, Japan, Australia and New Zealand. The brand's independence and credibility make it a leading destination for fans and a key partner for leagues and broadcasters around the globe. Today, The Sporting News is the official destination of the NBA in leading markets in the Americas and APAC, a premium publishing partner of fuboTV, DAZN, and Kayo, and the brand over 35 million users trust for their sports content every month.
ABOUT LEGAL SPORTS REPORT
LegalSportsReport.com covers the legal online sports wagering industry, including sports betting sites and daily fantasy sports in the US. LSR is produced by the team behind Online Poker Report, which covers the regulated online poker industry; PlayNJ.com, which covers the regulated NJ online casino industry; and PlayUSA.com, which covers the broader US gambling industry.
MEDIA CONTACT:
Charles Theiss
SportsGrid, Inc.
charles@sportsgrid.com
View original content to download multimedia:
SOURCE SportsGrid
|
https://www.whsv.com/prnewswire/2022/04/11/sportsgrids-newswire-debut-april-12th/
| 2022-04-11T12:25:37Z
|
Fully managed, cloud-based data lake leverages AWS Blockchain technology to ensure data integrity while enabling faster, automated workflows
PHILADELPHIA, April 11, 2022 /PRNewswire/ -- Staircase, the company building an integrated, digital infrastructure to accelerate tech-enabled mortgages, has launched Staircase Persistence, a fully managed, cloud-based data lake and immutable ledger that leverages AWS Blockchain technology to help lenders store and manage mortgage data. When combined with other Staircase products, Staircase Persistence allows lenders and their partners to share verified, high-confidence data while enabling faster automated workflows.
Available through a single REST API, Staircase Persistence maintains a client's mortgage data in its native format and quickly delivers results in simple, easy-to-use structures. Staircase Persistence helps companies manage the complexity of data points used by their different partners by grouping data into sets, such as transactions, collections, blobs, and client accounts. Data stored through Staircase Persistence can later be used for machine learning-trained data extraction and other mortgage processes, as well as translating data into different languages.
Staircase Persistence also uses AWS Blockchain technology to make certain the relationships between data and the sources of that data are kept intact. Ultimately, Staircase Persistence allows mortgage lenders, servicers and their partners to work faster while maintaining high confidence in data security and integrity. The technology is also easy to utilize: Staircase clients don't have to learn how to use Staircase Persistence—the product is available for any company that uses Staircase products—and Staircase simply stores and manages the data for its clients.
"Few industries deal with a greater volume data from different sources than the mortgage industry, but data is too often the industry's Achilles heel," said Soofi Safavi, Staircase cofounder and CTO. "For too long, there hasn't been a simple way to store and access 'big data' in ways that make it easier to perform any of the myriad processes that occur throughout the mortgage lifecycle. With Staircase Persistence, any mortgage industry participant—whether a lender, software company or third-party service provider—can store and use data in ways that work best for them."
Staircase Persistence follows the recent launch of Staircase Language, which enables any company in the mortgage industry to instantly translate data from any data language into another language using a single line of code. As a result, Staircase Language empowers lenders, servicers, software companies and third-party service providers to work seamlessly with each other without having to change their own data language.
About Staircase
Staircase is an API and low-code marketplace which automates complex technologies and makes them self-serve for the U.S. residential mortgage industry. Focused on providing automation for complicated mortgage functions, it allows for the integration and orchestration of all U.S. mortgage industry technology providers and enables all parties throughout mortgage origination, insurance, and servicing to easily communicate with zero friction. Staircase is based in Philadelphia, with employees in over 20 countries. For more information, visit www.staircase.co.
PRESS CONTACT:
For Staircase
Mary McGarity
Strategic Vantage Marketing and Public Relations
(203)260-5476
MaryMcGarity@StrategicVantage.com
View original content:
SOURCE Staircase
|
https://www.whsv.com/prnewswire/2022/04/11/staircase-persistence-launched-help-mortgage-companies-overcome-big-data-struggles/
| 2022-04-11T12:25:44Z
|
GREENSBORO, N.C., April 11, 2022 /PRNewswire/ -- Tanger Factory Outlet Centers, Inc. (NYSE:SKT), a leading operator of upscale open-air outlet centers, announced today that its Board of Directors approved a 9.6% increase in the annual dividend on its common shares from $0.73 per share to $0.80 per share. Simultaneously, the Board of Directors declared a quarterly cash dividend of $0.20 per share, payable on May 13, 2022, to common shareholders of record on April 29, 2022.
Tanger Factory Outlet Centers, Inc. (NYSE: SKT) is a leading operator of upscale open-air outlet centers that owns, or has an ownership interest in, a portfolio of 36 centers. Tanger's operating properties are located in 20 states and in Canada, totaling approximately 13.6 million square feet, leased to over 2,600 stores operated by more than 600 different brand name companies. The Company has more than 41 years of experience in the outlet industry and is a publicly-traded REIT. For more information on Tanger Outlet Centers, call 1-800-4TANGER or visit the Company's website at www.tangeroutlets.com.
Doug McDonald
SVP, Finance and Capital Markets
T: (336) 856-6066
doug.mcdonald@tangeroutlets.com
View original content to download multimedia:
SOURCE Tanger Factory Outlet Centers, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/tanger-increases-dividend-by-96/
| 2022-04-11T12:25:50Z
|
67% of Americans believe that misinformation and disinformation cause confusion and is a serious threat to the fabric of American society (Pew Research Center).
OAHU, Hawaii, April 11, 2022 /PRNewswire/ -- TDX International, LLC (TDXi), an Alaska Native Corporation based on Oahu, Hawaii, announces the establishment of a new National Innovation Center initiative with The Maryland Center at Bowie State University, a Historically Black College and University (HBCU), to perform Research & Development (R&D) projects aimed at countering misinformation and disinformation and associated negative consequences.
The new Bowie State University Influence Operations National Innovation Center (BIONIC) initiative includes strategic partners Forward Edge-AI, Inc., a minority-owned small business located in San Antonio, Texas, Greer Institute for Leadership and Innovation, a minority-owned small business nonprofit located in Washington D.C., and the nonprofit NineTwelve Institute headquartered in Indiana.
The goal of the BIONIC initiative is to leverage research in Artificial Intelligence, Publicly Available Information, and cognitive/human behavioral sciences to combat adverse misinformation campaigns.
Ken Spedden, General Manager for TDXi stated:
It is a blessing and honor to have co-created the BIONIC initiative in collaboration with our strategic partners. In the last three to five years, we have witnessed an unprecedented and exponential period of growth in misinformation/disinformation campaigns aimed at degrading our National Security posture as well as the social and moral fabric of our country. The BIONIC initiative propels Bowie State University to the front lines of new research and development in this critical area of national need. Equally important, this initiative is expected to have a correlative positive impact by creating new opportunities for the students and faculty of BSU, and potentially other HBCU's, to participate in new internships, apprenticeships, and career opportunities in advanced technology and science fields. The BIONIC initiative is expected to lead to research funding that aids both continuing education and the application of student ingenuity and brilliance toward solving real-world problems like misinformation/disinformation.
The BIONIC initiative also provides BSU with the opportunity to open a gateway for HBCU participation at the Hawai'i Pacific Innovation Campus (HI-PIC). The HI-PIC is an Oahu-based Independent Test Organization dedicated to supporting the growth of a robust innovation district in Hawai'i. The HI-PIC's focus is on bringing leading-edge technology and innovation together to solve hard problems and train the next generation of technologists for high-tech jobs. The HI-PIC is currently supporting the Department of Defense in the Indo-Pacific bringing together cutting-edge technologies and partners to address strategic challenges.
Mr. Spedden further noted, "The funding that can be realized through the BIONIC initiative will not only support students and important research at BSU, but it can also positively impact the university students, citizens, and regional economy of Hawai'i where the HI-PIC is physically located."
Chief Executive Officer for TDX Corporation, Mr. Christopher Mandregan Jr, added, "The management and employees of TDX Corporation and its subsidiaries truly understand the importance of engaging underserved populations, and to be able to do so as part of a program that will improve our national security posture is a win-win for all involved. We look forward to working closely with our partners on this initiative to address the critical challenges that confront us on the community, regional, and national levels."
About TDX International Corporation: TDX International, LLC (TDXi), is a Small Business Administration certified Alaska Native small business subsidiary of TDX Corporation located on Oahu, Hawaii and headquartered in Anchorage, Alaska. The mission of TDXi is to leverage its expertise in mission analytics, security solutions, and applied innovation to support national security priorities of the United States as well as create economic opportunities and protect our land for all Unangan descendants of St. Paul Island; and for the communities where our employees work and live.
About Bowie State University: Bowie State University is a public historically Black university in Prince George's County, Maryland, north of Bowie. It is part of the University System of Maryland. Founded in 1865, Bowie State is Maryland's oldest historically Black university and one of the ten oldest in the country.
About NineTwelve Institute: The NineTwelve Institute is a nonprofit organization committed to solving critical challenges by acting and driving innovation through cross sector collaborations with government, industry, and academia. Fueled by mission-driven subject matter experts in technologies including microelectronics, 5G, advanced manufacturing, unconventional energy, hypersonics, space, and cybersecurity, NineTwelve is dedicated to job creation, sustainable economic development and making the world a better place now and in the future.
View original content to download multimedia:
SOURCE TDX Corporation Alaska
|
https://www.whsv.com/prnewswire/2022/04/11/tdx-international-announces-bionic-initiative-combat-misinformation-disinformation/
| 2022-04-11T12:25:59Z
|
PHOENIX, April 11, 2022 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the "Company"), a leading provider of debt and equipment financing to venture capital backed growth stage companies, today announced the appointment of Rob Lake as Managing Director, Life Sciences in San Diego, California. Mr. Lake, a veteran in the venture ecosystem, has been supporting venture capital-backed growth stage companies for 18+ years. Focused primarily on the life sciences industry, Lake has funded over $1.6 billion in debt transactions during his career.
"We are excited to welcome Rob to Trinity. His robust experience in the venture ecosystem and notable contributions in the life sciences sector will make him a valuable member of our team as we continue to grow our portfolio," said Kyle Brown, President and Chief Investment Officer of Trinity Capital.
Mr. Lake joins Trinity Capital from Runway Growth Capital, where he founded and built their life sciences practice and served as Managing Director, Head of Life Sciences since 2020. Previously, Mr. Lake was with Bridge Bank, a division of Western Alliance Bank, where he founded and grew the bank's life sciences practice. Prior to that, Mr. Lake was an executive director at Oxford Finance, LLC, and has also held leadership positions at Silicon Valley Bank, Fifth Third Bank, FINOVA Capital Corporation, and the American Medical Association.
"I am thrilled to be joining a best-in-class origination team as they continue to build out a life sciences portfolio," Mr. Lake said. "Trinity Capital is a trusted partner in the space, and I look forward to playing a role in advancing Trinity's impressive track record."
About Trinity Capital Inc.
Trinity Capital (Nasdaq: TRIN), an internally managed specialty lending company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, is a leading provider of debt, including loans and equipment financing, to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth stage companies.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties, including the impact of the COVID 19 pandemic on the economy, financial markets, our business, our portfolio companies and our industry. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission ("SEC"). The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release. More information on risks and other potential factors that could affect the Company's financial results, including important factors that could cause actual results to differ materially from plans, estimates or expectations included herein or on the webcast/conference call, is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed annual report on Form 10-K and subsequent SEC filings.
View original content to download multimedia:
SOURCE Trinity Capital Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/trinity-capital-inc-further-expands-origination-team-with-industry-veteran-rob-lake/
| 2022-04-11T12:26:06Z
|
The Tampa Bay Times has selected its Top Places to Work for 2022 and Vantagepoint A.I. is in the Top 10 of Small Businesses.
WESLEY CHAPEL, Fla., April 11, 2022 /PRNewswire/ -- Vantagepoint A.I., LLC (www.vantagepointsoftware.com) continues to be recognized for its outstanding workplace culture. The Tampa Bay Times has named the company one of the top small businesses in the Tampa Bay region for the 5th year in a row. This year, Vantagepoint A.I. has been named one of the Top 10 small businesses in one of the hottest growing regions for business in the U.S.
While also receiving accolades for its strong growth, the Tampa Bay Times award is based on input from the company's employees. The Vantagepoint team has responded to the Times' survey with a massively positive response about the workplace culture, benefits, and company leadership.
"Our team told the Times that Vantagepoint feels like a family which means the world to me," says Lane Mendelsohn, President of Vantagepoint A.I., "we do everything we can to support them and keep them safe – while we remain working remotely my team still maintains our culture with a healthy mix of fun."
The positive work atmosphere reinforces Vantagepoint's core values of teamwork, communication, innovation, positivity, purpose, integrity, and respect. These set the tone for every action and decision at Vantagepoint A.I. and naturally spill over to how traders are treated.
Vantagepoint A.I. was the first company in the world to give independent traders the power of A.I. for their home computers. Since its inception in 1979, Vantagepoint has worked to empower traders in over 160 countries. With the release of its software in 1983, the company has given traders the ability to see global intermarket relationships and predictive market forecasts up to three days in advance with up to 87.4% proven accuracy based on its patented artificial intelligence processes. Easy-to-use, VantagePoint gives traders reliable information to make trading decisions in just minutes a day.
About Vantagepoint AI, LLC. VantagePoint AI software forecasts Stocks, Futures, Cryptocurrencies, Forex, and ETFs. Family owned and operated, Vantagepoint employs over 90 team members and is actively committed to giving back in the Tampa Bay community. The company regularly donates a portion of revenue to Shriners Hospitals for Children and The Children's Cancer Center. Schedule a demonstration at www.vantagepointsoftware.com/demo
Media contact: Lisa Moretti, lisam@vantagepointsoftware.com
View original content to download multimedia:
SOURCE Vantagepoint AI, LLC
|
https://www.whsv.com/prnewswire/2022/04/11/vantagepoint-ai-named-top-place-work-5th-year-row/
| 2022-04-11T12:26:17Z
|
BEIJING, April 11, 2022 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral Internet data center services provider in China, announced that its Board of Directors (the "Board") has recently received an unsolicited preliminary non-binding proposal letter (the "Proposal") from The Hina Group and Industrial Bank Co., Ltd., Shanghai Branch, proposing to acquire all of the outstanding ordinary shares of the Company for US$8.00 in cash per American depositary share, or approximately US$1.3333 per ordinary share.
The Board cautions the Company's shareholders and others considering trading the Company's securities that the Board has just received the Proposal and has not made any decisions with respect to the Proposal. There can be no assurance that any definitive offer will be made, that any agreement will be executed or that the proposed transaction or any other transaction will be approved or consummated.
The Company does not undertake any obligation to provide any updates with respect to the Proposal or any other transaction, except as required under applicable law.
Additional Information about the Proposal
About VNET
VNET Group, Inc. is a leading carrier- and cloud-neutral Internet data center services provider in China. VNET provides hosting and related services, including IDC services, cloud services, and business VPN services to improve the reliability, security, and speed of its customers' internet infrastructure. Customers may locate their servers and equipment in VNET's data centers and connect to China's internet backbone. VNET operates in more than 30 cities throughout China, servicing a diversified and loyal base of over 6,500 hosting and related enterprise customers that span numerous industries ranging from internet companies to government entities and blue-chip enterprises to small- to mid-sized enterprises.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "target," "believes," "estimates" and similar statements. Among other things, quotations from management in this announcement as well as VNET's strategic and operational plans contain forward-looking statements. VNET may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about VNET's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: VNET's goals and strategies; VNET's expansion plans; the expected growth of the data center services market; expectations regarding demand for, and market acceptance of, VNET's services; VNET's expectations regarding keeping and strengthening its relationships with customers; VNET's plans to invest in research and development to enhance its solution and service offerings; and general economic and business conditions in the regions where VNET provides solutions and services. Further information regarding these and other risks is included in VNET's reports filed with, or furnished to, the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of this press release, and VNET undertakes no duty to update such information, except as required under applicable law.
Investor Relations Contact:
Xinyuan Liu
Tel: +86 10 8456 2121
Email: ir@vnet.com
View original content:
SOURCE VNET Group, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/vnet-receives-unsolicited-preliminary-non-binding-proposal-acquire-all-its-shares/
| 2022-04-11T12:26:24Z
|
SINGAPORE, April 11, 2022 /PRNewswire/ -- Algorand, the leading blockchain network for processing fast, final transactions, announces a strategic decision to be integrated with the WadzPay Atlytica engine. WadzPay will leverage Algorand to develop new blockchain-based solutions for its network of partners across governments, financial institutions, issuers, acquirers, and processors.
While blockchain solutions are gaining in awareness and relevance as a technological means to solve legacy payment pain points, real world use cases and implementations are still lagging behind. The WadzPay team–which collectively brings over 250 years of experience from corporations including Mastercard, Visa, SWIFT, Ripple and GE Capital–believes that by working with Algorand to implement its leading blockchain technology on WadzPay's already in-progress projects, they will be able to supercharge adoption in the payments space.
The near-term scope for collaboration includes, but is not limited to: integrating WadzPay's digital wallet ecosystem with the Algorand blockchain; exploring white-labelled solutions focusing on real-time POS payments, wallet and e-Commerce products for WadzPay and its customers; leveraging Algorand for remittances where licensed exchange houses or digital banks in various corridors are using WadzPay's suite of services; reinventing loyalty by introducing tradable programs on both permissioned and hybrid blockchain networks, aimed at attracting coalition plays; and utilising the Algorand network for novel gaming and NFT projects.
There are multiple proof of concept-stage projects that WadzPay will utilise Algorand for, including Asia and Africa-based CBDC launches, which will accelerate this blockchain adoption drive.
WadzPay has identified Algorand as an ideal partner for the applications it develops due to the network's leading transaction speeds, near-instant finality, and unrivalled stability; attributes which are vital for seamless payments.
These projects complement existing programs that WadzPay has launched or currently developing including a digital currency acceptance program with real money gaming operator, Dafabet; a cross-border payments program for an acquirer, integrated with over 500,000 POS terminals; a play-to-earn NFT gaming platform, Frontera; decentralised email solution LedgerMail; and, integration with six major e-Commerce CMS platforms enabling digital currency acceptance at up to 6.5 million stores.
As a blockchain-agnostic company, WadzPa will also develop a bridge allowing the WadzPay Token (WTK) to be interoperable across ERC-20, BSC, XDC Network and Algorand.
"WadzPay and Algorand speak the same language when it comes to payments. Our innovative approach to payments, loyalty programs, and interoperability between legacy and next generation payment ecosystems is completely synchronised. WadzPay is looking forward to adding value to Algorand by bringing years of our expertise in the payment and technology spaces, while providing our partners with best in class solutions enabled by the solutions that we will co-create with the fantastic Algorand team," Anish Jain, Managing Director & CEO - WadzPay.
"WadzPay has an impressive team with unparalleled experience and a vast network of partners and clients in the finance and corporate sectors across Southeast Asia, The Middle East and Africa. Together with WadzPay, we will help these entities design and deploy extraordinary business models, predicated on efficiency, access and inclusion", said Giuliana Berchicci, Head of New Markets at Algorand. "We look forward to collaborating with WadzPay to extend the benefits of Algorand's protocol to the institutions and people of these vibrant and highly innovative regions."
WadzPay is an interoperable and agnostic blockchain-based payments ecosystem. The company was founded in 2018 in Singapore and is currently operating in Southeast Asia, South Asia, the Middle East and Africa. WadzPay saw the potential for CBDC and Digital Assets to lead the next revolution in the payments industry: enabling faster payments, improvements in security, and cost-efficiency with optionality. WadzPay is working with large international payment companies, banks, and global companies to enable digital asset-based transaction processing and settlement.
Founded by Turing Award–winning cryptographer Silvio Micali, Algorand's high–performing Layer-1 blockchain is unparalleled for bringing fast, frictionless, and inclusive technologies to everyone. Algorand is reshaping every industry–from TradFi and DeFi to new creator economies and beyond. With an extraordinary commitment to interoperability and consistent delivery, its sustainable technology powers more participation, transparency, and efficiency for all. As the technology of choice for 2000+ global organizations, the Algorand ecosystem is transforming the next generation of financial products, protocols and exchange of value. For more information, visit www.algorand.com.
Media Contact
Francisca Adinda
Vice President of PR & Communication, WadzPay
francisca.adinda@wadzpay.com
+6281290111429
View original content to download multimedia:
SOURCE Algorand
|
https://www.whsv.com/prnewswire/2022/04/11/wadzpay-selects-algorand-power-digital-asset-payments-revolution-its-partner-network-governments-financial-institutions-issuers-beyond/
| 2022-04-11T12:26:31Z
|
The top 5 novelty brand is the first to launch Mochi with Greek Yogurt
BOULDER, Colo., April 11, 2022 /PRNewswire/ -- Yasso, the beloved frozen greek yogurt brand and #5 novelty brand is launching the first-ever frozen Greek yogurt Mochi, furthering its position as a leader in frozen snacking and continuing to deliver new innovation that meets consumers' demands on both taste and nutrition.
Yasso's latest innovation is made with deliciously creamy frozen Greek yogurt wrapped in fluffy, sweet rice dough. Available in four flavors, chocolate, mango, vanilla, and strawberry, each individual Mochi is just 80 calories. Staying true to Yasso's standards, the product has no artificial ingredients, is gluten free, and packs big flavor.
"The launch of Yasso Mochi furthers our position as a leader in frozen snacking as we continue to innovate outstanding new products that marry superior taste and quality nutrition," said Craig Shiesley, Chief Executive Officer of Yasso. "This new platform allows consumers to reach for Yasso during new occasions and delivers on our brand promise of permissible indulgence, now in a new snackable format."
Throughout the brand's 10-year tenure, Yasso's prioritization of consumer satisfaction and innovation has proven successful as it continues to climb in brand rank and outpace other novelty brands' growth.
Yasso Mochi (SRP $5.49 per 6-pack) is available at select retailers nationwide and for online delivery on yasso.com. To find a store near you, or learn more information please visit Yasso.com and follow the brand @yasso.
About Yasso
Kindergarten friends turned entrepreneurs, founders Drew Harrington and Amanda Klane set out on a mission to create desserts that deliver on everyday indulgence with great taste, quality ingredients and superb nutritionals. Since hitting store shelves in 2011 as the first to market frozen Greek yogurt, Yasso quickly became one of the fastest-growing dessert brands in the world, disrupting the brand ranks of deeply entrenched competitors and attracting a loyal following of brand enthusiasts. Yasso currently offers 11 flavors of novelty stick bars, four flavors of dipped chocolate bars, three frozen Greek yogurt sandwiches, three flavors of bite-size Yasso Poppables and four Yasso Mochi, all of which can be found at grocery and club stores nationwide. In 2021, Yasso Inc was named one of the Best Places to Work by Inc. and Denver Business Journal in addition to garnering a spot on Inc.'s 2021 list of the 5000 Fastest Growing Companies in America. Yasso is also an active, positive contributor to the community via its Game On! Foundation which inspires health and wellness for people of all ages. To find your local retailers and to learn more about Yasso, please visit www.yasso.com and follow @yasso.
Contact:
Nicole Albert
yasso@azionepr.com
View original content to download multimedia:
SOURCE Yasso Frozen Greek Yogurt
|
https://www.whsv.com/prnewswire/2022/04/11/yasso-continues-pioneer-snacking-category-with-launch-frozen-greek-yogurt-mochi/
| 2022-04-11T12:26:38Z
|
Average US gas price drops 10 cents to $4.27 per gallon
CAMARILLO, Calif. (AP) — The average U.S. price of a gallon of regular-grade gasoline dropped 10 cents over the past two weeks to $4.27 per gallon as oil prices continue to “yo-yo,” industry analyst Trilby Lundberg said Sunday.
The price at the pump was $1.32 above what it was one year ago, according to the Lundberg Survey taken Friday.
Nationwide, the highest average price for regular-grade gas was in Los Angeles, at $5.85 per gallon. The lowest average was in Tulsa, Oklahoma, at $3.52 per gallon.
According to the survey, the average price of diesel was $5.13 per gallon, down 2 cents over two weeks.
Lundberg said prices dropped dramatically in the past two weeks, in part because higher prices reduced demand during the second half of March.
However, the drop isn’t predictive of further declines because among other things, the global oil supply is tight due to a dip in output last month by OPEC, Lundberg said.
The war in Ukraine also has sparked global uncertainty. The U.S. has banned all Russian energy supplies but Lundberg said sanctioned Russian oil is still finding “big buyers like India and China happy to pay discount prices.”
In a bid to reduce spiking energy prices, President Joe Biden last month ordered the release of 1 million barrels of oil per day from the nation’s strategic petroleum reserve for six months.
On Thursday, the International Energy Agency said that its member countries are releasing 60 million barrels of oil from their emergency reserves on top of previous United States pledges.
The Paris-based organization says the new commitments made by its 31 member nations, which include the U.S. and much of Europe, amount to a total of 120 million barrels over six months, the largest release in the group’s history.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.whsv.com/2022/04/11/average-us-gas-price-drops-10-cents-427-per-gallon/
| 2022-04-11T12:26:45Z
|
Once a retail giant, Kmart will be down to 3 stores after NJ closing
AVENEL, N.J. (AP) — The familiar sights and sounds are still there: the scuffed and faded floor tiles, the relentless beige-on-beige color scheme, the toddlers’ clothes and refrigerators and pretty much everything in between.
There’s even a canned recording that begins, “Attention, Kmart shoppers” — except it’s to remind folks about COVID-19 precautions, not to alert them to a flash sale over in ladies’ lingerie like days of old.
Many of the shelves are bare, though, at the Kmart in Avenel, New Jersey, picked over by bargain hunters as the store prepares to close its doors for good April 16.
Once it shutters, the number of Kmarts in the U.S. – once well over 2,000 – will be down to three last holdouts, according to multiple reports, in a retail world now dominated by Walmart, Target and Amazon.
The demise of the the store in the middle-class suburb, 15 miles south of New York City, is the tale of the death of the discount department store writ small.
“You’re always thinking about it because stores are closing all over, but it’s still sad,” said cashier Michelle Yavorsky, who said she has worked at the Avenel store for 2 ½ years. “I’ll miss the place. A lot of people shopped here.”
In its heyday, Kmart sold product lines endorsed by celebrities Martha Stewart and Jaclyn Smith, sponsored NASCAR auto races and was mentioned in movies including “Rain Man” and “Beetlejuice.” It was name-dropped in songs by artists from Eminem to the Beastie Boys to Hall and Oates; in 2003, Eminem bought a 29-room, suburban Detroit mansion once owned by former Kmart chairman Chuck Conaway.
The chain cemented a place in American culture with its Blue Light Specials, a flashing blue orb affixed to a pole that would beckon shoppers to a flash sale in progress. Part of its success was due to its early adoption of layaway programs, which allowed customers who lacked credit to reserve items and pay for them in installments.
For a time, Kmart had a little bit of everything: You could shop for your kids’ back-to-school supplies, get your car tuned up and grab a meal without leaving the premises.
“Kmart was part of America,” said Michael Lisicky, a Baltimore-based author who has written several books on U.S. retail history. “Everybody went to Kmart, whether you liked it or not. They had everything. You had toys. You had sporting goods. You had candy. You had stationery. It was something for everybody. This was almost as much of a social visit as it was a shopping visit. You could spend hours here. And these just dotted the American landscape over the years.”
Kmart’s decline has been slow but steady, brought about by years of falling sales, changes in shopping habits and the looming shadow of Walmart, which coincidentally began its life within months of Kmart’s founding in 1962.
Struggling to compete with Walmart’s low prices and Target’s trendier offerings, Kmart filed for Chapter 11 bankruptcy protection in early 2002 — becoming the largest U.S. retailer to take that step — and announced it would close more than 250 stores.
A few years later, hedge fund executive Edward Lampert combined Sears and Kmart and pledged to return them to their former greatness, but the recession and the rising dominance of Amazon contributed in derailing those goals. Sears filed for Chapter 11 in 2018 and currently has a handful of stores left in the U.S. where it once had thousands.
Kmarts continue to operate in Westwood, New Jersey; Bridgehampton, on New York’s Long Island, and Miami.
It didn’t have to end this way, according to Mark Cohen, director of retail studies at Columbia University in New York and former CEO of Sears Canada. Trying to compete with Walmart on price was a foolish strategy, he said, and Lampert was criticized for not having a retail background and appearing more interested in stripping off the assets of the two chains for their cash value.
“It’s a study in greed, avarice and incompetence,” Cohen said. “Sears should have never gone away; Kmart was in worse shape, but not fatally so. And now they’re both gone.
“Retailers fall by the wayside sometimes because they’re selling things people don’t want to buy,” he continued. “In the case of Kmart, everything they used to sell, people are buying but they’re buying it from Walmart and Target.”
Transformco, which owns Kmart and Sears, did not respond to an email seeking comment and a phone number listed for the company was not taking messages.
Nationwide, some former Kmarts remain vacant while others have been replaced by other big-box stores, fitness centers, self-storage facilities, even churches. One former site in Colorado Springs, Colorado, is now a popular dine-in movie theater.
Employees at the Kmart in Avenel found out last month that the store would close.
Unlike 20 years ago, when news of impending Kmart closures around the country prompted an outpouring of support from loyal shoppers and a Detroit radio station even mounted a campaign to try and save a local store, the closing of the Avenel location was met mostly with an air of resignation.
“It’s maybe a little nostalgic because I’ve lived my whole life in this area, but it’s just another retail store closing,” said Jim Schaber, a resident of nearby Iselin who said his brother worked in the shoe department at Kmart for years. “It’s just another sign of people doing online shopping and not going out to the retail stores.”
The closing packed a little more of an emotional punch for Mike Jerdonek, a truck driver who recalled shopping at Kmart in Brooklyn and Queens in his younger days.
“It’s like history passing right in front of our eyes,” he said as he sat in his car outside the Avenel store. “When I was younger I didn’t have any money, so it was a good place to shop because the prices were cheap. And to see it gone right now, it’s kind of sad.”
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.whsv.com/2022/04/11/once-retail-giant-kmart-will-be-down-3-stores-after-nj-closing/
| 2022-04-11T12:26:51Z
|
WAEPA now offering guaranteed coverage with no medical requirements
FALLS CHURCH, Va., April 11, 2022 /PRNewswire/ -- WAEPA (Worldwide Assurance for Employees of Public Agencies) is now offering $100k in Guaranteed Life Insurance coverage for a limited time.
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/9031651-waepa-guaranteed-life-insurance-100k/
Civilian Federal Employees under the age of 50 who are not currently WAEPA members are eligible to apply for $100k in Guaranteed Life Insurance coverage with no medical exam required. Approval is guaranteed, and coverage is fully portable for those that leave federal service.
"At WAEPA, we want to provide Civilian Feds with the peace of mind that their family's financial future is secure," said M. Shane Canfield, CEO of WAEPA. "Civilian Feds serve our country every day, and our goal is to serve them. This guaranteed offer provides the opportunity to realize that goal."
This limited time offer expires on May 25, 2022. Existing WAEPA members, spouses, and dependents are ineligible, and you must be a United States citizen to apply. To learn more about WAEPA's $100k Guaranteed Issue Group Term Life Insurance and to apply, please visit: https://www.waepa.org/100k
About WAEPA
Worldwide Assurance for Employees of Public Agencies (WAEPA), is a nonprofit association (not an insurance company) formed For Feds, By Feds. The goal of WAEPA is to provide access to products and services that promote the health, welfare, and financial well-being of its members. After more than 75 years in business, WAEPA has over 46,000 members. For more information, visit waepa.org, or give us a call at (888) 353-1308.
View original content:
SOURCE WAEPA
|
https://www.whsv.com/prnewswire/2022/04/11/100k-guaranteed-life-insurance-now-available-through-waepa/
| 2022-04-11T12:26:59Z
|
- Data show enhanced antitumor effects and improved survival were observed in a preclinical NSCLC model compared to a naked HER3 antibody
- HER3 targeted radiotherapy represents a novel therapeutic strategy for tumors expressing HER3 and tumors with acquired resistance to HER1/2 therapies.
- Data Supports Actinium Pharmaceutical's research collaboration with AVEO Oncology to develop and advance a HER3 targeted radiotherapy to clinical studies
NEW YORK, April 11, 2022 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs, today announced positive results from preclinical studies evaluating an anti-HER3 antibody, conjugated with an Actinium-225 (Ac-225) radioisotope payload, for targeting HER3-positive non-small cell lung cancer (NSCLC) cells. These data were presented at the American Association of Cancer Research (AACR 2022) annual meeting, which is being held April 8th – 13th at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
AACR Poster Highlights:
- Ac-225-HER3 antibody radio conjugate (ARC) eliminated HER3-postive tumors in an in vivo animal model of human non-small cell lung cancer (NSCLC) at multiple dose levels with increased survival
- A dose-dependent cytotoxic effect against HER3 expressing cells was observed in vitro with the Ac-225-HER3-ARC
- Biodistribution data demonstrates accumulation of the Ac-225-HER3-ARC in HER3 expressing tumors in the in vivo model of NSCLC
- Conjugation of Ac-225 to the HER3 antibody did not affect the antibody's targeting properties as determined by binding to HER3 expressing cells
Dr. Helen Kotanides, Vice President, Translational Research and Preclinical Development, stated, "HER3 is a well-validated target that is overexpressed in a number of cancers and associated with poor survival in breast, ovarian, lung, gastric and prostate cancer. It is also upregulated in response to HER1 and HER2 targeted therapies as part of acquired resistance against these EGFR therapies. These data show that arming a HER3-targeting agent with Actinium-225 results in potent anti-tumor agent, which improved survival in our NSCLC models. These data support our goal of developing a HER3 targeted radiotherapy for use in a patient population in need of new treatments and give us great excitement for our ongoing collaboration with AVEO centered around HER3."
Sandesh Seth, Chairman and CEO of Actinium, stated, "We are excited to continue to demonstrate Actinium's enhanced R&D capabilities and commitment to developing potent radiotherapies targeting solid tumors. We look forward to sharing these data, which show the efficacy for our novel approach of conjugating Actinium-225 to a HER3 antibody at AACR 2022. The development of Ac-225-HER3-ARC, a product of our validated Antibody Warhead Enabling (AWE) technology platform, represents a departure from conventional HER3-targeting approaches, such as naked antibodies and antibody drug conjugates, that are currently being explored for this tumor antigen. These exciting data highlight Actinium's leadership in developing novel targeted radiotherapy approaches for treating cancers having high unmet needs."
The full poster is available as an e-poster on the AACR 2022 platform and will be presented in-person at the conference with details below:
AACR Poster Details
Title: Targeting HER3 receptor positive cancers with a novel anti-HER3 antibody radioconjugate (ARC)
Session Category: Experimental and Molecular Therapeutics
Session Title: Preclinical Radiotherapeutics
Session Date and Time: Tuesday, April 12, 2022, 1:30 PM – 5:00 PM
Location: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 25
Poster Board Number: 4
Permanent Abstract Number: 3306
The poster will be accessible via Actinium's website here.
About Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs not addressed by traditional cancer therapies. Actinium's current clinical pipeline is led by ARCs or Antibody Radiation-Conjugates that are being applied to targeted conditioning, which is intended to selectively deplete a patient's disease or cancer cells and certain immune cells prior to a BMT or Bone Marrow Transplant, Gene Therapy or Adoptive Cell Therapy (ACT) such as CAR-T to enable engraftment of these transplanted cells with minimal toxicities. Actinium's targeted conditioning ARCs seek to improve patient outcomes and access to these potentially curative treatments by eliminating or reducing the non-targeted chemotherapy that is used for conditioning in standard practice currently. Our lead product candidate, Iomab-B (I-131 apamistamab) has been studied in several hundred patients including in the 150-patient, pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning, which completed patient enrollment in the third quarter of 2021. Iomab-ACT, low dose I-131 apamistamab is being studied as a targeted conditioning agent in a Phase 1 study with a CD19 CAR T-cell Therapy with Memorial Sloan Kettering Cancer Center. In addition, we are leaders in the field of Actinium-225 alpha therapies. Actimab-A, our clinical stage CD33 targeting ARC alpha therapy has been studied in nearly 150 patients including our ongoing combination trials with the salvage chemotherapy CLAG-M and the Bcl-2 targeted therapy venetoclax. Underpinning our clinical programs is our proprietary AWE (Antibody Warhead Enabling) technology platform. This is where our intellectual property portfolio of over 170 patents, know-how, collective research and expertise in the field are being leveraged to construct and study novel ARCs and ARC combinations such as with CD47 immunotherapies to bolster our pipeline for strategic purposes. Our AWE technology platform is currently being utilized in a collaborative research partnership with Astellas Pharma, Inc., AVEO Oncology and EpicentRx. Website: https://www.actiniumpharma.com/
Forward-Looking Statements for Actinium Pharmaceuticals, Inc.
This press release may contain projections or other "forward-looking statements" within the meaning of the "safe-harbor" provisions of the private securities litigation reform act of 1995 regarding future events or the future financial performance of the Company which the Company undertakes no obligation to update. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with preliminary study results varying from final results, estimates of potential markets for drugs under development, clinical trials, actions by the FDA and other governmental agencies, regulatory clearances, responses to regulatory matters, the market demand for and acceptance of Actinium's products and services, performance of clinical research organizations and other risks detailed from time to time in Actinium's filings with the Securities and Exchange Commission (the "SEC"), including without limitation its most recent annual report on form 10-K, subsequent quarterly reports on Forms 10-Q and Forms 8-K, each as amended and supplemented from time to time.
Investors:
Hans Vitzthum
LifeSci Advisors, LLC
Hans@LifeSciAdvisors.com
(617) 430-7578
View original content to download multimedia:
SOURCE Actinium Pharmaceuticals, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/actinium-pharmaceuticals-highlights-potent-anti-tumor-activity-her3-targeted-radiotherapy-aacr/
| 2022-04-11T12:27:05Z
|
- Data further expand Actinium's leadership in combining targeted radiotherapy with CD47 immunotherapy in solid tumors and blood cancers
- Significant increase in tumor control with the HER3 ARC magrolimab combination compared to magrolimab alone in HER3-expressing NSCLC in vivo model supports further development
NEW YORK, April 11, 2022 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs, today announced that preclinical data highlighting the efficacy of the combination of an anti-HER3 antibody radiation conjugate (ARC) and a CD47 blocking antibody immunotherapy was presented at the American Association for Cancer Research (AACR 2021) annual meeting, which is being held April 8th – 13th at the Ernest N. Morial Convention Center in New Orleans, Louisiana. Actinium assessed an Actinium-225 (Ac-225)-conjugated anti-HER3 antibody with magrolimab, an anti-CD47 antibody being developed by Gilead Sciences, in HER3-positive preclinical models.
AACR Poster Highlights:
- Dramatic improvement in tumor growth inhibition is observed in vivo with the Ac-225-HER3-ARC and magrolimab combination therapy compared to magrolimab alone
- The combination of Ac-225-HER3-ARC and magrolimab significantly enhanced phagocytosis in HER3-positive cells compared to either single agent in vitro
- Upregulation of cell surface calreticulin is observed following treatment with 225Ac-HER3-ARC in HER3-positive cell lines
Dr. Helen Kotanides, Vice President, Translational Research and Preclinical Development, said, "We hypothesize that the upregulation of the 'eat me' signal, calreticulin, induced by targeted radiotherapy could enhance the immunomodulatory effects of an anti-CD47 antibody, resulting in increased anti-tumor efficacy. These data presented at AACR corroborate our previous work presented at SITC and support our rationale in targeting both blood cancer and solid tumors with a CD47 targeted radiotherapy combination. We are highly encouraged by the remarkable improvement in anti-tumor efficacy observed with the combination of an Ac-225-HER3-ARC with magrolimab. Collectively, the in vitro and in vivo data support further investigation of this novel combination and we look forward to continuing to advance the first ever targeted radiotherapy CD47 combinations."
Sandesh Seth, Chairman and CEO of Actinium, said, "We continue to demonstrate the potential of combining targeted radiotherapy with a CD47 blocking antibody immunotherapy such as magrolimab. These results support our vision to develop more effective treatments for cancer patients through the expansion of our pipeline into solid tumors and to develop innovative targeted radiotherapy combinations with immunotherapy leveraging our strong technology platform, IP and clinical experience. We are excited to highlight these results showing the potential for adding Ac-225-HER3 ARC to CD47 antibodies to enhance the latter's immunotherapeutic efficacy at AACR. These data along with our recent collaborations with EpicentRx and AVEO Oncology give us strong momentum towards the clinic with highly novel CD47-SIRPα combinations and HER3 targeted radiotherapies."
The full poster is available as an e-poster on the AACR 2022 platform with details below:
AACR Poster Details
Title: Anti-HER3 radioimmunotherapy enhances the anti-tumor effects of CD47 blockade in solid tumors
Session Category: Immunology
Session Title: Immune Checkpoints
Session Date and Time: Sunday, April 10, 2022, 1:30 PM – 5:00 PM
Location: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 38
Poster Board Number: 19
Permanent Abstract Number: 609
The poster will be accessible via Actinium's website here.
About Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs not addressed by traditional cancer therapies. Actinium's current clinical pipeline is led by ARCs or Antibody Radiation-Conjugates that are being applied to targeted conditioning, which is intended to selectively deplete a patient's disease or cancer cells and certain immune cells prior to a BMT or Bone Marrow Transplant, Gene Therapy or Adoptive Cell Therapy (ACT) such as CAR-T to enable engraftment of these transplanted cells with minimal toxicities. Actinium's targeted conditioning ARCs seek to improve patient outcomes and access to these potentially curative treatments by eliminating or reducing the non-targeted chemotherapy that is used for conditioning in standard practice currently. Our lead product candidate, Iomab-B (I-131 apamistamab) has been studied in several hundred patients including in the 150-patient, pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning, which completed patient enrollment in the third quarter of 2021. Iomab-ACT, low dose I-131 apamistamab is being studied as a targeted conditioning agent in a Phase 1 study with a CD19 CAR T-cell Therapy with Memorial Sloan Kettering Cancer Center. In addition, we are leaders in the field of Actinium-225 alpha therapies. Actimab-A, our clinical stage CD33 targeting ARC alpha therapy has been studied in nearly 150 patients including our ongoing combination trials with the salvage chemotherapy CLAG-M and the Bcl-2 targeted therapy venetoclax. Underpinning our clinical programs is our proprietary AWE (Antibody Warhead Enabling) technology platform. This is where our intellectual property portfolio of over 170 patents, know-how, collective research and expertise in the field are being leveraged to construct and study novel ARCs and ARC combinations such as with CD47 immunotherapies to bolster our pipeline for strategic purposes. Our AWE technology platform is currently being utilized in a collaborative research partnership with Astellas Pharma, Inc., AVEO Oncology and EpicentRx. Website: https://www.actiniumpharma.com/
Forward-Looking Statements for Actinium Pharmaceuticals, Inc.
This press release may contain projections or other "forward-looking statements" within the meaning of the "safe-harbor" provisions of the private securities litigation reform act of 1995 regarding future events or the future financial performance of the Company which the Company undertakes no obligation to update. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with preliminary study results varying from final results, estimates of potential markets for drugs under development, clinical trials, actions by the FDA and other governmental agencies, regulatory clearances, responses to regulatory matters, the market demand for and acceptance of Actinium's products and services, performance of clinical research organizations and other risks detailed from time to time in Actinium's filings with the Securities and Exchange Commission (the "SEC"), including without limitation its most recent annual report on form 10-K, subsequent quarterly reports on Forms 10-Q and Forms 8-K, each as amended and supplemented from time to time.
Investors:
Hans Vitzthum
LifeSci Advisors, LLC
Hans@LifeSciAdvisors.com
(617) 430-7578
View original content to download multimedia:
SOURCE Actinium Pharmaceuticals, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/actinium-pharmaceuticals-presents-preclinical-data-aacr-showing-her3-targeted-radiotherapy-combined-with-cd47-immunotherapy-magrolimab-increases-anti-tumor-effect/
| 2022-04-11T12:27:13Z
|
BEIJING and TEL AVIV, Israel, April 11, 2022 /PRNewswire/ -- ADAMA Ltd. (SZSE 000553), one of the leading global crop protection companies, announces the appointment of Shahar Florence as Chief Financial Officer (CFO) effective as of May 1, 2022. As CFO, Shahar will manage and oversee the Company's global financial processes, policies and strategies, as well as work closely with Syngenta Group on all financial aspects of the business. Likewise, Shahar will lead all investor relations activities in ADAMA.
Shahar joins ADAMA with over 25 years of financial experience and a track record as a strategic decision-maker and an innovative financial visionary leader, with proven ability to drive sustainable profitable growth, translating corporate vision into bottom line results. Shahar is joining ADAMA following filling various financial positions at Strauss Group LTD for the last 14 years. Most recently, Shahar held the position of Chief Growth & Innovation Officer, having previously held the position of the Group's CFO. Among others, he was responsible for heading the Finance, Business Development and Investor Relations, as well as driving overall innovation for creating economic and strategic value. Shahar holds a bachelor's degree in Economics and Accounting from the Tel-Aviv University, and is a certified CPA.
"Shahar is a strong leader with a track record of proven financial expertise, his global experience and value-enhancing insights will further strengthen our global management team to continue the execution of our growth strategy," says Ignacio Dominguez, President and CEO of ADAMA. "Shahar's wealth of experience, integrity and expertise in international business strategic partnerships and business models, makes him the right person to join our executive management team."
"I am excited to join ADAMA as CFO, to assist the Company in continuing to execute its strategic plans, accelerate sustainable growth and bottom-line results, while delivering value to all stakeholders. I look forward to working with the global team and to build on ADAMA's momentum as we grow and achieve our collective goals," added Shahar Florence.
About ADAMA
ADAMA Ltd. is a global leader in crop protection, providing solutions to farmers across the world to combat weeds, insects and disease. ADAMA has one of the widest and most diverse portfolios of active ingredients in the world, as well as state-of-the-art R&D, manufacturing and formulation facilities. With a culture that empowers our people to listen to farmers and ideate from the field, ADAMA is uniquely positioned to offer a vast array of distinctive mixtures, formulations and high-quality differentiated products, delivering solutions that meet local farmer and customer needs in over 100 countries globally. For more information, visit us at www.ADAMA.com and follow us on Twitter® at @ADAMAAgri.
ADAMA Contact:
Efrat Dayan
Public Relations
Email: pr@adama.com
View original content to download multimedia:
SOURCE ADAMA Ltd.
|
https://www.whsv.com/prnewswire/2022/04/11/adama-announces-appointment-shahar-florence-chief-financial-officer/
| 2022-04-11T12:27:20Z
|
VANCOUVER, BC, April 11, 2022 /PRNewswire/ - Alexco Resource Corp. (NYSE: AXU) (TSX: AXU) ("Alexco" or the "Company") is pleased to announce that it has entered into an agreement for a non-brokered private placement offering (the "Offering") of 7,473,495 common shares (the "Shares") at a price of $1.75 per share, raising gross proceeds of $13,078,616 for the Company.
The Company intends to use the net proceeds of the Offering for general corporate purposes, including to fund the continued ramp-up of mining operations at Keno Hill.
The closing of the Offering is expected on or about April 13, 2022 (the "Closing Date") and is subject to customary closing conditions including regulatory approval from the Toronto Stock Exchange and NYSE American.
The Shares were subscribed for pursuant to a subscription agreement which confirms, among other things, the availability of an exemption from the prospectus requirements of applicable securities laws in respect of the sale of Shares in the Offering.
The Shares being issued pursuant to the Offering are subject to a statutory hold period expiring four months and one day after closing of the Offering. None of the Shares will be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor there any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.
Alexco is a Canadian primary silver company that owns and operates the majority of the historic Keno Hill Silver District, in Canada's Yukon Territory, one of the highest-grade silver deposits in the world. Alexco is currently advancing Keno Hill to commercial production and commenced concentrate production and shipments in the first quarter of 2021. Keno Hill is expected to produce an average of approximately 4.4 million ounces of silver per year contained in high quality lead/silver and zinc concentrates. Keno Hill retains significant potential to grow and Alexco has a long history of expanding the operation's mineral resources through successful exploration.
Some statements ("forward-looking statements") in this news release contain forward-looking information concerning the Offering, made as of the date of this news release. Forward-looking statements may include, but are not limited to, statements with respect to the use of proceeds from the Offering and the anticipated closing date of the Offering. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors, which could cause actual events or results to differ from those expressed or implied by the forward-looking statements. Such factors include, among others, risks involved in fluctuations in commodity prices and currency exchange rates; the risks and uncertainties related to the Offering not being completed in the event that the conditions precedent thereto (including receipt of requisite regulatory approvals) are not satisfied; uncertainties related to raising sufficient financing in a timely manner and on acceptable terms; and other risks and uncertainties disclosed in Alexco's annual information form and Form 40-F, and other information released by Alexco and filed with the applicable regulatory agencies. Forward-looking statements are based on certain assumptions that management believes are reasonable at the time they are made. In making the forward-looking statements included in this news release, Alexco has applied several material assumptions, including, but not limited to, the assumptions that all regulatory approvals will be received in a timely manner and on acceptable terms; that general business conditions will not change in a materially adverse manner and that the Offering will proceed as planned. There can be no assurance that forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Alexco expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as otherwise required by applicable securities legislation.
View original content:
SOURCE Alexco Resource Corp.
|
https://www.whsv.com/prnewswire/2022/04/11/alexco-announces-131-million-non-brokered-private-placement-common-shares/
| 2022-04-11T12:27:27Z
|
AIGIS enables businesses and government agencies to jumpstart AI pipeline
PITTSBURGH, April 11, 2022 /PRNewswire/ -- Allvision IO, a geospatial analytics company, is pleased to announce the release of AIGIS (AI for GIS), a fully integrated system that empowers users to leverage or augment mapping workflows with the latest machine learning, AI, and LiDAR processing technologies available. Allvision AIGIS provides transportation, logistics, and telecommunications professionals with the data, platform, and tools needed to train AI models specific to their needs, then execute them in the Allvision cloud to extract location, geometry, or other attributes. With this platform, organizations can automatically pinpoint assets like signage, streetlights, overpasses, paint lines, guardrails, telephone poles, ADA compliant sidewalks, and more with minimal human interaction. As soon as the platform is deployed, it continually improves for unparalleled accuracy and reliability.
Since its founding in 2017, Allvision has developed and deployed its AI capabilities across millions of images, billions of 3D points, and thousands of miles of road and rail. Allvision AIGIS has delivered high quality, validated results to customers in DOTs, AV companies, freight rail, engineering firms, city governments, and beyond. To learn more about AIGIS and Allvision's additional technologies, visit www.allvision.io.
"Allvision AIGIS is just the latest in our line of innovations providing AI to people and services that would normally do things by hand or by feet-on-street," said Dr. Aaron Morris, co-founder and CEO of Allvision. "The power of AI is now available for everyone regardless of the skill level or industry - we can train or customize to any demand and with the benefit of approachable financing."
About Allvision
Allvision develops the platform to enable street level analytics at global scale. We provide the means to make sense of our dynamic environment to solve the world's most pressing problems from the human point of view. The founders have spent their careers at the intersection of the digital and physical worlds and are experts in geospatial analytics and machine learning. www.allvision.io
View original content:
SOURCE Allvision IO
|
https://www.whsv.com/prnewswire/2022/04/11/allvisions-new-offering-provides-customizable-access-geospatial-ai-platform/
| 2022-04-11T12:27:34Z
|
WALTHAM, Mass., April 11, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that it has reached an agreement with its Japanese collaboration partner, Kyowa Kirin Co. Ltd., to amend the license agreement, originally executed in 2017, that grants to Kyowa Kirin exclusive rights to develop and commercialize Ardelyx's tenapanor for the treatment of cardiorenal diseases, including hyperphosphatemia, in Japan.
Under the agreement, in consideration for a reduction in the royalty rate due Ardelyx upon net sales in Japan, Kyowa Kirin has agreed to pay Ardelyx consideration of up to additional U.S. $40 million payable in two tranches, with payment due following Kyowa Kirin's filing with the Japanese Ministry Health, Labour and Welfare (MHLW) of its application for marketing approval for tenapanor and the second payment due following Kyowa Kirin's approval to market tenapanor for hyperphosphatemia in Japan. Kyowa Kirin is finalizing its Phase 3 clinical program for tenapanor for hyperphosphatemia and has disclosed its current expectation to file for approval with Kyowa Kirin in the second half of 2022 and its current expectation that it will receive a decision from Kyowa Kirin regarding its application in the second half of 2023. The royalty rate at which Kyowa Kirin will make payments on net sales to Ardelyx under the License Agreement will be reduced from the high teens to low double digits for a two-year period, and then to mid-single digits.
"We are pleased to amend our longstanding agreement with Kyowa Kirin in a mutually beneficial way," said Mike Raab, president and chief executive officer of Ardelyx. "We believe that this agreement is reflective of both the positive clinical data Kyowa Kirin has generated for tenapanor and the attractive opportunity for treating hyperphosphatemia in dialysis patients in Japan."
About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx's first approved product, IBSRELA® (tenapanor), is available in the United States. Ardelyx is developing XPHOZAH® (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, which has completed three successful Phase 3 trials. Ardelyx is also advancing RDX013, a potassium secretagogue, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease and has an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. Ardelyx has established agreements with Kyowa Kirin in Japan, Fosun Pharma in China and Knight Therapeutics in Canada for the development and commercialization of tenapanor in their respective territories.
Forward Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Ardelyx, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Reform Act of 1995, including Ardelyx's expectation regarding the timing of Kyowa Kirin's filing for marketing approval for tenapanor for hyperphosphatemia in Japan and Ardelyx's expectations regarding the potential timing for Kyowa Kirin's marketing approval in Japan. Such forward-looking statements involve substantial risks and uncertainties that could cause Ardelyx's future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, uncertainties in the drug development and regulatory processes in Japan. Ardelyx undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ardelyx's business in general, please refer to Ardelyx's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 28, 2022, and its future current and periodic reports to be filed with the Securities and Exchange Commission.
View original content to download multimedia:
SOURCE Ardelyx
|
https://www.whsv.com/prnewswire/2022/04/11/ardelyx-kyowa-kirin-amend-license-agreement-tenapanor/
| 2022-04-11T12:27:41Z
|
TSX Venture Exchange (TSX-V): LIT
Frankfurt Stock Exchange (FSE): OAY3
OTCQB Venture Market (OTC): PNXLF
VANCOUVER, BC, April 11, 2022 /PRNewswire/ - Argentina Lithium & Energy Corp. (TSXV: LIT) (FSE: OAY3) (OTC: PNXLF) ("Argentina Lithium" or the "Company") is pleased to announce that it has entered into an option agreement with a local vendor to earn a 100% interest in three granted mine concession properties totalling 5411 hectares in the Salar de Antofalla in Catamarca Province, Argentina (the "Option").
Argentina Lithium's Antofalla North project includes both 100% held and optioned properties (see News Release dated August 4, 2021). With this new Option the Company now controls 14,987 hectares of mining leases in the salar, distributed between the adjacent provinces of Salta and Catamarca.
"Our team has identified the Antofalla Salar as one of the most prospective undeveloped lithium brine basins in Argentina, and we are aggressively consolidating our land position in Antofalla North. With these new acquisitions, Argentina Lithium's properties extend from a half kilometre north of Albemarle concessions, towards the north for approximately 27 kilometres. We have begun the permitting process, in order to explore this salt flat with advanced geophysical imaging and drill testing," stated Nikolaos Cacos, President and C.E.O.
Located in the famed Lithium Triangle, the geological environment at the Salar de Antofalla is similar to other salars in the region where lithium and potash are found, and the project is located approximately 25 km west of Argentina's largest lithium producing operation at Salar de Hombre Muerto. The Salar de Antofalla is over 130 km long and varies between 5 km and 10 km in width, with reported basin depths exceeding 500 m.
The southern boundary of the Antofalla North project is situated approximately 500 metres north of properties controlled by global lithium producer Albemarle Inc. Albemarle has stated that it believes the lithium resource on its property has potential to rank amongst the largest in Argentina1. [Investors are cautioned that this information is taken from the publicly available sources, has not been independently verified by the Company and it is not known if this resource conforms to the standards of NI 43-101. Furthermore, proximity to a discovery, mine, or mineral resource, does not indicate that mineralization will occur at the Company's Project, and if mineralization does occur, that it will occur in sufficient quantity or grade that would result in an economic extraction scenario.]
There has been no significant historical exploration work on the new optioned properties. The Option provides the Company with coverage to protect its mineral rights in the area of the provincial boundary between Salta and Catamarca and extend its holdings 4.6 km southwards to within 500 metres of Albemarle Corporation's property boundary; a portion of the northern part of the optioned properties may overlap a third party concession in the provincial boundary area.
Terms of the option include cash payments totaling US$2,800,000 over four years, including mandatory commitments totalling US$180,000 in the first twelve months. The option also includes annual exploration expenditure commitments of $500,000 in year one, followed by $1.5M in year two, $2.0M in year 3 and $3.0M in year 4. The vendor retains a 2% Net Smelter Royalty ("NSR") which can be repurchased for US$3M.
David Terry, Ph.D., P.Geo. is the Company's Qualified Person as defined in National Instrument 43-101. The contents of this news release have been reviewed and approved by Dr. Terry.
Argentina Lithium & Energy Corp is focused on acquiring high quality lithium projects in Argentina, and advancing them towards production in order to meet the growing global demand from the battery sector. The management group has a long history of success in the resource sector of Argentina, and has assembled a first rate team of experts to acquire and advance the best lithium properties in the "Lithium Triangle". The Company is a member of the Grosso Group, a resource management group that has pioneered exploration in Argentina since 1993.
ON BEHALF OF THE BOARD
"Nikolaos Cacos"
_______________________________
Nikolaos Cacos, President, CEO and Director
Facebook, Twitter, LinkedIn, Google+
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. All statements, other than statements of historical fact, that address activities, events or developments the Company believes, expects or anticipates will or may occur in the future, including, without limitation, statements about the Company's plans for its mineral properties; the Company's business strategy, plans and outlooks; the future financial or operating performance of the Company; and future exploration and operating plans are forward-looking statements.
Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations include, among other things: the impact of COVID-19; risks and uncertainties related to the ability to obtain, amend, or maintain licenses, permits, or surface rights; risks associated with technical difficulties in connection with mining activities; and the possibility that future exploration, development or mining results will not be consistent with the Company's expectations. Actual results may differ materially from those currently anticipated in such statements. Readers are encouraged to refer to the Company's public disclosure documents for a more detailed discussion of factors that may impact expected future results. The Company undertakes no obligation to publicly update or revise any forward-looking statements, unless required pursuant to applicable laws. We advise U.S. investors that the SEC's mining guidelines strictly prohibit information of this type in documents filed with the SEC. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties.
View original content to download multimedia:
SOURCE Argentina Lithium & Energy Corp.
|
https://www.whsv.com/prnewswire/2022/04/11/argentina-lithium-expands-land-position-salar-de-antofalla/
| 2022-04-11T12:27:48Z
|
SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies, including the first autologous neuron replacement for Parkinson's disease (PD), announced that this month it will launch the first patient screening study of its kind, working with multiple clinical screening sites in the U.S.
The company's Trial-Ready Cohort Study is a preliminary step to filing an Investigational New Drug (IND) application with the US Food & Drug Administration for ANPD001, its first therapeutic development candidate for potential treatment of idiopathic Parkinson's disease (PD). The Trial-Ready Cohort Study will provide information to and screen potential patient candidates for the company's planned Phase 1/2A first-in-patient clinical trial of ANPD001. The company will announce multiple U.S. screening sites throughout the spring.
"This is an historic moment for patients and for the Aspen Neuroscience team, as we open our first screening study to expedite our investigation of iPSC-derived cell replacement therapies for Parkinson's disease," said Damien McDevitt, Ph.D., president and chief executive officer. "We are excited and very humbled to begin this next phase during Parkinson's Awareness Month. This is a significant step forward for the patient community, for health care providers and the neuroscience field."
PD is the second most common neurodegenerative disease, affecting around one million Americans and more than ten million people worldwide. Even with the current standard of care therapy, patients can eventually develop debilitating motor complications due to loss of dopamine neurons in the brain; approximately 50% are lost even before diagnosis.
Aspen Neuroscience is the leading company developing a personalized cell replacement that can eliminate the need for immunosuppressive therapy. The approach utilizes a patient's own skin cell-derived iPSCs to produce replacement dopamine neurons for transplantation back into the same patient. Developed from a simple skin biopsy, each patient's cells will be evaluated for potential effectiveness using proprietary AI-based genomics tools, before being transplanted for clinical use.
About Aspen Neuroscience
Headquartered in San Diego, Aspen Neuroscience, Inc. is a development stage, private biotechnology company focused on personalized cell therapies. The company is developing iPSCs to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of PD, and extending across the brain and central nervous system.
Aspen Neuroscience combines stem cell biology with the latest artificial intelligence and genomic approaches to investigate patient-specific, restorative treatments. The company has developed a best-in-class platform to create and characterize pluripotent-derived cell medicines, which includes in-house bioinformatics, manufacturing and QC. For more information and important updates, please visit http://www.aspenneuroscience.com.
View original content to download multimedia:
SOURCE Aspen Neuroscience, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/aspen-neuroscience-launches-first-patient-screening-study-planned-clinical-trial-personalized-cell-replacement-parkinsons-disease/
| 2022-04-11T12:27:55Z
|
TSX Venture Exchange: BSK
Frankfurt Stock Exchange: MAL2
OTCQB Venture Market (OTC): BKUCF
VANCOUVER, BC, April 11, 2022 /PRNewswire/ - Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (OTC: BKUCF) ("Blue Sky" or the "Company") is pleased to announce that the Company is resuming its 4,500 metre exploration drilling program with new holes planned at the Ivana Central target, located 10 kilometres north of the Company's Ivana Deposit at its wholly-owned Amarillo Grande Uranium-Vanadium Project in Rio Negro Province, Argentina ("AGP") (see Figure 1).
Six holes totaling 286 metres were drilled at Ivana Central in 2020 before the program was paused, leaving approximately 1,200 metres to be completed at this target. Two of the first six holes at Ivana Central intersected anomalous uranium, including 120 ppm U3O8 over 1 metre in hole AGIC-01 (see News Release date October 21, 2021) and all holes returned anomalous vanadium and pathfinder elements similar to those associated with uranium mineralization at the Ivana deposit. The new drilling will test the continuity of the prospective horizons intersected in the initial holes.
Nikolaos Cacos, Blue Sky President & CEO commented, "Ivana Central is the next area we are evaluating in our continued push to identify and delineate new mineralization and deposits at the district-scale Amarillo Grande project. We look forward to completing this tranche of drilling so that we can plan detailed follow up and advance to testing other targets in the Ivana area."
A total of 1,584 metres have also been completed at the Ivana North target (see October 21, 2021 News Release). Following completion of the current tranche of drilling at Ivana Central, approximately 1,500 metres of drilling will be deployed in refining delineation of areas with the best results from both targets.
Ivana Central is a blind exploration target consisting of a mainly soil-covered depression covering an area of 5 by 9 kilometres. This target zone was initially identified by Blue Sky's previous joint venture partner Areva in 2013 via a drilling program of 11 core holes totaling 2023.5 metres, with depths ranging from 110 to 280 metres, in the southern sector of the Amarillo Grande project. In 2018 Blue Sky's exploration team relogged, sampled and re-interpreted those holes and applied the in-house geological and exploration models and experience that have been developed and refined as the Ivana deposit has been discovered and advanced. This work identified a suite of pathfinder element anomalies, including molybdenum, selenium, cobalt, lanthanum, rhenium, yttrium, lead, and zinc, that the Company employs as geochemical indicators to vector towards blind uranium deposits.
The exploration work at Ivana Central continued with auger-holes, radiometric surveys and pit-sampling, followed by induced polarization ("IP") Pole-Dipole tomography (see Press Releases May 16 and September 19, 2019). From the auger-holes surveyed, radiometric anomalies were detected in some holes and at several different depths; some are open to depth. The sampling program encountered reduced carbonaceous alteration and carnotite mineralization. The IP survey detected areas with high chargeability anomalies interpreted to represent moderate to low levels of disseminated pyrite, suggesting proximity to an oxidation-reduction ("REDOX") zone as potential "trap" for uranium mineralization.
This information was used to plan the initial reverse circulation ("RC") drilling program originally launched in 2020, as reported on March 2, 2020. Two holes successfully intercepted uranium-vanadium anomalies at the expected depths, with a third showing weak uranium values. Those intercepts suggest that the mineralization potentially continues to the west, onto a mineral tenure for which permits were pending at that time but which have now been secured. The new program is designed primarily to test that potential westward continuity of the mineralization (see Figure 1) as well as to test some undrilled areas to the east showing IP chargeability anomalies.
The drilling program will employ a multipurpose direct circulation hydraulic drilling rig on tracks. This drill produces wet chip samples which are collected from sampling buckets every metre; the drill rig also has the ability to recover drill core. Every hole will be surveyed with a calibrated radiometric Mount SoprysTM probe. An additional geoelectrical SP-SPR survey will be completed on holes in order to approximate the location of geological contacts between sedimentary units.
The design of the Company's exploration program was undertaken by the Company's geological staff under the supervision of David Terry, Ph.D., P.Geo. Dr. Terry is a Director of the Company and a Qualified Person as defined in National Instrument 43-101. The contents of this news release have been reviewed and approved by Dr. Terry.
The Company's 100% owned Amarillo Grande Uranium-Vanadium Project in Rio Negro Province, Argentina is a new uranium district controlled by Blue Sky. The Ivana deposit is the cornerstone of the Project and the first part of the district for which both a Mineral Resource Estimate and a Preliminary Economic Assessment have been completed. Mineralization at the Ivana deposit has characteristics of sandstone-type and surficial-type uranium-vanadium deposits. The sandstone-type mineralization is related to a braided fluvial system and indicates the potential for a district-size system. In the surficial-type deposits, mineralization coats loosely consolidated pebbles, and is amenable to leaching and simple upgrading.
The Project includes several other target areas over a regional trend, at or near surface. The area is flat-lying, semi-arid and accessible year-round, with nearby rail, power and port access. The Company's strategy includes delineating resources at multiple areas and advancing the entire project to prefeasibility level.
For additional details on the project and properties, please see the Company's website.
Blue Sky Uranium Corp. is a leader in uranium discovery in Argentina. The Company's objective is to deliver exceptional returns to shareholders by rapidly advancing a portfolio of surficial uranium deposits into low-cost producers, while respecting the environment, the communities, and the cultures in all the areas in which we work. Blue Sky has the exclusive right to properties in two provinces in Argentina. The Company's flagship Amarillo Grande Project was an in-house discovery of a new district that has the potential to be both a leading domestic supplier of uranium to the growing Argentine market and a new international market supplier. The Company is a member of the Grosso Group, a resource management group that has pioneered exploration in Argentina since 1993.
ON BEHALF OF THE BOARD
"Nikolaos Cacos"
______________________________________
Nikolaos Cacos, President, CEO and Director
Facebook, Twitter, YouTube, LinkedIn, Google+
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. All statements, other than statements of historical fact, that address activities, events or developments the Company believes, expects or anticipates will or may occur in the future, including, without limitation, statements about the Company's plans for its mineral properties; the Company's business strategy, plans and outlooks; the future financial or operating performance of the Company; and future exploration and operating plans are forward-looking statements.
Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations include, among other things: the impact of COVID-19; risks and uncertainties related to the ability to obtain, amend, or maintain licenses, permits, or surface rights; risks associated with technical difficulties in connection with mining activities; and the possibility that future exploration, development or mining results will not be consistent with the Company's expectations. Actual results may differ materially from those currently anticipated in such statements. Readers are encouraged to refer to the Company's public disclosure documents for a more detailed discussion of factors that may impact expected future results. The Company undertakes no obligation to publicly update or revise any forward-looking statements, unless required pursuant to applicable laws. We advise U.S. investors that the SEC's mining guidelines strictly prohibit information of this type in documents filed with the SEC. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties.
View original content to download multimedia:
SOURCE Blue Sky Uranium Corp.
|
https://www.whsv.com/prnewswire/2022/04/11/blue-sky-uranium-resumes-exploration-drilling-program-targets-close-ivana-deposit-within-uranium-vanadium-amarillo-grande-project-argentina/
| 2022-04-11T12:28:02Z
|
MILWAUKEE, April 11, 2022 /PRNewswire/ -- Briggs & Stratton is pleased to announce the launch of its new Power Protect™ Non-Emergency 20kW1 and 26kW1 standby generators2 as the latest addition to its Power Protect line of standby home generators. The PPNE20 and PPNE26 models come with the same efficiency, durability and serviceability of current Power Protect models with the added benefit of being non-emergency certified. The non-emergency certification allows homeowners to partner with their utility or power cooperative on available demand response programs3.
Demand response programs are a mutually beneficial way for homeowners to partner with utility companies and cooperatives in reducing and preventing outages caused by overloaded power grids. With demand response, homeowners who select the PPNE20 or PPNE26 standby generator can rely on an alternate power source during high-demand periods, reducing the overall load on the utility's power grid.
"Demand for backup power and greater energy independence continues to grow due to increasing grid instability, severe weather events and the shift to spending more time in our homes," said Tom Rugg, senior vice president and president – Energy Solutions at Briggs & Stratton. "The new PPNE20 and PPNE26 standby generators put more power in the hands of homeowners to manage their energy consumption costs and ensure peace of mind even when the grid is experiencing outages. We anticipate more utility companies and energy cooperatives will add demand response programs, making the PPNE20 or PPNE26 a great investment for the future."
The PPNE20 and PPNE26 can be used in off-grid applications where utility power is unavailable; making it possible for consumers to enjoy the comforts brought by reliable access to power at their cabins or remote retreat locations.
These new units are a part of Briggs & Stratton's comprehensive line of high-quality home generators ranging in power from 10kW to 26kW for residential use and up to 200kW for commercial applications. It is another addition to the growing range of energy solutions offered by Briggs & Stratton, which includes home generators and SimpliPhi® Power energy storage and management systems.
The PPNE20 and PPNE26 are powered by a VanguardⓇ commercial-grade engine along with a high output alternator and Capacitive Discharge Ignition (CDI) coils that work together to provide the most power available on the market. The new units also allow for easier, streamlined routine maintenance with tool-less entry to all major components and back panel two screw removal. As on the 26kW, the internal components have an improved layout and are protected by a durable aluminum enclosure certified to withstand hurricane-force winds up to186mph.
Like the 12kW, 17kW, 20kW and 26kW predecessors, the PPNE20 and PPNE26 can be connected with an updated InfoHub™ system. The InfoHub collects in-depth data on performance and maintenance needs for enhanced generator management. It works in conjunction with the Briggs & Stratton® Service Diagnostic Tool, which simplifies service and troubleshooting.
About Briggs & Stratton
Briggs & Stratton, headquartered in Milwaukee, Wisconsin, provides innovative products and diverse power solutions to help people get work done. Briggs & Stratton is the world's largest producer of engines for outdoor power equipment, and is a leading designer, manufacturer and marketer of lithium-ion battery, standby generator, energy storage system, lawn and garden, turf care and job site products through its Briggs & Stratton®, Vanguard®, Ferris®, Simplicity®, Snapper®, Billy Goat®, Allmand®, SimpliPhi®, Branco® and Victa® brands. Briggs & Stratton products are designed, manufactured, marketed and serviced in more than 100 countries on six continents.
1 This generator is listed in accordance with UL (Underwriters Laboratories) 2200 (stationary engine generator assemblies) and CSA (Canadian Standards Association) standard C22.2 No. 100-14 (motors and generators).
2 This generator is certified for non-emergency use in conjunction with a power utility/cooperative demand response program. Not for sale in California.
3 Please contact your power utility/cooperative for details regarding available demand response programs. Programs may not be offered in all areas.
View original content to download multimedia:
SOURCE Briggs & Stratton
|
https://www.whsv.com/prnewswire/2022/04/11/briggs-amp-stratton-introduces-new-non-emergency-certified-standby-generators/
| 2022-04-11T12:28:08Z
|
Cisco is followed by Hilton, Wegmans Food Markets, Salesforce, and Nvidia
NEW YORK, April 11, 2022 /PRNewswire/ -- Today FORTUNE and Great Place to Work revealed their annual 100 Best Companies to Work For list, with Cisco taking top honors for the second year in a row. Of this year's leader, FORTUNE Senior Reporter Megan Leonhardt writes, "The tech giant has offered free counseling sessions through the company's employee assistance program for more than 20 years and recently boosted its digital therapy options […] It launched a companywide Day for Me, essentially an additional paid vacation day in spring 2020 to help workers prioritize self-care. Cisco formally implemented the benefit last year and has offered an extra eight days of paid time off so far, with an additional three planned in 2022." Read more about the companies on the list here.
Of this year's list, FORTUNE's editors write: "FORTUNE and our partner Great Place to Work have been publishing the Best Companies list for 25 years—none more fraught than the past two. While COVID-19 has forever changed the way we work, the best businesses are stepping up to support their employees as they navigate uncharted waters."
For the 25th anniversary of this list, FORTUNE has also noted the Longest-Recognized Best Companies to Work For. Cisco and Wegmans Food Markets, ranked first and third on this year's list, have been recognized every year the list has been published, along with Marriott International (23rd) and Publix Supermarkets (92nd).
The 2022 Top 10 Best Companies to Work For are:
- Cisco
- Hilton
- Wegmans Food Markets
- Salesforce
- Nvidia
- Accenture
- Rocket Companies
- American Express
- David Weekley Homes
- Capital One Financial
See the full list of the 100 Best Companies to Work For.
The 2022 100 Best Companies to Work For by the numbers:
- 238,959: The current number of open positions at the 100 Best Companies to Work For
- $24: The minimum amount Target will pay some retail workers per hour in 2022
- $2,000: The amount of the grant David Weekley Homes gives employees taking a four- to six-week sabbatical
- 18: The number of companies on the list that provide fully paid sabbaticals
- 20%: The percentage of Wegmans employees who are related to someone else who works at the supermarket chain
- $450 million: The amount that American Express spent on its DEI initiative between October 2020 and mid-2021
Also in the April/May 2022 issue of FORTUNE: "Feed Your Career," by Senior Editor Beth Kowitt, in which she explores why Publix and Wegmans have accomplished the rare feat of claiming a place on FORTUNE's Best Companies list for 25 straight years, and how the grocers are keeping employees happy and loyal at a time when retail workers are quitting in droves.
Kowitt writes, "Most striking about the Publix and Wegmans streak is that supermarket jobs, already notoriously low paying, have become even more grueling over the past two years as workers put their lives at risk by showing up every day in the middle of a pandemic. Layer on the stress of dealing with disgruntled customers, and it's clear why so many workers have reached a breaking point. In December 2021 some 786,000 retail employees quit—a record in an industry already plagued by high turnover." Read more here.
On April 25, 2022, in celebration of the 25th anniversary of the 100 Best Companies to Work For list, Fortune CEO Alan Murray, Great Place to Work® CEO Michael C. Bush, Target CEO Brian Cornell, Hilton CEO Chris Nassetta, Cisco CEO Chuck Robbins, and Accenture CEO Julie Sweet and other leading CEOs will discuss what it takes to make a company great, and how diversity, equity, inclusion, and belonging are essential for all modern companies seeking top talent and engaged employees. They will also discuss how remote and hybrid work is changing employee experience, focusing on what has worked, what hasn't worked, and the challenges to come. This virtual event is supported by Great Place to Work and UKG, and it is free and open to the public. Register here.
Great Place to Work determines the list using its proprietary For All methodology to evaluate and certify thousands of organizations in America's largest ongoing annual workforce study, based on over 870,000 employee survey responses and data from companies representing more than 6.1 million employees, this year alone.
The survey enables employees to share confidential quantitative and qualitative feedback about their organization's culture by responding to 60 statements on a five-point scale and answering two open-ended questions. Collectively, these statements describe a great employee experience, defined by high levels of trust, respect, credibility, fairness, pride, and camaraderie. In addition, companies provide organizational data like size, location, industry, demographics, roles, and levels.
Great Place to Work measures the differences in survey responses across demographic groups and roles within each organization to assess both the quality and consistency of the employee experience. Statements are weighted according to their relevance in describing the most important aspects of an equitable workplace.
Each company also answers six essay questions that provide greater insight into how and why the organization is great for all people. Responses are rigorously evaluated and cross-reviewed according to Great Place to Work's research-driven criteria. Survey data analysis and essay evaluation results are then factored into a combined score to compare and rank the companies that create the most consistently positive experience for all employees. Many companies survey every employee, far surpassing the minimum threshold of 5,000. While essay responses provide important context for rankings, only survey data can garner a list placement.
To be considered for the list, companies must be Great Place to Work-Certified™, have at least 1,000 U.S. employees, and cannot be a government agency. Great Place to Work requires statistically significant survey results, reviews anomalies in responses, news, and financial performance, and investigates any employee reports of company incompliance with strict surveying rules to validate the integrity of the results and findings. Data is also normalized to compare companies fairly across sizes and industries.
To find out more about how to become Great Place to Work-Certified and apply to this or other Best Workplaces lists, visit greatplacetowork.com.
The April/May 2021 issue of FORTUNE is on newsstands now.
FORTUNE drives the conversation about business. With a global perspective, the guiding wisdom of history, and an unflinching eye to the future, we report and reveal the stories that matter today-and that will matter even more tomorrow. With the trusted power to convene and challenge those who are shaping industry, commerce, and society around the world, FORTUNE lights the path for global leaders-and gives them the tools to make business better. For more information, visit www.fortune.com.
Alison Klooster
+1 646-437-6613
Alison.klooster@fortune.com
View original content to download multimedia:
SOURCE FORTUNE Media
|
https://www.whsv.com/prnewswire/2022/04/11/cisco-tops-fortunes-25th-annual-100-best-companies-work-list-in-2022/
| 2022-04-11T12:28:15Z
|
Florida municipality reduces costs and boosts employees' productivity by moving finance and HR applications to the cloud
AUSTIN, Texas, April 11, 2022 /PRNewswire/ -- The City of Tampa, one of Florida's largest municipalities, has upgraded its systems and operations with the Oracle Fusion Cloud Applications Suite. With Oracle Fusion Cloud Enterprise Resource Planning (ERP) and Oracle Fusion Cloud Human Capital Management (HCM), Tampa has been able to strengthen its IT security, reduce costs, and streamline employee tasks by improving its finance and HR processes. With the newly freed up time and resources, Tampa's staff has been able to dedicate more time to directly serving citizens.
Oracle Consulting led the implementation using its proven Oracle Soar methodology, migrating the city from its existing on-premises systems to Oracle Cloud Applications on time and on budget.
"When we saw that Oracle could deliver significantly more modern and secure systems, at a lower cost and in such a short timeframe using Oracle Soar, it was a no-brainer," said Russell Haupert, CIO, CTO and Director of IT, City of Tampa. "From ideation to implementation, Oracle brought their A-team. Moving key business systems is no easy feat. I've been through many implementations in my career, and this particular one was one we could be proud of with the help of Oracle Consulting."
With Oracle Cloud HCM and Oracle Cloud ERP, Tampa is standardizing processes, removing data silos across departments, and empowering employees with more self-service capabilities. Among other improvements, the city has already replaced its once onerous invoice process; reconfigured its approval processes, which were previously executed on two conflicting approval engines; and revamped the user experience for its employees. In addition, Tampa has also improved IT security with Oracle's consistent, automatic patching and is benefitting from the delivery of hundreds of new features every 90 days.
"Local governments work tirelessly to ensure the needs of their residents are met, which can be challenging with limited resources," said Steve Miranda, executive vice president of applications development, Oracle. "With Oracle Fusion Applications, the City of Tampa has an integrated suite of HR and finance solutions in the cloud that will help it drive innovation and increase organizational efficiency so that it can better serve its constituents."
About Oracle Soar
Oracle Soar is the world's first automated upgrade to the Oracle Cloud for business and governments. More than 400 customers have already moved to the cloud with Oracle Soar. These migrations have been 20 percent faster and up to 30 percent less expensive than migrations that do not use Oracle Soar. To learn more, visit: https://www.oracle.com/applications/soar/
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.
Trademarks
Oracle, Java, and MySQL are registered trademarks of Oracle Corporation.
Other
This document is not considered a recommendation or promotion of services of products.
View original content to download multimedia:
SOURCE Oracle
|
https://www.whsv.com/prnewswire/2022/04/11/city-tampa-redesigns-staff-operations-with-oracle-fusion-cloud-applications/
| 2022-04-11T12:28:22Z
|
The new code enables greater access to patients and surgeons in the treatment of massive irreparable rotator cuff tears
KALAMAZOO, Mich., April 11, 2022 /PRNewswire/ -- Stryker announced today The United States Centers for Medicare & Medicaid Services (CMS) has established a new Healthcare Common Procedure Coding System (HCPCS) code C9781 for outpatient hospitals and ambulatory surgery centers to report the insertion of Stryker's InSpace balloon implant, effective April 1.
The new HCPCS code will be used to facilitate the process of health insurance claims for individuals enrolled in Medicare and other health insurance programs, allowing for more patients to have access to care with InSpace.
Massive irreparable rotator cuff tears (MIRCTs) are one of the most common causes of shoulder dysfunction, and about 10 million Medicare beneficiaries are estimated to have such tears with prevalence increasing with age.1,2,3
The InSpace balloon implant* is a breakthrough solution in the shoulder continuum of care that addresses massive irreparable rotator cuff tears and provides a new, simple surgical treatment option, allowing surgeons to better meet the needs of their patients. InSpace is designed to restore the subacromial space, provides a less invasive solution compared to other surgical treatment options that require fixation devices or grafts and has been demonstrated to improve shoulder motion and function.4
"Pursuing an HCPCS code for InSpace has been a top priority for us to enable greater access for patients and surgeons in the treatment of MIRCTs," said Matt Moreau, Stryker's Sports Medicine Vice President and General Manager. "Reimbursement for new technologies can be a significant barrier for healthcare professionals and their patients. We are excited about the CMS code decision and are committed to continuing to provide opportunities to help create better care and access for patients."
About the decision
The CMS decision was based on findings from the Level 1 InSpace pivotal study – a prospective, single-blinded, multi-center, randomized, controlled trial which assessed the safety and effectiveness of the InSpace Implant (IS) compared to Partial Repair (PR). The study evaluated 184 (n=93 IS; n=91 PR) randomized patients > 40 years of age with symptomatic massive full thickness rotator cuff tears that failed non-operative management, through 24 months of follow-up. 4
More information about the InSpace balloon implant is available at www.stryker.com/inspace.
About Stryker
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
Media contact
Kara Rasmussen
Sr. Director, Communications and PR
kara.rasmussen@stryker.com
Phone: 408 529 7512
1. Novi M, et al. Irreparable rotator cuff tears: challenges and solutions. Orthop Res Rev. 2018; 10:93-103.
2. Yamamoto A, et al. Prevalence and risk factors of a rotator cuff tear in the general population. J Shoulder Elbow Surg. 2010; 19(1):116-120.
3. Minagawa H, et al. Prevalence of symptomatic and asymptomatic rotator cuff tears in the general population: From mass-screening in one village. J Orthop. 2013; 10(1):8-12.
4. A prospective, single-blinded, multi-center, randomized, controlled, pivotal study to assess the safety and effectiveness of the InSpace device, compared to arthroscopic partial repair, for treatment of full thickness massive rotator cuff tears (MRCT). NCT02493660
*The InSpace™ subacromial tissue spacer system is indicated for the treatment of patients with massive, irreparable full-thickness torn rotator cuff tendons due to trauma or degradation with mild to moderate gleno-humeral osteoarthritis in patients greater than or equal to 65 years of age whose clinical conditions would benefit from treatment with a shorter surgical time compared to partial rotator cuff repair.
View original content to download multimedia:
SOURCE Stryker
|
https://www.whsv.com/prnewswire/2022/04/11/cms-grants-outpatient-facility-code-insertion-strykers-inspace-subacromial-balloon-spacer/
| 2022-04-11T12:28:28Z
|
- Terminal would satisfy up to 15% of Germany's current natural gas demand
- Project capable of providing nearly 25% of U.S. annual commitment to increase LNG supplies to Europe
- Dow to contribute land for the construction of the terminal as well as infrastructure services
- Zero-carbon emissions terminal expected to be operational by 2026
MIDLAND, Mich., April 11, 2022 /PRNewswire/ -- Dow Inc. (NYSE: DOW) announced today it has signed a definitive agreement to take a minority stake in the Hanseatic Energy Hub GmbH (HEH) and is working with HEH's current members to advance Germany's capabilities to import supplies of liquified natural gas (LNG), bio-liquified natural gas and synthetic natural gas through the construction of an import terminal.
The HEH consortium, which now includes Dow, Fluxys, Partners Group and Buss Group, is planning to build, own, and operate an import terminal for liquified gases on Dow's Stade, Germany industrial park. This zero-carbon emission terminal is to be built by 2026 and will be co-located with Dow's facilities in Stade. Dow is contributing the land for the construction of the terminal as well as infrastructure services, off-gas heat, site services and mutual harbor use rights.
With a projected regasification capacity of 13.3 billion cubic metres (bcm) of natural gas per year, the import terminal supports the Joint Statement between the European Commission and the United States on European Energy Security by satisfying up to 15% of Germany's current natural gas demand. The agreement would also allow the United States to meet nearly 25% of its goal to export 50 bcm of natural gas annually to Europe by 2030. Additionally, the terminal will repurpose off-gas heat at the Dow site for the carbon emissions-free regasification of the liquefied gas back to its gaseous state.
"This collaboration to construct an LNG import terminal in Germany takes a major step in enabling a stable, cost-effective and sustainable supply of energy to Europe," said Neil Carr president of Dow Europe, Middle East, Africa and India. "For Dow, this allows us to make a significant contribution to transforming the energy supply in Germany in support of its 2045 climate targets while increasing the competitiveness of Stade, a site important for serving Dow customers throughout Europe."
While Germany is retiring nuclear and coal fired power generation, its dependency on natural gas is expected to increase as a transition fuel until sufficient renewable energy comes available longer term. Today, Germany receives approximately half of its natural gas through pipeline imports from Russia and the country currently has no LNG regasification and import facilities.
The project is subject to final investment decision, which is expected by 2023.
Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance (ESG) leadership to achieve profitable growth and deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates 104 manufacturing sites in 31 countries and employs approximately 35,700 people. Dow delivered sales of approximately $55 billion in 2021. References to Dow or the Company mean Dow Inc. and its subsidiaries. For more information, please visit www.dow.com or follow @DowNewsroom on Twitter.
Twitter: https://twitter.com/DowNewsroom
Facebook: https://www.facebook.com/dow/
LinkedIn: http://www.linkedin.com/company/dow-chemical
Instagram: http://instagram.com/dow_official
View original content to download multimedia:
SOURCE The Dow Chemical Company
|
https://www.whsv.com/prnewswire/2022/04/11/dow-takes-minority-stake-consortium-constructing-lng-import-terminal-germany-diversifying-european-energy-supply/
| 2022-04-11T12:28:36Z
|
RYE, N.Y., April 11, 2022 /PRNewswire/ -- Premium Label & Packaging Solutions, LLC ("PLPS"), a portfolio company of Dunes Point Capital, LP ("DPC"), has acquired HP Mile, Inc, Label One and Privateer, LTD (collectively "HP Mile"). Located in Syracuse, NY, HP Mile is a converter of custom pressure sensitive labels, extended content labels and specialty tapes for the healthcare, food and beverage and aerospace markets. HP Mile has manufacturing facilities in Syracuse, NY and Old Saybrook, CT and employs approximately 40 people.
About DPC: DPC is a family office and private investment firm, pursuing control investments in companies operating in the general industrial and business services sectors. DPC targets companies with enterprise values of up to $1 billion. For more information, please visit www.dunespointcapital.com.
About PLPS: Headquartered in Rye, NY, PLPS is a specialty label converter producing custom pressure sensitive labels, shrink sleeves, booklet labels, flexible packaging and other products for the health, wellness, personal care, specialty food and beverage and other markets. For more information, please visit www.premiumlabelandpackaging.com.
About HP Mile: Located in Syracuse, NY, HP Mile is a converter of custom pressure sensitive labels, extended content labels and specialty tapes for the healthcare, food and beverage and aerospace markets. HP Mile has manufacturing facilities in Syracuse, NY and Old Saybrook, CT and employs approximately 40 people. For more information, please visit www.hpmile.com, www.labeloneusa.com, and www.privateerusa.com.
View original content:
SOURCE Dunes Point Capital, LP
|
https://www.whsv.com/prnewswire/2022/04/11/dunes-point-capital-lp-announces-premium-label-amp-packaging-solutions-llcs-acquisition-hp-mile-inc-label-one-privateer-ltd/
| 2022-04-11T12:28:43Z
|
BiomEdit intends to discover and develop animal health products that leverage microbiome science to improve animal health, animal protein production, and livestock disease monitoring
GREENFIELD, Ind. and BOSTON, April 11, 2022 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN), a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, today announced the launch of BiomEdit, a microbiome innovation company that is expected to discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines and microbial monitoring services for animal health.
Microbiome science is a rapidly growing field creating breakthroughs in animal health based on the microbial communities in animals and the surrounding environment. BiomEdit intends to discover, develop and introduce differentiated products that address some of the greatest needs for innovation in animal health, including medicated feed ingredients, nutritional health and therapeutics for livestock and pet species, as well as biosecurity technology for animal disease monitoring.
In October 2021, Elanco announced its intention to carve out its microbiome platform and pipeline under the leadership of Aaron Schacht, BiomEdit CEO and former Elanco executive vice president of Innovation, Regulatory and Business Development, to concentrate and focus more resources on its high value late-stage Pet Health pipeline. BiomEdit is the result of this separation, and was developed with Ferment Co., the company creation studio that helps ideate and launch new companies across a variety of end-markets that use cell programming to support human and environmental health and well-being.
Elanco will contribute intellectual property and a pipeline of ongoing programs to BiomEdit, which will be staffed with members of the former Elanco microbiome R&D team. The team brings the expertise and experience needed to build on the foundation of microbiome work started at Elanco. By leveraging foundational programs from Elanco, intellectual property from both Elanco and Ginkgo, and an experienced team, BiomEdit should be well positioned as a stand-alone company to develop and launch innovative products to address unmet needs in animal health.
"Livestock producers and veterinarians are calling for new products that address antibiotic resistance and improve livestock sustainability," said Mr. Schacht. "Coupling the platform, pipeline and deep expertise of the former Elanco microbiome team with Ginkgo's unique screening and strain engineering capabilities will accelerate and amplify our ability to advance novel animal microbiome inspired products for animal health."
"Elanco is excited to continue its participation in the microbiome by partnering with Ginkgo, Viking Global Investors and Anterra Capital to create the next-generation animal health innovation player," said Jeff Simmons, president and CEO of Elanco Animal Health. "We wish Aaron and his team the best as they build out this novel innovation platform to address unmet needs in animal health, such as alternatives to antibiotics."
Ginkgo has significant expertise in the discovery, design and monitoring of microbes at scale for a wide array of functions. BiomEdit plans to leverage Ginkgo's state-of-the-art cell programming platform to improve the design and development of probiotics, bioactives, engineered microbial medicines, and microbial monitoring services. BiomEdit joins other Ginkgo Bioworks platform ventures such as Joyn Bio, Motif FoodWorks, Allonnia, Arcaea, Verb Biotics and Ayana Bio.
"We are always on the lookout for opportunities to accelerate our partners' abilities to address massive challenges, such as antibiotic resistance in livestock," said Jason Kelly, CEO of Ginkgo. "Together, we see Ginkgo and BiomEdit addressing significant opportunities in the animal health industry with new breakthroughs based on microbiome science. We deeply depend on the health of animals in our ecosystem and supply chains; the potential applications for our cell programming platform in this area are far reaching."
In addition to the assets and intellectual property contributed by Elanco and Ginkgo, BiomEdit is launching with a targeted Series A funding raise of $40 million, with participation by Viking Global Investors and Anterra Capital. In exchange for their respective asset and intellectual property contributions, Elanco and Ginkgo are expected to retain approximately 40% combined proportional ownership of BiomEdit, on a fully-diluted basis, upon the completion of the Series A financing. Elanco's ownership will be in non-voting shares.
J.P. Morgan Securities LLC acted on behalf of Elanco as sole placement agent on the financing.
About BiomEdit
BiomEdit is a microbiome innovation company that discovers, designs and develops novel probiotics, microbiome derived bioactives and engineered microbial medicines to address unmet needs in animal health. We partner with Ginkgo Bioworks to amplify and accelerate product discovery and development with a goal of introducing breakthrough innovation for livestock producers and veterinarians.
About Elanco
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ Sustainability/ESG Pledges –all to advance the health of animals, people, and the planet. Learn more at elanco.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
About FermentCo
The Ferment Co is a company creation studio for the next wave of synthetic biology product companies. The Ferment Co is powered by Ginkgo Bioworks, the world's most advanced platform for cell programming. Learn more at www.Ferment.co.
Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the potential success of the partnership and Ginkgo's cell programming platform. These forward-looking statements generally are identified by the words "believe," "can," "project," "potential," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the effect of Ginkgo's business combination with Soaring Eagle Acquisition Corp. ("Soaring Eagle") on Ginkgo's business relationships, performance, and business generally, (ii) risks that the business combination disrupts current plans of Ginkgo and potential difficulties in Ginkgo's employee retention, (iii) the outcome of any legal proceedings that may be instituted against Ginkgo related to its business combination with Soaring Eagle, (iv) volatility in the price of Ginkgo's securities now that it is a public company due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, changes in laws and regulations affecting Ginkgo's business and changes in the combined capital structure, (v) the ability to implement business plans, forecasts, and other expectations after the completion of the business combination, and identify and realize additional opportunities, (vi) the risk of downturns in demand for products using synthetic biology, (vii) the unpredictability of the duration of the COVID-19 pandemic and the demand for COVID-19 testing and the commercial viability of our COVID-19 testing business, and (viii) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of Ginkgo's annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on March 29, 2022 and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Ginkgo does not give any assurance that it will achieve its expectations.
Forward-Looking Statements of Elanco
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (Exchange Act). Forward-looking statements are based on Elanco's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, Elanco's actual results may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include regional, national, or global political, economic, business, competitive, market, and regulatory conditions, including but not limited to the impact of disruptive innovations and advances in veterinary medical practices, animal health technologies and alternatives to animal-derived protein; whether the operational and strategic benefits of the transaction described herein can be achieved; and whether the uncertainty of announcing the separation initiative will have adverse impacts on the employees, customers and suppliers related to Elanco's microbiome platform or its business generally. For additional information about the factors that could cause actual results to differ materially from forward-looking statements, please see Elanco's latest Form 10-K and subsequent Form 10-Qs filed with the Securities and Exchange Commission. Although Elanco has attempted to identify important risk factors, there may be other risk factors not presently known to Elanco or that it presently believes are not material that could cause actual results and developments to differ materially from those made in or suggested by the forward-looking statements contained in this press release. If any of these risks materialize, or if any of the above assumptions underlying forward-looking statements prove incorrect, actual results and developments may differ materially from those made in or suggested by the forward-looking statements contained in this press release. Elanco cautions you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements that are included elsewhere in this press release. Any forward-looking statement made by Elanco in this press release speaks only as of the date thereof. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible to predict all of them. Elanco undertakes no obligation to publicly update or to revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com
ELANCO INVESTOR CONTACT
Katy Grissom
+1.317.273.9248
kathryn.grissom@elancoah.com
ELANCO MEDIA CONTACT
Colleen Parr Dekker
+1.317.989.7011
olleen.dekker@elancoah.com
View original content:
SOURCE Ginkgo Bioworks
|
https://www.whsv.com/prnewswire/2022/04/11/elanco-ginkgo-bioworks-launch-biomedit-new-animal-health-company-leveraging-microbiome-technology/
| 2022-04-11T12:28:49Z
|
TORONTO, April 11, 2022 /PRNewswire/ - Electra Battery Materials Corporation (TSXV: ELBM) (OTCQX: ELBMF) ("Electra") today announced the appointment of Renata Cardoso as Vice-President, Sustainability and Low Carbon. In this capacity, Renata will have overall responsibility for the Company's mission to exceed global ESG norms in the industry, in line with Electra's business objective to be the partner of choice in the EV market. Ms. Cardoso is joining the Company after 15 years with global miner Vale. Ms. Cardoso has extensive experience leading corporate sustainability and climate change strategy in the international mining and metals industry.
- Electra is committed to being the most sustainable and lowest GHG producer of battery materials in the world
- As a key member of the senior leadership team, Ms. Cardoso will guide the development of ESG strategy
- In her previous roles, Ms. Cardoso led cross functional teams to develop and implement a low carbon roadmap for operations across Canada, Indonesia, UK and Brazil
"We are very pleased to have attracted a global leader in sustainability to our organization," said Trent Mell, CEO. "Renata's track record in climate change management, sustainability strategy and transparency will serve Electra well as we commission our cobalt sulfate refinery in December and advance our battery recycling plant in 2023. We intend to have the lowest carbon footprint of all cobalt sulfate producers in the world, and Renata will oversee our journey to carbon neutrality and ensure that the same standards are applied to all phases of future growth."
"It is an honour to join Electra as the company executes its strategic plan to become the most sustainable battery materials company in the world," said Renata Cardoso. "The North American battery materials supply chain is quickly evolving and our leading ESG credentials will be what establishes Electra as an industry leader."
Ms. Cardoso is a seasoned professional from one of the largest mining companies in the world. An economist by training who also holds an MBA, Renata began her career in Vale's corporate strategy group. In 2008, she transitioned to help create Vale's approach for Sustainability with responsibilities for climate change management, sustainability strategy and transparency, and social and environmental indicators performance management. In 2019, she joined Vale Canada, last serving in low carbon initiatives, leading cross functional teams to develop and implement a low carbon roadmap for operations in Canada, Indonesia, UK and Brazil.
In accordance with the Company's long term incentive plan, Electra has granted incentive stock options to purchase an aggregate of 350,000 pre-consolidation common shares of Electra exercisable at the previous day's closing price of C$0.32 for a period of five years. The stock options will vest in three equal tranches on the first, second and third anniversary of the grant date. Long-term incentive grants are a key retention and incentive tool for key employees and new hires and remain subject to the approval of the TSX Venture Exchange.
Electra is planning to build a fully integrated, localized and environmentally sustainable battery materials park. Leveraging the Company's own mining assets and business partners, the Electra Battery Materials Park is expected to host cobalt and nickel sulfate production plants, a large-scale lithium-ion battery recycling facility, and battery precursor materials production, which will serve both North American and global customers. Electra also owns the advanced exploration-stage Iron Creek cobalt-copper project in Idaho, USA. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable and traceable raw materials for the region's fast growing electric vehicle industry.
On behalf of Electra Battery Materials.
Trent Mell
Chief Executive Officer
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements and forward-looking information (together, "forward-looking statements") within the meaning of applicable securities laws and the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified by the use of terminology such as "plans", "expects', "estimates", "intends", "anticipates", "believes" or variations of such words, or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Forward-looking statements involve risks, uncertainties and other factors that could cause actual results, performance, and opportunities to differ materially from those implied by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements are set forth in the management discussion and analysis and other disclosures of risk factors for Electra Battery Materials Corporation, filed on SEDAR at www.sedar.com. Although Electra Battery Materials Corporation believes that the information and assumptions used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed times frames or at all. Except where required by applicable law, Electra Battery Materials Corporation disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
View original content to download multimedia:
SOURCE Electra Battery Materials Corporation
|
https://www.whsv.com/prnewswire/2022/04/11/electra-strengthens-esg-leadership/
| 2022-04-11T12:29:01Z
|
CORPUS CHRISTI, Texas, April 11, 2022 /PRNewswire/ - enCore Energy Corp. ("enCore" or the "Company") (TSXV: EU), (OTCQB: ENCUF) is pleased to announce positive results from its on-going uranium delineation and exploration drill programs at its 100% owned Rosita South project. The Rosita South project is adjacent to enCore's licensed past-producing Rosita In-Situ Recovery (ISR) Uranium Processing Plant (Rosita Plant), Texas. The Rosita South area provides one of the most optimal source of future feed for the Rosita Plant. The Company has recently added a 3rd drill rig with 2 additional rigs expected to begin in the near term.
Highlights of the Rosita South uranium delineation and exploration drill programs include:
- 32 drill holes reported for a total of ~11,000 feet including 20 delineation drill holes and 12 exploration drill holes;
- The exploration drilling has identified 8 mineralized sands plus an additional 4 potentially mineralized sands, all within 800 feet of the surface, which provide opportunities for discovery of future uranium resources across the entire Rosita project
- Delineation drill results established an extension of mineralization in the Production Area which supports the start-up of the Rosita Plant expected next year.
To view the project map and geologic section: https://bit.ly/3NXX1Fl.
"We are pleased with the initial results from the on-going drill programs which have been designed to expand known mineralization at Rosita South and explore for new deposits at depth. The results indicate enhanced potential for further uranium mineralization not only from the previously known shallow deposits but more importantly the virtually untested numerous stacked mineralized sands underlying the licensed production area," said William M. Sheriff, Executive Chairman. "The potential of multiple stacked uranium mineralized units can be compared in concept to oil and gas where there are commonly multiple pay zones (oil and gas bearing units) in a producing well or in many gold systems where near surface gold deposits overlay one or more deeper-rooted structures or units with gold mineralization. The addition of more drill rigs will increase the pace and breadth of both our delineation of known mineralization and exploration of these deeper mineralized sands."
Twenty drill holes for a total of 4,030 feet were designed to in-fill and confirm known mineralization at Rosita South. The current drilling has extended uranium mineralization over 300 feet laterally beyond the previously known limits of ISR amenable uranium mineralization.
Twelve deeper exploration holes, totaling 7,380 feet, were designed to test for uranium bearing sands below the known shallow mineralized sands at Rosita South. The success of this exploration program has been made possible through the recently acquired access to more than 1,500 drill logs and historical geological data from Mobil Energy Minerals Company, Moore Energy Corporation and URI, Inc.
The evaluation of this newly-acquired data led to the 12 drill holes which intercepted highly anomalous down-hole gamma radiation indicative of uranium mineralization from 8 mineralized sands and an additional 4 potentially mineralized sands within the Goliad and Oakville formations. All of these sands lie within 800 feet of surface beneath the project area. Previous ISR recovery in the Rosita Production Area was confined to the shallowest of these units, leaving the lower sandstone units essentially untested. "Acquisition and archiving of historical exploration data has been an important part of our corporate strategy from the beginning and promises to save us millions of dollars in exploration expense as we go forward with our expansion plans," Sheriff noted.
enCore's Rosita Plant, located approximately 60 miles from Corpus Christi, Texas, is a licensed, past-producing in-situ recovery (ISR) uranium plant currently under refurbishment. With a completion deadline at the end of Q2/2022, the plant is on schedule and on budget to meet a 2023 production target. The Rosita Plant is designed to process uranium feed from multiple satellite operations, all located in the South Texas area and is 1 of 11 licensed uranium processing plants in the United States, 2 of which are owned by enCore Energy.
The Company also advises it has appointed Red Cloud Securities Inc. and Red Cloud Financial Services Inc. (together "Red Cloud") to provide the Company with a range of capital markets advisory services. Red Cloud is a Toronto-based financial services company that provides assistance to mineral exploration and mining companies in accessing capital markets and enhancing their corporate profile. Under the engagement, Red Cloud will be paid a fee of $10,000 per month for the services it will render for a one year period.
All drill holes are 5.625 inch diameter rotary-mud holes. Each hole is logged with electrical and gamma methods upon completion. Any anomalous gamma readings are followed up with Prompt Fission Neutron (PFN) surveys which provide direct and accurate in-situ uranium values eliminating any concerns over disequilibrium. The Company owns and operates 2 logging trucks and 5 PFN tools.
Many uranium deposits have a degree of disequilibrium, whereby the radioactivity measured in drill holes using traditional gamma methods does not accurately correspond to ore grade, due to the continued decay of uranium daughter products including potassium, thorium, lead and bismuth relative to radium (Ra226), a significant gamma emitter. Traditionally, accurate uranium values are determined by chemical assay of drill core which is time consuming and expensive.
Without accurate uranium values, the potential to make inaccurate estimates of mineralization on both the high and low side is ever present. PFN analysis is instantaneous and accurate eliminating potential errors by using neutron activation to directly detect and quantify uranium content in place down the drill hole.
The PFN tool creates very fast neutrons (14MeV) and fires 108 neutrons per second. Therefore, the neutrons emitted by the PFN tool excite, at an atomic level, in-situ uranium atoms in the drill hole, creating fast (epithermal) neutrons and slow (thermal) neutrons. The ratio of epithermal to thermal neutrons is proportional to uranium, allowing the U3O8 ore grade to be accurately calculated. This provides a relatively inexpensive and instantaneous means for accurate assaying in-situ ore grades over large areas, and allows for accurate ore body mapping, resource estimation, and wellfield planning.
Mark Pelizza, MSc. Geo. Eng., CPG-11821, a Director for the Company, and a Qualified Person under NI 43-101, has approved the technical disclosure in this news release.
enCore Energy is rapidly advancing towards becoming the next producer of American uranium. With approximately 90 million pounds of U3O8 estimated in the measured and indicated categories and 9 million pounds of U3O8 estimated in the inferred category1, enCore is the most diversified in-situ recovery uranium development company in the United States. enCore is focused on becoming the next uranium producer from its licensed and past-producing South Texas Rosita Processing Plant by 2023. The South Dakota-based Dewey Burdock and Wyoming Gas Hills projects offer mid-term production opportunities with significant New Mexico uranium resource endowments providing long-term opportunities. The enCore team is led by industry experts with extensive knowledge and experience in all aspects of ISR uranium operations and the nuclear fuel cycle.
____________________________
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements relating to the intended use of the net proceeds of the Offering and the completion of any capital project or property acquisitions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; future legislative and regulatory developments; inability to access additional capital; the ability of enCore to implement its business strategies; and other risks. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
View original content to download multimedia:
SOURCE enCore Energy Corp.
|
https://www.whsv.com/prnewswire/2022/04/11/encore-energy-discovers-stacked-multiple-uranium-bearing-sandstones-extends-mineralization-rosita-south-project-texas/
| 2022-04-11T12:29:07Z
|
Partnership Brings Combined Expertise in Electronic Transit Payments
MARKHAM, ON, April 11, 2022 /PRNewswire/ - Enghouse Transportation, a unit of Enghouse Systems Limited (TSX: ENGH) has partnered with electronic payment firm Switchio (a division of Monet+) to expand its automated transit fare collection offering.
Enghouse Transportation, an established provider of automated fair collection transit software solutions in the Netherlands, Central Europe and Eastern Europe, is expanding into the North American market.
"Our strategic cooperation with Switchio bolsters our ability to deliver transit solutions in the United States, Canada and other markets," said Toofan Otaredian, Managing Director of Enghouse Transportation.
"Switchio has unique strengths in its Smart Cities portfolio, especially EMV card acceptance in public transit and parking. Switchio also offers modular solutions that enable quick and effortless EMV bank card payments for transit systems and operators."
Switchio is headquartered in the Czech Republic. The Company participated in the country's first chip payment card systems. "We're very pleased to embark on this new collaboration with Enghouse," said Switchio transport business leader, Jaroslav Stuchlík. "We have already established a presence in the Americas with a successful implementation in Guatemala and another is currently underway in Chile. We now look forward to introducing our innovative digitalization solution to the North American market."
Enghouse Transportation is an innovative provider of end-to-end electronic ticketing technologies that also provides transit agencies and operators with improved passenger experiences and cost-cutting hardware and software solutions. Customized to the needs of each client, Enghouse Transportation delivers expert solutions in automated fare collection (AFC), sales and service, and back-office systems. For more information, please visit www.enghousetransportation.com.
Switchio is a powerful software platform that enables public transit operators to manage multiple open-loop electronic payments in a variety of ticketing modes under a single system. Delivered as a comprehensive white-label solution for contactless passenger ticketing, it brings operators substantial savings while elevating the passenger experience to new levels of convenience. In addition to transport, Switchio also has applications in sectors that include retail, parking and petrol stations. At its core is a secure payment switch that gives businesses the ability to partner with the acquirer and hardware provider of their choice. For more information, please visit Switchio.com.
View original content:
SOURCE Enghouse Systems Limited
|
https://www.whsv.com/prnewswire/2022/04/11/enghouse-transportation-partners-with-switchio-expand-transit-customer-payment-offering/
| 2022-04-11T12:29:14Z
|
- Fedasz will Focus on Opening New Markets for Evofem's First - and Only – in-Class Contraceptive, Phexxi® (lactic acid, citric acid, and potassium bitartrate)
SAN DIEGO, April 11, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced the appointment of Karina Fedasz as its Head of Business Development. At Evofem, Karina will oversee the company's business development, product and pipeline portfolios, new business ventures, and the advancement of access partnerships around the world.
"Evofem is bringing increasing numbers of women access to Phexxi, a hormone-free contraceptive, in the United States. We are now stepping up efforts to bring women access to Phexxi outside the U.S.," said Saundra Pelletier, Chief Executive Officer of Evofem. "Karina's decades of success in deal-making, in our ever-increasing global economy, has already started helping Evofem establish and build the partnerships that will allow Phexxi access to new markets around the world."
Fedasz has held various executive roles in business development, operations, finance, and mergers and acquisitions. Earlier in her career, while at JP Morgan, she executed partnerships and deals around the globe as well as at a variety of start-ups. These deals and partnerships have included nine-figure acquisitions and have assisted companies in growing into multi-million-dollar corporations in less than three years. Fedasz graduated from UCLA and received her MBA from Columbia Business School.
"Evofem offers the opportunity to work with a world-class team focused on helping women around the globe maintain control of their reproductive health," said Karina Fedasz, Head of Business Development. "Our strategy is clear and set on opening new markets for Phexxi outside the U.S."
Evofem will report its first-quarter 2022 results on May 4, 2022.
About Phexxi® (lactic acid, citric acid, and potassium bitartrate)
Phexxi® is an on-demand method of birth control used to prevent pregnancy. Phexxi is not effective when used after sex.
Important Safety Information
- Rare cases (0.36%) of bladder and kidney infections have been reported. If you have a history of urinary tract problems that keep coming back, you should not use Phexxi.
- Contact your healthcare provider if you are experiencing genitourinary side effects such as vaginal burning, itching, discharge, genital discomfort (including in male partners), yeast infection, urinary tract infection, or bacterial vaginosis.
- Phexxi does not protect against sexually transmitted infections, including HIV.
For more information about Phexxi, talk to your healthcare provider and see full Product Information at www.phexxi.com.
Please report side effects by contacting Evofem Biosciences toll-free at 1-833-EVFMBIO or contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Intended for United States residents only.
About Evofem Biosciences
Evofem Biosciences, Inc. (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from chlamydia and gonorrhea. The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and evofem.com.
Phexxi® is a registered trademark of Evofem Biosciences, Inc.
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor for forward-looking statements provided by Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Various factors could cause actual results to differ materially from those discussed or implied in the forward-looking statements, including, without limitation, market and other conditions, the likelihood or ability to consummate an ex-U.S. transaction, whether any regulatory approvals for marketing of Phexxi outside the U.S. can be obtained, and you are cautioned not to place undue reliance on these forward-looking statements, which are current only as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Important factors that could cause actual results to differ materially from those discussed or implied in the forward-looking statements or that could impair the value of Evofem Biosciences' assets and business are disclosed in the Company's SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 10, 2022. All forward-looking statements are expressly qualified in their entirety by such factors. The Company does not undertake any duty to update any forward-looking statement except as required by law.
Media Contact
Jack Hirschfield
Evofem Biosciences, Inc.
jhirschfield@evofem.com
(512) 674-5163
Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
(917) 673-5775
View original content to download multimedia:
SOURCE Evofem Biosciences, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/evofem-announces-karina-fedasz-companys-new-head-business-development/
| 2022-04-11T12:29:20Z
|
PHOENIX, April 11, 2022 /PRNewswire/ - Excelsior Mining Corp. (TSX: MIN) (PFSE: 3XS) (OTCQX: EXMGF) ("Excelsior" or the "Company") is pleased to announce assay results from the infill drill program on the Johnson Camp mine pits (JCM) located in Cochise County, southeastern Arizona.
"The infill drill results from the Burro pit are in-line with existing drilling. If anything, mineralization appears better and shallower at the north end, but thinning at the south end of the existing pit. We look forward to getting all the results back, completing the geological and resource interpretations and design optimization, with our goal of restarting of the JCM open pits later this year." Comments Roland Goodgame, Senior Vice President Business Development.
The improved results at the north end of the pit, including the high average leaching potential, should allow the Company to develop a mine plan that targets the high-grade section to maximize cashflows at the start of operations. Permitting of the new leach pad to restart operations is in progress and the Company's goal remains to restart mining operations at JCM later this year.
A total of 31 of the 34 planned holes have been drilled using diamond drill rigs, with 6 holes drilled waiting on assays. Sequential copper assays for approximately 73% of the entire drill program are complete, with the average leaching potential exceeding 60% (excludes intervals that contain sulfide mineralization). Assay highlights are included in Table 1 below. Full assays are included in Table 2.
Mineralized Zone: O = Oxide, T = Transition, S = Sulfide.
The leaching potential of copper ores is defined as acid soluble copper (AsCu) plus sodium cyanide soluble copper (CNCu) divided by total copper (TCu).
All samples are prepared from manually split or sawn PQ or HQ core sections on site in Arizona. Split drill core samples are then sent to Skyline Assayers & Laboratories in Tucson, Arizona for Total Copper and Sequential Copper analyses. Standards, blanks, and duplicate assays are included at regular intervals in each sample batch submitted from the field as part of an ongoing Quality Assurance/Quality Control Program. Pulps and sample rejects are stored by Excelsior for future reference.
Table 2
Mineralized Zone: O = Oxide, T = Transition, S = Sulfide.
The Johnson Camp Mine ("JCM") has historically been an open pit, heap leach operation since Cyprus Minerals opened the property in the 1970's. The operation includes two open pits, a two-stage crushing-agglomerating circuit, a fully functioning SX-EW plant capable of producing 25 million pounds of cathode copper per year, a complete set of PLS and raffinate ponds, and full infrastructure (ancillary facilities, access, power, water, and communications).
Excelsior's exploration work on the Johnson Camp mine is supervised by Stephen Twyerould, Fellow of AUSIMM, President and CEO of Excelsior and a Qualified Person as defined by NI 43-101. Mr. Twyerould has reviewed and is responsible for the technical information contained in this news release. Mr. Twyerould has verified the data disclosed in this news release, including sampling, analytical and test data underlying the information disclosed in this news release. Mr. Twyerould has verified that the results were accurate from the official assay certificates provided to Excelsior
Excelsior "The Copper Solution Company" is a mineral exploration and production company that owns and operates the Gunnison Copper Project in Cochise County, Arizona. The project is a low cost, environmentally friendly in-situ recovery copper extraction project that is permitted to 125 million pounds per year of copper cathode production. Excelsior also owns the past producing Johnson Camp Mine and a portfolio of exploration projects, including the Peabody Sill and the Strong and Harris deposits.
For more information on Excelsior, please visit our website at www.excelsiormining.com.
This news release contains "forward-looking information" concerning anticipated developments and events that may occur in the future. Forward looking information contained in this news release includes, but is not limited to, statements with respect to: (i) the intention to mine Johnson Camp and future production therefrom; (ii) permitting timelines; and (iii) the development timeline to mine Johnson Camp.
In certain cases, forward-looking information can be identified by the use of words such as "plans", "expects" or "does not expect", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved" suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Forward-looking information contained in this news release is based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and mineral reserves, the realization of resource and reserve estimates, expectations and anticipated impact of the COVID-19 outbreak, copper and other metal prices, the timing and amount of future development expenditures, the estimation of initial and sustaining capital requirements, the estimation of labour and operating costs (including the price of acid), the availability of labour, material and acid supply, receipt of and compliance with necessary regulatory approvals and permits, the estimation of insurance coverage, and assumptions with respect to currency fluctuations, environmental risks, title disputes or claims, and other similar matters. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.
Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include risks inherent in the construction and operation of mineral deposits, including risks relating to changes in project parameters as plans continue to be redefined including the possibility that mining operations may not be sustained at the Gunnison Copper Project, risks relating to variations in mineral resources and reserves, grade or recovery rates, risks relating to the ability to access infrastructure, risks relating to changes in copper and other commodity prices and the worldwide demand for and supply of copper and related products, risks related to increased competition in the market for copper and related products, risks related to current global financial conditions, risks related to current global financial conditions and the impact of COVID-19 on the Company's business, uncertainties inherent in the estimation of mineral resources, access and supply risks, risks related to the ability to access acid supply on commercially reasonable terms, reliance on key personnel, operational risks inherent in the conduct of mining activities, including the risk of accidents, labour disputes, increases in capital and operating costs and the risk of delays or increased costs that might be encountered during the construction or mining process, regulatory risks including the risk that permits may not be obtained in a timely fashion or at all, financing, capitalization and liquidity risks, risks related to disputes concerning property titles and interests, environmental risks and the additional risks identified in the "Risk Factors" section of the Company's reports and filings with applicable Canadian securities regulators.
Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information is made as of the date of this news release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information.
View original content to download multimedia:
SOURCE Excelsior Mining Corp.
|
https://www.whsv.com/prnewswire/2022/04/11/excelsior-mining-announces-interim-assay-results-jcm-infill-drill-program/
| 2022-04-11T12:29:27Z
|
ATLANTA, April 11, 2022 /PRNewswire/ -- Family Ties Enterprises, Inc. and TQIntelligence today announced that Family Ties Enterprises, Inc. will integrate Clarity AI, TQIntelligence's digital health platform, into in-school programs throughout Georgia to provide mental health services to the most vulnerable patient population.
TQIntelligence's Clarity AI features a unique voice-based algorithm that objectively identifies and targets high-risk patients to improve treatment outcomes, reduce unnecessary hospitalizations, ER visits, and other high-dollar services. Using predictive analytics to manage high-risk patients in this way supports Family Ties Enterprises, Inc.'s vision of being a data-driven behavioral health organization.
Family Ties Enterprises, Inc. will be piloting Clarity AI in its school-based program, which serves more than 90 schools in Georgia, and has been awarded the APEX grant, with school year 2022-2023 being its second-year funding. The grant, which is sanctioned through the Governor's office of Georgia, strives to build capacity, and increase access to mental health services for school-aged youth, Pre-Kindergarten to 12th grade, throughout the state.
"The youth and families served in our Intensive In-Home behavioral health programs represent some of the most complex youth in the Georgia system of care," said Ciara Green, CEO of Family Ties Enterprises, Inc. "These are youth that due to exposure are usually plagued with complex trauma and higher ratings on clinical assessment scales; we have a history of using evidence based modalities to address complex trauma. Due to attrition in the field on a national level right now, cases at times can also be staffed by clinicians that are newer in the field, so I am beyond thrilled that we are putting this innovative tool in their toolbelts."
The two organizations will use the cutting-edge voice algorithm to support school systems as a whole. Schools have been under a great deal of pressure to address additional trauma-related cases brought about by COVID. The new initiative will focus on improving mental health outcomes for this population with the goal of improving the quality of life of youth, increasing their level of function, and improving academic performance.
"COVID has disproportionately impacted underserved communities that were struggling before COVID and schools need innovative technologies to measure students' trauma burden," said Dr. Yared Alemu, founder and CEO of TQIntelligence. "Our digital health solutions help identify trauma severity quickly, track treatment outcomes systematically, and monitor high-risk students remotely."
This collaboration highlights Family Ties Enterprises, Inc.'s commitment to innovation, not only to address current problems of affordable quality mental health services but also to deal with the upcoming shortage of mental health providers. Clarity AI has added a solution to support providers by automating the clinical documentation process, which reduces the amount of time therapists spend documenting by 50 percent.
"We are excited to see how TQIntelligence will help us respond to patient data in real-time to improve the quality of interventions performed by the Therapists," Green continued. "As the pilot renders successful outcomes, it is Family Ties Enterprises, Inc.'s hope that we could find pathways to expand TQIntelligence more broadly across our continuum of mental health services at Family Ties Enterprises, Inc."
About Family Ties Enterprises, Inc. Headquartered in Atlanta Georgia, Family Ties Enterprises, Inc. is a human services leader transforming lives through early childhood, family stability, and mental health services. Family Ties Enterprises, Inc. is a leader in adopting evidence-based services, and trauma-informed care, for children 4-18 and Adults and their families, via telehealth and in-person. They have been recognized on the national level as a NNED partner of the month Family Ties Enterprises, Inc. who employs 160 staff in 12 counties throughout the state of Georgia, and is led by President Ciara Green, LCSW. To read more about Family Ties Enterprises, Inc., go to https://www.familytiesinc.com/, or email info@familytiesinc.com
About TQIntelligence, Inc
TQIntelligence is a Georgia Institute of Technology incubator company and the National Science Foundation (NSF) Small Business Innovation Research (SBIR Phase I and II) recipient. The grant supports TQIntelligence's R&D leveraging human voice/speech and Artificial Intelligence (AI) to develop a voice biomarker of psychological distress in children and adolescents. The voice-based algorithm enables multidisciplinary teams to collaborate to deliver affordable quality mental health care. TQI's innovation augments emerging therapists' clinical capabilities to improve their therapeutic effectiveness. TQI is a portfolio company for Startup Health, BCBS of Massachusetts and Jumpstart Foundry. https://www.tqintelligence.com
View original content to download multimedia:
SOURCE Family Ties; TQIntelligence
|
https://www.whsv.com/prnewswire/2022/04/11/family-ties-enterprises-inc-tqintelligence-launch-voice-ai-digital-health-solution-georgia-youth/
| 2022-04-11T12:29:36Z
|
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
MOUNTAIN VIEW, Calif., April 11, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it closed an oversubscribed fundraising round to support the next stage of its development.
Investments from two international pharmaceutical organizations and a venture capital group associated with a third underscored widespread interest in Turn Bio's unique cell rejuvenation therapy, which is built on the company's proprietary ERA™ platform.
International pharmaceutical industry backing came from three groups:
- Astellas Venture Management LLC, a venture capital organization within Astellas Pharma, which is actively engaged in business as an R&D-driven global pharmaceutical company with the business philosophy to "Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products";
- Daewoong Pharmaceutical, recognized as one of the world's most collaborative pharmaceutical companies; and
- HanAll Biopharma, which is conducting innovative research in ophthalmology, immunology, oncology, neurology, and produces therapeutics in endocrine, circulatory and urological diseases.
"The attention and support Turn Bio is receiving from organizations around the world shows the confidence companies have in our ability to utilize our proprietary technology platforms to develop cures for now-untreatable conditions that afflict millions of people globally," said CEO Anja Krammer. "Turn Bio is closer to proving that cell rejuvenation will transform how medicine treats human disease – and ultimately extends the human healthspan."
An executive from HanAll acknowledged the importance of Turn Bio's work.
"Many age-related diseases have long been significant areas of unmet patient need," said Dr. Almira Chabi, chief medical officer and chief development officer at HanAll Pharmaceutical International, a U.S. organization HanAll created to strengthen its R&D. "Turn Bio's innovative platform may bring a pivotal transformation to a wide array of therapeutic areas. HanAll is committing support and investment to help realize the full potential of this pioneering technology as Turn Bio advances to a new phase of growth."
The round also attracted investment from LongeVC, which is focused on accelerating companies' development in the longevity space; ThreeD Capital, which invests in disruptive technologies, and Vitality Healthspan Foundation. Existing investors, Methuselah Fund, Formic Ventures and Shanda Group, increased their investments this round.
ABOUT TURN BIOTECHNOLOGIES
Turn Bio is a pre-clinical-stage company focused on repairing tissue at the cellular level. The company's proprietary mRNA platform technology, ERA™, restores optimal gene expression by combatting the effects of aging in the epigenome. This restores the cells' ability to prevent or treat disease, and heal or regenerate tissue and will help to fight incurable chronic diseases.
The company is currently completing pre-clinical research on tailored therapies targeting indications in dermatology and immunology, as well as developing therapies for ophthalmology, osteo-arthritis and the muscular system. For more information, see www.turn.bio.
FOR MORE INFORMATION, CONTACT:
Jim Martinez, rightstorygroup
jim@rightstorygroup.com or (312) 543-9026
View original content:
SOURCE Turn Biotechnologies
|
https://www.whsv.com/prnewswire/2022/04/11/global-pharma-organizations-back-turn-biotechnologies-advance-its-cell-rejuvenation-program/
| 2022-04-11T12:29:47Z
|
The Company Continues to be a Disruptive Innovator
WESTON, Fla., April 11, 2022 /PRNewswire/ -- Golden Grail Technology (OTC: GOGY) a fast-growing company with a strategic mission to innovate, build and streamline the growth of its beverage portfolio through fiscally responsible investing today announced it is launching its Master of Beverage™ initiative. Master of Beverage™ will allow the company to participate and maximize profit potential through joint ventures with disruptive, emerging, and established brands. The new initiative is another unique method that reinforces Golden Grail Tech Beverages as a true "disruptive innovator" in the business of beverages.
The company has already changed the standard of the antiquated playbook most have followed to enter the beverage industry by blazing a different path and introducing new business techniques. Specifically, Golden Grail's business model identifies established brands that already have a proven sales history, a loyal consumer base and retail presence that are in need of a more experienced and diversified management team in order to advance their brands. The company acquires these brands working its best business practice of fiscally responsible investing as opposed to the long-established method of spending millions of dollars and many years to develop these brands.
Master of Beverage™ was developed in order to accelerate the company's growth and expand lines of revenue. Throughout business operations Golden Grail has identified other drawbacks of many beverage brands such as the lack of funding for production and/or distribution. Golden Grail is well positioned to help these brands and form a joint venture to maximize profit potential.
"Golden Grail has been built to bring consistent innovation to the beverage industry and simply to do things differently. To be a true disruptive innovator you must prevent something from continuing or operating in a traditional way. We are constantly looking at our business and evaluating how we can establish multiple lines of revenue to bring consistently long-term value to our shareholders. Master of Beverage™ is the next initiative we are disrupting the way most beverage companies operate. By creating a new focus on joint ventures that will accelerate our growth and drive revenue, adds another pillar of confidence in our future," said Steven Hoffman, CEO, Golden Grail Tech.
About Golden Grail Technology
Golden Grail Technology (OTC: GOGY) is a fast-growing company with a strategic mission to innovate, build and streamline the growth of its beverage portfolio through fiscally responsible investing. The company targets brands that have a proven sales history, loyal consumer following, retail presence and strong value proposition who need assistance to get to the next few levels. Golden Grail has been actively acquiring brands within emerging beverage categories, such as energy, flavored water, sparkling flavored water and bottled spring water. Our robust product offerings reach multiple demographic and lifestyle categories, creating a dynamic, comprehensive and diverse beverage portfolio.
After an acquisition, the company utilizes a series of operational technologies to apply its business expertise, fiscal techniques and various manufacturing processes know-how to improve the economics and performance of each brand while advancing marketing and distribution for its beverage holdings. The company's focus on sophisticated management and development of beverage brands, coupled with its rapidly growing and recognizable portfolio of healthy, functional beverages sets Golden Grail apart as a leader in acquiring and advancing existing beverage brands.
For more information on Golden Grail, visit
www.GoldenGrailBeverages.com
https://www.facebook.com/GoldenGrailTechBeverages
https://twitter.com/golden_grail
Golden Grail's Beverage Portfolio
Cause Water is Pristine Mountain Spring Water with a Cause
We are Doing Our Part … Going Beyond Our Fully Recyclable Can… Cause We Promise to Partner with Other Groups Helping Reduce Global Plastic… Cause Together We Can Make a Difference!
Join The Cause. Drink Cause Water.
Cause Water has three key initiatives be a vessel for change, do your part and encouraging consumers to join the cause, by drinking Cause Water. A fully recyclable aluminum bottle and cap supports its core mission of plastic reduction and ocean preservation. Cause Water can be found in high-end, influential natural food stores along the West Coast.
For more information visit: https://causewater.com/
Tickle Water is a premium sparkling water company dedicated to providing honest and clean hydration. Tickle Water is the first sparkling water in the market created specifically for children, yet enjoyed by all ages, complete with delicious flavors and a recyclable can, making it the perfect beverage for any occasion. Every can of Tickle Water is simply made with premium sparkling water and natural flavors without artificial ingredients, sugar, sodium, or preservatives.
For more information visit http://www.drinkticklewater.com
https://www.facebook.com/drinkticklewater
Trevi Essence Water is a true clean-label beverage with a superior flavor that stays true to the fruit. Trevi has zero sugar, zero calories, no preservatives, no artificial ingredients, gluten free, vegan, kosher and diet friendly. Trevi comes in four delicious flavors Mango Orange, Coconut Lime, Peach and Grapefruit.
For more information visit www.DrinkTrevi.com
https://www.facebook.com/DrinkTrevi
Spider Energy Drink is packed with serious energy. This formula is the perfect balance of energy boosting B-vitamins, Taurine, Guarana, Ginseng, Key Levels of Amino Acids and herbal extracts. Made with 100% real sugar, Spider Energy is known as one of the best tasting with a fresh-citrus, smooth and refreshing flavor, without the medicinal aftertaste associated with most energy drinks.
For more information visit https://spiderenergydrink.com/
https://www.facebook.com/SpiderEnergyDrink
https://www.instagram.com/spiderenergydrink/
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
View original content to download multimedia:
SOURCE Golden Grail Technology
|
https://www.whsv.com/prnewswire/2022/04/11/golden-grail-launches-master-beverage/
| 2022-04-11T12:29:54Z
|
Sapiens modern, intuitive solution for electronic application and illustrations empowers Guardian with an exceptional agent experience
RALEIGH, N.C., April 11, 2022 /PRNewswire/ -- Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that Guardian Group, a $1 billion carrier serving 21 countries across the English and Dutch Caribbean, is integrating Sapiens' customer acquisition solution for their life and health operations.
Sapiens IllustrationPro and Sapiens ApplicationPro will be deployed in Guardian's Share Services organization, providing a cohesive user experience across Guardian's three carriers, including Guardian Life of the Caribbean Ltd. (Trinidad), Fatum (Curacao) and Guardian Life Ltd. (Jamaica). The platform features flexible branding and omni-channel integrations to cater to the agent experience to provide a next generation quoting and illustration system to improve how Guardian can present their offering in a clear and concise manner to improve their closure rate. Also, the integration of IllustrationPro and ApplicationPro to Guardian's UnderwritingPro will provide a straight-through processing and auto decision environment to decrease their time to issue.
"Strategic partnerships based on trust are critically important to Guardian, and Sapiens has proven to be able to deliver an invaluable solution to address our customer acquisition and agent needs," said Alan Sadler, Guardian Group COO. "Sapiens' solution empowers us with simple, intuitive and modern user engagement with flexible branding and integrations, to improve our agents' experience and increase their sales."
"Sapiens' innovative solution for digital acquisition will bring us significant benefits, including swift time to market and self-sufficiency to provide a next generation customer acquisition experience to our agents. The SaaS and cloud-native deployment will enhance our previously deployed accelerated underwriting from Sapiens to keep our digital momentum," said Naresh Mongroo, Guardian Group Chief Data Officer.
"Sapiens is delighted to align with Guardian's mission and to offer our extensive customer acquisition expertise and technology," said Jamie Yoder, Sapiens North America President & General Manager. "By providing the functionality to integrate and augment all of their data and illustrations into a complete insurance hub, Sapiens empowers Guardian with keen customer insights and critical decision-making capabilities across the entire life insurance value chain."
Sapiens IllustrationPro for Life & Annuities is a cloud-based point-of-sale illustration and quoting solution, offering a fully-responsive, modern, intuitive user experience for the life and annuities and health markets.
Sapiens ApplicationPro is a robust electronic application software that helps carriers address critical business drivers, such as decreasing time–to–issue and reducing policy acquisition costs, all in an extremely intuitive and easy–to–use package.
About Guardian Group
Guardian Group, a $1 billion carrier serving the markets of 21 countries across the English and Dutch Caribbean, including Trinidad & Tobago, Barbados, Jamaica, Curacao, Aruba, St. Maarten and Bonaire.
Guardian Group, whose history dates back nearly 170 years, offers coverage lines including life, health, property, and casualty in addition to products and services in areas such as asset management and bancassurance. Guardian Holdings Limited (GHL) is the parent company for an integrated financial services group known as Guardian Group. For more information visit https://trinidad.myguardiangroup.com/
About Sapiens
Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. Backed by more than 40 years of industry expertise, Sapiens offers a complete insurance platform, with pre-integrated, low-code solutions and a cloud-first approach that accelerates customers' digital transformation. Serving over 600 customers in 30 countries, Sapiens offers insurers across property and casualty, workers compensation and life markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management. For more information visit www.sapiens.com or follow us on LinkedIn.
Forward Looking Statements
Certain matters discussed in this press release that are incorporated herein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to pandemic risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.
While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.
View original content:
SOURCE Sapiens International Corporation
|
https://www.whsv.com/prnewswire/2022/04/11/guardian-group-selects-sapiens-revolutionize-customer-acquisition-solution-improve-agents-experience/
| 2022-04-11T12:30:01Z
|
Inspired by real-life stories, the new greeting cards and gifts combine Nichols' inspirational designs with poetic sentiments
KANSAS CITY, Mo., April 11, 2022 /PRNewswire/ -- Hallmark Cards, Inc. is proud to announce a new offering of greeting cards and gifts created in partnership with poet and artist Morgan Harper Nichols. Available now as part of its Real Stories collection, the new cards and gifts combine Nichols' words of hope, self-acceptance and perseverance with inspirational designs.
"I'm so excited to partner with Hallmark for the Real Stories collection," Nichols said. "The beauty of tapping into our sensitivity and empathy is when people are experiencing these positive, encouraging messages they feel seen."
Hallmark introduced the Real Stories collection in 2021 to help consumers support their loved ones through a wide range of "real-life" experiences – from difficult and bittersweet situations to joyful new beginnings. Kristy Lewis, vice president of marketing and consumer experience at Hallmark, said they partnered with the poet and artist to introduce new, inspirational designs to the existing collection.
"This new offering of greeting cards and gifts brings together Morgan Harper Nichols' unique artistic talent and Hallmark's mission to help people connect with the ones they care about," Lewis said. "And if you ask us, it's a perfect match."
The Morgan Harper Nichols Real Stories collection features 24 greeting cards and a wide variety of unique gifts including a travel mug, easel calendar, cube caddy, tea towel, daily affirmation set and more. Covered in words of comfort and support, and splashed with colors that soothe or energize, the collection features cards for everyday life, as well as milestone moments and special occasions.
Greeting Cards
Like all items in the Real Stories collection, greeting card sentiments are inspired by real-life stories and experiences, making it easy for people to find relatable cards that say all the right things.
- Thank someone who has positively impacted your life with the Your Presence Makes a Difference Thank-You Card or You Make My World Brighter Thank-You Card.
- Recognize new beginnings in someone's life with the Here's to a New Chapter Card, perfect for occasions like graduation, a new job, a move, a marriage, a new family member and more.
- Send encouragement and support to someone going through a tough time with the Keep Dreaming Encouragement Card, You Are Not Alone Encouragement Card or I Believe in You Encouragement Card.
- Celebrate happy milestones with the Wise, Strong, Beautiful Birthday Card for Her or Bold Audacious Joy Blank Card.
Gifts
Stylish and special gifts in the Real Stories collection feature Nichols' unique and radiant artwork paired with her encouraging, inspirational words.
- Give the gift of optimism in the form of unique stationary with the Art Prints, Notes and Memo Pad Set, or drawn inspiration and organization for day-to-day life with the 2022 Month-at-a-Glance Easel Calendar.
The new offering of Morgan Harper Nichols greeting cards and select gifts are available online now and at select Hallmark Gold Crown Stores as part of the Real Stories collection. Additional gifts in the collection will be available later this month. Please visit hallmark.com to shop online or find the nearest store.
About Hallmark
For more than 100 years, family-owned Hallmark Cards, Inc. has been dedicated to creating a more emotionally connected world. Headquartered in Kansas City, Missouri and employing 30,000 worldwide, the approximately $4 billion company operates a diversified portfolio of businesses. The Hallmark Global business sells greeting cards, gift wrap and related products in more than 30 languages with distribution in more than 100 countries and 100,000 rooftops worldwide, including about 2,000 Hallmark Gold Crown stores in five countries. Crayola® offers a wide range of art materials and creative play toys designed to spark children's creativity around the globe. Crown Media Family Networks operates three cable channels — Hallmark Channel, Hallmark Movies & Mysteries, and Hallmark Drama — in addition to Hallmark Publishing, a leading publisher of uplifting eBooks, audiobooks and print editions, and Hallmark Movies Now, a subscription-based streaming service. Crown Center is a real estate development company that manages the 85-acre hotel, office, entertainment and residential campus surrounding Hallmark's headquarters. For more information, visit Hallmark.com. Connect on Facebook, Twitter, Instagram, Pinterest, LinkedIn and YouTube.
About Morgan Harper Nichols
Popular Instagram poet and artist Morgan Harper Nichols (@morganharpernichols) has garnered a loyal online following of nearly 2 million, and each poem she shares is created in response to the personal stories submitted by her friends and followers. In addition to her burgeoning career as a poet and illustrator, Morgan has also successfully established her reputation as a musician, with her song "Storyteller" amassing more than 1 million Spotify plays thus far. She and her family live in Phoenix, Arizona.
View original content to download multimedia:
SOURCE Hallmark Cards, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/hallmark-introduces-new-real-stories-collection-items-collaboration-with-poet-artist-morgan-harper-nichols/
| 2022-04-11T12:30:08Z
|
More Nails in the Coffin of Optum's Unconscionable Arbitration Clause
PHILADELPHIA , April 11, 2022 /PRNewswire/ -- For the third time in less than a year, Jacobs Law Group has defeated Optum's effort to force independent pharmacies to arbitrate their challenges to Optum's reimbursement rates. From the State court in California, to the Federal District Court in Pennsylvania and now to another State court in Illinois, JLG's attorneys have crafted a winning approach to defeating Optum's unconscionable and plainly unfair arbitration clause; a clause that attempts to illegally skew the legal playing field in Optum's favor. Now three courts have all agreed with JLG's legal arguments and have ruled that Optum's arbitration clause is unconscionable and cannot be imposed on independent pharmacies.
The holding of the Illinois State court, the Circuit Court in the Twentieth Judicial Circuit in and for St. Clair County Illinois, is nearly identical to that of the California State Court that Optum's arbitration clause is both procedurally and substantively unconscionable. Indeed, the Illinois Court agreed with the California court that Optum's arbitration clause is "unfairly one-sided", indeed, it is "so one sided as to shock the conscience" and therefore the Illinois Court found the clause to be unconscionable.
Lead JLG Attorney Mark Cuker said "Defeating Optum's unconscionable arbitration clause yet again is another nail in the coffin of oppressive unfair arbitration clauses that are structured solely to advantage huge companies at the expense of smaller businesses without significant bargaining power. We are well on our way toward ripping away the secrecy curtain imposed by companies like Optum and exposing their dirty secrets." Managing Partner Neal Jacobs added, "this win could help save your local pharmacy and should be a lesson to those who rig the system with unconscionable arbitration clauses."
About:
The Jacobs Law Group (JLG) is an award-winning law firm, peer reviewed with the highest ratings for legal ability and ethics. JLG provides winning business & litigation services and represents over 1,000 independent pharmacies nationwide pursuing claims for PBM abuses. JLG seeks to represent those parties (including pharmaceutical companies and governmental units) with claims against the PBM's.
View original content to download multimedia:
SOURCE Jacobs Law Group, PC
|
https://www.whsv.com/prnewswire/2022/04/11/jacobs-law-group-wins-again-defeating-optumrxs-arbitration-clause/
| 2022-04-11T12:30:14Z
|
Leading Supplier of Highly Engineered, Complex and Advanced Components and Sub-Systems Business Becomes Sixth Firm to Integrate into Accurus Aerospace Platform
CHARLESTON, S.C. and TULSA, Okla. and BRISBANE, Australia, April 11, 2022 /PRNewswire/ -- Liberty Hall Capital Partners ("Liberty Hall"), a private equity firm focused exclusively on investments in businesses serving the global aerospace and defense industry, announced today the acquisition of Ferra Holdings Limited ("Ferra") by Accurus Aerospace Corporation ("Accurus"), a leading global supplier of highly engineered structural parts, complex assemblies and electromechanical subsystems to the global aerospace industry focused on the highest value and fastest growing commercial, business jet, military aerospace and space platforms. Terms of the transaction were not disclosed.
"The acquisition of Ferra is highly strategic and transformational for Accurus," said Rowan Taylor, Liberty Hall's founding and Managing Partner. "The combination creates a truly global, more diversified and balanced business with expanded capabilities allowing us to better serve all of our customers – whether commercial aerospace, military aerospace or space customers – across the globe."
Robert Kirkpatrick, President and CEO of Accurus, said: "The acquisition of Ferra expands our complex and advanced manufacturing capabilities, extends our geographic presence and creates greater end market, customer and platform balance. The 'new' Accurus is a highly differentiated aerospace supplier with a global manufacturing footprint and strategic relevance to our customers and serves as a partner of choice for complex and advanced manufacturing work statements."
Brisbane, Australia-based Ferra is a leading global provider of highly engineered, complex and advanced components, sub-systems and assemblies for the military aerospace and commercial aerospace end markets and serves as a strategic supplier to several key industry original equipment manufacturers as well as the Australian Department of Defence. Founded in 1992, Ferra operates four manufacturing facilities located in Australia, the United States and India with approximately 200 employees. Ferra's largest customers are The Boeing Company and Lockheed Martin, and its largest platforms are the F-35 Joint Strike Fighter and the Ghost Bat (formerly known as the Loyal Wingman).
Ferra's existing management team, led by Managing Director Aaron Thompson, will remain in their roles following the acquisition. "We are incredibly proud of what we have accomplished over our thirty-year history, and we are excited to partner with Accurus in order to accelerate growth across our core business areas," said Mr. Thompson. "We look forward to leveraging Accurus's resources, relationships and manufacturing excellence to continue to expand sovereign supply chain capability within Australia, better serve our strategic partners, including the Australian Department of Defence, and further penetrate the military aerospace and space end markets," he added.
Lazard served as financial advisor and equity placement agent to Liberty Hall and Accurus. Equity financing was provided by funds managed by Oaktree Capital Management, L.P. and Northleaf Capital Partners. Legal advice to Liberty Hall and Accurus was provided by Gibson Dunn & Crutcher, MintnerEllison and Schulte Roth & Zabel.
Friday Capital served as financial advisor to Ferra and the seller. Legal advice was provided by Corrs Chambers Westgarth, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and Osborne Clarke.
About Liberty Hall Capital Partners
Liberty Hall Capital Partners is a private equity firm focused exclusively on investments in businesses serving the global aerospace and defense industry. Liberty Hall's principals have a 25-plus year history of working together and have led the investment of over $2.5 billion in equity capital in over 25 businesses serving multiple segments of the aerospace and defense industry. Liberty Hall was founded in July 2011 as the first, and remains the only, private equity firm focused solely on investments in middle market businesses serving the aerospace and defense industry. Liberty Hall executes a proven and repeatable investment strategy designed to transform middle market businesses into larger, more capable and diverse strategic assets. For more information, please visit http://www.libertyhallcapital.com/.
About Accurus Aerospace Corporation
Accurus Aerospace Corporation is a leading global supplier of highly engineered structural parts, complex assemblies and electromechanical subsystems to the global aerospace industry focused on the highest value and fastest growing commercial, business jet, military aerospace and space platforms. Accurus was formed in November 2013 by Liberty Hall Capital Partners and has since completed six acquisitions, including Precise Machining & Manufacturing (2013), McCann Aerospace Machining (2014), LaCroix Industries (2015), J&M Machine (2016), ZTM (2016) and Ferra Holdings. Accurus operates eight manufacturing facilities located in the United States, Australia and India and possesses highly complementary capabilities that allows the company to deliver its products to its customers with optimal cost, quality and delivery. For more information, please visit https://www.accurusaero.com/.
View original content:
SOURCE Liberty Hall Capital Partners
|
https://www.whsv.com/prnewswire/2022/04/11/liberty-hall-capital-partners-acquires-ferra-holdings-limited/
| 2022-04-11T12:30:21Z
|
LiveOne Recognized Alongside Amazon Music, Apple Music, SiriusXM, Spotify, YouTube Music
LOS ANGELES, April 11, 2022 /PRNewswire/ -- LiveOne (Nasdaq: LVO), a creator-first, music, entertainment and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events, today announced that it has been recognized as one of the "Best Android Music Apps for 2022" by PC Mag. The recognition puts LiveOne alongside other music streaming notables like Amazon Music, Apple Music, SiriusXM, Spotify and YouTube Music.
PC Mag stated: "Curated channels, smart DJ hosts, and an overall slick design make [LiveOne] one of our top choices for music streaming services."
"Being recognized as a best Android music app by PC Magazine is a major honor," said Robert Ellin, Chairman and CEO of LiveOne. "PC Mag represents everything relevant in the tech and entertainment world, and their praise is the ultimate validation for our app and platform. As we continue to broaden our flywheel, we know that the best of curated entertainment starts and ends with LiveOne."
The last two years, PC Mag also recognized LiveOne as one of the top 10 "Best Online Music Streaming Services" and "one of the most complete streaming music services on the market today," and LiveOne has received PC Mag's Editors' Choice Award.
LiveOne is the first talent-centric platform focused on superfans and building long-term franchises in on-demand audio and video, podcasting, vodcasting, OTT linear channels, pay-per-view, NFTs, and livestreaming. Its unique model includes multiple monetization paths including subscription, advertising, sponsorship, merchandise sales, licensing, and ticketing.. For more information about LiveOne, please visit www.liveone.com.
About LiveOne, Inc.
Headquartered in Los Angeles, California, LiveOne, Inc. (NASDAQ: LVO) (the "Company") is a creator-first, music, entertainment and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events. As of April 1, 2022, the Company has accrued a paid and free membership base of over 2.23 million**, streamed over 2,900 artists, has a library of 30 million songs, 600 curated radio stations, nearly 270 podcasts/vodcasts, hundreds of pay-per-views, personalized merchandise, released music-related NFTs, and created a valuable connection between fans, brands, and bands. The Company's wholly-owned subsidiaries include Slacker Radio, React Presents, Gramophone Media, Palm Beach Records, Custom Personalization Solutions, LiveXLive, PPVOne and PodcastOne, which generates more than 2.48 billion downloads per year and 300+ episodes distributed per week across its stable of top-rated podcasts. LiveOne is available on iOS, Android, Roku, Apple TV, Amazon Fire, and through OTT, STIRR, and XUMO. For more information, visit www.liveone.com and follow us on Facebook, Instagram, TikTok, and Twitter at @liveone.
Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are "forward-looking statements," which may often, but not always, be identified by the use of such words as "may," "might," "will," "will likely result," "would," "should," "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "continue," "target" or the negative of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including: the Company's reliance on one key customer for a substantial percentage of its revenue; the Company's ability to consummate any proposed financing, acquisition, spin-out, distribution or transaction, the timing of the closing of such proposed event, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all, or that the closing of any proposed financing, acquisition, spin-out, distribution or transaction will not occur or whether any such event will enhance shareholder value; the Company's ability to continue as a going concern; the Company's ability to attract, maintain and increase the number of its users and paid subscribers; the Company identifying, acquiring, securing and developing content; the Company's intent to repurchase shares of its common stock from time to time under its announced stock repurchase program and the timing, price, and quantity of repurchases, if any, under the program; the Company's ability to maintain compliance with certain financial and other covenants; the Company successfully implementing its growth strategy, including relating to its technology platforms and applications; management's relationships with industry stakeholders; the effects of the global Covid-19 pandemic; changes in economic conditions; competition; risks and uncertainties applicable to the businesses of the Company's subsidiaries; and other risks, uncertainties and factors including, but not limited to, those described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2021, filed with the U.S. Securities and Exchange Commission (the "SEC") on July 14, 2021, Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, filed with the SEC on August 16, 2021, Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021, filed with the SEC on October 29, 2021, Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed with the SEC on February 14, 2022, and in the Company's other filings and submissions with the SEC. These forward-looking statements speak only as of the date hereof, and the Company disclaims any obligations to update these statements, except as may be required by law. The Company intends that all forward-looking statements be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.
** Included in the total number of paid members for the reported periods are certain members which are the subject of a contractual dispute. LiveOne is currently not recognizing revenue related to these members.
Press Contact:
LiveOne
aileen@liveone.com
917.842.9653
aavidon@liveone.com 516.522.1349
LiveOne IR Contact:
IR@liveone.com
310.601.2505
View original content to download multimedia:
SOURCE LiveOne, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/liveone-recognized-one-the-best-android-music-apps-2022-by-pc-mag/
| 2022-04-11T12:30:28Z
|
Signatera ctDNA dynamics are both predictive and prognostic in neoadjuvant TNBC.
Lead time up to 30 months between Signatera positivity and radiographic recurrence.
AUSTIN, Texas, April 11, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will present new data relating to its personalized and tumor-informed molecular residual disease (MRD) test, Signatera™, at the annual meeting of the American Association for Cancer Research taking place April 8 – 13, 2022.
Natera will have two data presentations in early-stage breast cancer, focused on patients that are high-risk hormone receptor-positive/HER2-negative (HR+/HER2-) and/or with triple negative breast cancer (TNBC). These data are the latest in a fast-growing body of evidence supporting the clinical use of Signatera MRD in breast cancer across all major subtypes.
Details about the presentations are as follows:
Abstract # 2796 | Poster Presentation | Date/time: Tuesday April 12, 9am-12:30pm
Circulating Tumor DNA Prognosis in Adjuvant Triple Negative Breast Cancer
Tumor tissue and longitudinal plasma samples were collected post-surgery from 186 TNBC patients enrolled in the phase 3 BEATRICE clinical trial (NCT00528567) and analyzed using a research-use-only version of Natera's personalized ctDNA technology. The results demonstrate that ctDNA status in samples collected post-surgery provided independent prognostic value beyond the known risk factors of lymph node involvement, tumor size and presence of tumor infiltrating lymphocytes.
- 19.9% of patients with early-stage TNBC were found to have detectable ctDNA after surgery, which was strongly associated with inferior outcomes (IDFS and OS)
- Lead time between first ctDNA positivity and radiographic recurrence was 6.1 months at the median, ranging up to 30.5 months
"TNBC is the most aggressive type of breast cancer, with a major unmet need for better diagnostic tools to identify high risk patients and inform cancer management," said Angel Rodriguez, M.D., medical director of oncology at Natera. "This study builds upon the prior scientific literature, further validating Signatera as a strong prognostic factor in TNBC, with significant potential to improve patient care."
Abstract # 7878 | Poster Presentation | Date/time: Tuesday April 12, 9am-12:30pm
Comparison of the Predictive and Prognostic Significance of Circulating Tumor DNA in Patients with High-Risk HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
This study analyzed 734 blood samples collected serially during neoadjuvant chemotherapy (NAC) from 106 HR+/HER2- and 97 TNBC patients enrolled in the I-SPY2 trial, one of the largest trials in the neoadjuvant setting.
- In TNBC, early clearance of ctDNA after just three weeks of treatment was a significant predictor of pathologic complete response
- Patients who were ctDNA-negative after NAC, in both subtypes, showed significantly improved distant recurrence-free survival, even among those patients who did not achieve pathologic complete response
"This data shows the potential utility of personalized ctDNA monitoring with Signatera during neoadjuvant treatment, giving us the ability to, in conjunction with MR imaging, improve the prediction of response early in the course of treatment," said Laura Esserman, M.D., M.B.A., and Laura van 't Veer, Ph.D., breast cancer specialists on the I-SPY2 Trial. "We are integrating this technology into the I-SPY Trial and prospectively testing it to help improve patient care in breast cancer."
More information on Signatera in breast cancer is available here.
Signatera is a custom-built circulating tumor DNA (ctDNA) test for treatment monitoring and molecular residual disease (MRD) assessment in patients previously diagnosed with cancer. The test is available for both clinical and research use, and has been granted three Breakthrough Device Designations by the FDA for multiple cancer types and indications. The Signatera test is personalized and tumor-informed, providing each individual with a customized blood test tailored to fit the unique signature of clonal mutations found in that individual's tumor. This maximizes Signatera's accuracy for detecting the presence or absence of residual disease in a blood sample, even at levels down to a single tumor molecule in a tube of blood. Signatera is intended to detect and assess how much cancer is left in the body, to identify recurrence earlier and to help optimize treatment decisions.
Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.
All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to our efforts to develop and commercialize new product offerings, whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy and performance of our tests, or of the benefits of our tests and product offerings to patients, providers and payers Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera's recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com
View original content to download multimedia:
SOURCE Natera, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/natera-present-data-beatrice-i-spy2-trials-early-stage-tnbc-hrher2-breast-cancer-2022-aacr-annual-meeting/
| 2022-04-11T12:30:36Z
|
Nutritional shake range includes dairy and vegan formulations to support children's development needs
TEL AVIV, Israel, April 11, 2022 /PRNewswire/ -- Nutritional Growth Solutions, Ltd., (NGS) (ASX: NGS) launches Healthy Heights® KidzProtein and KidzProtein Vegan to support children's development. The new product line includes 10 products: KidzProtein comes in chocolate, vanilla, and strawberry; KidzProtein Vegan comes in chocolate and vanilla.
Initially launching in the US, the new nutritional shakes which include both dairy and plant-based formulas can serve as a nutritious and delicious breakfast or a healthy tasty snack between meals. They contain a proprietary blend of micro- and macronutrients demonstrated to support optimal childhood growth and development, as well as a fruit and veggie blend. They complement an existing product line shown in a clinical study to help children grow in height and weight.
"There is a high demand from parents for a nutritional shake formula for children to support everyday wellness," remarks Liron Fendell, CEO and Managing Director for Nutritional Growth Solutions. We created our evidence-based Healthy Heights KidzProtein range in both dairy and vegan versions to support the unique nutritional needs of children including those with dairy allergies. Milk allergy is the most common allergy among children, as well as intolerance to lactose."
KidzProtein and KidzProtein Vegan provide 10g of protein and a full array of vitamins and minerals. The versatile line allows parents to sneak the added nutrients into smoothies and other recipes. "It is formulated to fill common nutritional gaps," explains Fendell. "You cannot fool kids; the product has to be designed for flavor as well as their needs and preferences. The products contain real fruit and veggie powders for an extra boost of nutrition." KidzProtein and KidzProtein Vegan are also supplemented with omega-3 fatty acids, which are incredibly important for brain and cognitive health and neurological development. This nutrient is often deficient in children's diets.
Innova Market Insights reports that the most popular flavors for NPD continue to follow those of the traditional shakes market, namely chocolate, vanilla and strawberry in the first three in 2019-2021. Plant-based is the fastest growing claim on products positioned for children and is emerging in most categories for children. In general products for children are being reformulated with features that are popular and trending in general products, including immune health, clean, plant-based and vegan.
KidzProtein Vegan is a great addition to a child's diet to ensure they are getting enough protein, vitamins, and minerals to fuel their bodies and brains. It contains increased levels of iron, zinc, vitamin B12, and folate to address specific nutritional gaps typically found in vegan diets.
"We are excited to finally offer a fully plant-based formula to serve children who cannot consume dairy or who adhere to a vegan diet," says Kaitlin Cushman, M.S. Director of Product Development and Education at NGS. It was important for us to include vegan products to ensure even more children have access to our products, and to do so without compromising on quality, effectiveness, or flavor. Our easy-to-drink formulas contain all the same micro and macro nutrients as our non-vegan formulas, and taste great. They are a perfect way for picky eaters or those with dairy intolerances to gain the necessary nutrients to support growth and development."
KidzProtein Vegan includes pea protein and fava bean protein. In combination, these two proteins contribute all of the essential amino acids, creating a complete protein source.
"The launch of the Healthy Heights KidzProtein line in the US is a key factor in our growth strategy," adds Fendell. "We will be expanding the product line into other global markets and into more distribution channels."
About Nutritional Growth Solutions
Nutritional Growth Solutions, Ltd. (NGS) is a global nutritional health company focused on the well-being of children. NGS develops, produces, and sells clinically tested nutritional supplement formulae for children based on 20 years of medical research into pediatric nutrition at Schneider Children's Medical Centre, Israel's largest pediatric hospital. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The 3–12-year-old demographic represents a larger market opportunity, and NGS is highly differentiated from its competitors to better capture this opportunity with clinically tested products and an expanding portfolio.
For further information, please contact:
View original content to download multimedia:
SOURCE Nutritional Growth Solutions, Ltd.
|
https://www.whsv.com/prnewswire/2022/04/11/ngs-launches-healthy-heights-kidzprotein-nutritional-shakes/
| 2022-04-11T12:30:43Z
|
Ongoing Phase 1 Clinical Trial Has Provided New Data Sets for Analysis of T Cell Receptor (TCR) Landscape of Tumor-Specific T Cells in Human Cancers
Study Findings Being Leveraged to Enhance Company's T Cell Therapy Platform Including Predictive PACTImmune™ Database and Novel PACT^NV™ Non-Viral Gene Editing Technology
SOUTH SAN FRANCISCO, Calif., April 11, 2022 /PRNewswire/ -- PACT Pharma, Inc., a clinical-stage company developing transformational personalized neoantigen-specific T cell receptor (neoTCR) T cell therapies for the eradication of solid tumors, today announced that new data highlighting several aspects of its first-of-its-kind personalized neoantigen platform for adoptive cell therapies were presented in five separate poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022. The breadth of presented data reflects the expansive collection of pioneering insights into patient-specific TCR repertoires against solid tumors that the company has been able to accumulate through analysis of research samples, as well as patient samples from its ongoing first-in-human Phase 1 trial. The AACR conference is being held April 8-13, 2022, in New Orleans, Louisiana.
"The scope of presented findings at AACR highlights the significant progress that we have made across all aspects of our unique neoTCR T cell therapy platform, spanning identification and verification of patient-specific tumor driving mutations, gene editing, cell manufacturing, machine learning and bioinformatics," said Stefanie Mandl, Ph.D., senior vice president, head of research at PACT Pharma. "This continued progress speaks to the dynamic research and development approach that we are undertaking at PACT, as we aggressively advance our clinical-stage assets in human studies while using the evolving data set and learnings from our Phase 1 trial to continue to enhance various aspects of our technology platforms. This constellation of activities is focused on the single goal of bringing much needed, first-of-its kind neoTCR T cell therapies to patients battling solid tumors."
PACT is currently conducting a Phase 1 clinical trial evaluating the safety, tolerability and feasibility of adoptive cell therapy with its non-viral PACT^NV™ gene-edited autologous neoTCR T cells in advanced and metastatic solid tumors. This trial, in combination with extensive preclinical studies, has provided the company with unique data sets and insights derived from the core technologies that comprise its personalized adoptive T cell therapy platform for the treatment of solid tumors.
Key presented findings at AACR included:
imPACT Isolation Technology® Platform for TCR Discovery and Validation: Identifies TCRs to Patient-Specific Tumor Driver Mutations
By applying its imPACT Isolation Technology® platform to peripheral blood samples of more than 170 patients with solid tumors, PACT generated key findings on the relative distribution of patient-private mutations versus mutations in known cancer driver genes. Data demonstrated that tumor-specific T cells preferentially recognize patient-private mutations. However, TCRs that target known cancer driver mutations were shown to constitute > 5% of the functionally characterized TCRs, highlighting a high-value opportunity for "off-the-shelf" TCR therapies. Based on these findings, PACT is expanding its platform to develop such "off-the-shelf" treatments, and anticipates filing an investigational new drug (IND) application in the second half of 2022.
Proprietary Machine Learning and Bioinformatics Optimize Personalized Treatment Strategies
In two separate AACR posters, PACT highlighted its continued work building and utilizing its PACTImmune™ Database with extensive pre-, on- and post-treatment data from its ongoing Phase 1 trial. Analysis of this maturing data set with proprietary machine learning and bioinformatics produced new insights into patient-specific tumor immunogenicity in solid cancers, providing opportunities to optimize personalized neoTCR T cell treatment. The company's application of its proprietary PACT-ESCAPE™ technology provided key learnings regarding neoepitope presentation escape mechanisms, which is a critical aspect of personalized TCR-based immunotherapy.
PACT^NV™: Efficiently Enabling Single-Step Precision Gene Editing
In two separate poster presentations, PACT reported continued progress with PACT^NV, the company's non-viral precision gene editing approach for generating clinical-grade TCR T cells for adoptive cell therapy. Importantly, the company has demonstrated the ability to execute precise, time-efficient, single-step gene editing to simultaneously knock-out TCR genes and insert neoantigen-specific TCRs isolated from a patient's own blood. Furthermore, the company described its success incorporating additional complex modifications, which are intended to address challenges presented by the immunosuppressive nature of some tumor microenvironments, into the single-step gene editing process.
Copies of the posters presented at the AACR conference are available on the "Events" page of the PACT Pharma website at: https://www.pactpharma.com/news/?filter=events.
About PACT Pharma, Inc.
PACT is a clinical-stage biopharmaceutical company pioneering individualized, non-viral precision genome engineered, tumor-specific T cell therapies for the treatment of patients with solid cancers. PACT is now enrolling patients in its first-in-human Phase 1 clinical trial.
Each person's cancer emerges with a private signature of mutations. PACT identifies these cancer mutation targets (neoantigens) for each person, biochemically verifies and captures T cells from their blood and uses its proprietary, non-viral precision genome engineering technologies to manufacture a personalized immune cell therapy product for each person with cancer.
For more information, please visit www.pactpharma.com.
Contacts:
PACT Pharma
Atulya Agarwal
atulya@pactpharma.com
Vida Strategic Partners (on behalf of PACT Pharma)
Tim Brons (Media)
415-675-7402
tbrons@vidasp.com
View original content to download multimedia:
SOURCE PACT Pharma
|
https://www.whsv.com/prnewswire/2022/04/11/pact-reports-new-data-first-of-its-kind-personalized-neoantigen-platform-adoptive-t-cell-therapies-american-association-cancer-research-aacr-annual-meeting-2022/
| 2022-04-11T12:30:52Z
|
CLERMONT, Fla., April 11, 2022 /PRNewswire/ -- Parallel, one of the largest privately-held multi-state medical marijuana operators in the U.S., announces the opening of a new Surterra Wellness (Surterra) medical marijuana dispensary in Clermont, Florida. The dispensary will complement Surterra's existing Central Florida locations. The grand opening celebration and ribbon cutting is planned for April 14, 2022. The Clermont dispensary is located at 1495 State Road 50 within a bustling shopping center neighbored by a variety of retail and dining options.
"We are excited to open our Clermont dispensary and broaden Surterra's presence in serving the wellness needs of our patients in Central Florida. This new location enables us to continue to fulfill the needs of as many patients as possible, providing access to the many high-quality medical marijuana products that Surterra provides," said Parallel CEO James Whitcomb.
At more than 2,000 square feet, the dispensary will offer patients Surterra's array of high-quality medicinal products developed to enhance a patient's well-being. Surterra products are all produced from plants grown here in Florida in state-of-the-art cultivation facilities where no harmful chemicals or ingredients are used in the growing process. Products available to patients come from the Surterra Wellness, Coral Reefer (collaboration with Jimmy Buffett), Float, and Heights brands.
"It's a great honor to finally bring Surterra to the beautiful City of Clermont, and to provide its residents access to our world-class products and service," said President of Surterra Wellness, Karim Bouaziz. "We're very excited at the opportunity to serve all new and existing patients in this fast-growing market, and look forward to joining and actively participating in the local community as well."
In celebration of the store's grand opening, customers will enjoy 42.0% off all items (excludes accessories) as well as double Loyalty Points for the entire day of the grand opening. Loyalty Rewards enable shoppers to save more when they spend, with 1 point awarded for every $1 spent and at 500 points members receive a 10% discount, which can be stacked for more savings. They will also have branded giveaways for early shoppers. Surterra welcomes anyone 18 and older in its stores so that they can ask questions and learn more about products directly from their highly educated staff.
Surterra is also calling all artists for a unique opportunity. Surterra's Artist Showcase is coming soon to a Surterra store near you! We're looking for local artists to put their work on display in our stores for a two to four month period. Selected artists will gain exposure to new audiences in the store as well as through Surterra's email subscriber lists and popular social media channels. If you're an artist, show us your work by applying at www.surterra.com/artist-showcase/.
The Lake County location is currently open. Days of operation and hours are Monday through Saturday from 10 a.m. to 8 p.m. and Sunday from 11 a.m. to 5 p.m. Patients who are registered in the state of Florida with a medical marijuana card can are welcome to purchase. All other visitors are welcome to seek consultations. The Clermont store also offers Free Delivery on orders of $150 or more. For more information on delivery, please visit https://www.surterra.com/customer-care/delivery/.
For more information, visit Surterra Wellness at Surterra.com or follow on Instagram, Twitter, and Facebook.
ABOUT SURTERRA WELLNESS
Surterra Wellness, a retail brand of Parallel, is a vertically integrated cannabis company that operates 43 Medical Marijuana Treatment Centers in the state of Florida, with more planned to open in 2022. Its diverse portfolio of branded medical marijuana products enhance a patient's well-being, and are produced with plants grown in Surterra Wellness' state of the art cultivation facility, where no harmful chemicals or ingredients are used in the growing process. Surterra Wellness' brand intent is to deliver a trusted, consistent, and seamless way for patients to connect and learn, and for patients to have access to the highest-quality medical marijuana products in the state of Florida. The ethos of Surterra Wellness is based on Parallel's commitment to compliance, quality, innovation, and to be a great employer and local community partner, as well as its actions to improve diversity, inclusivity, and economic empowerment in the cannabis industry. To learn more about Surterra Wellness visit, www.surterra.com or on Facebook and Instagram.
ABOUT PARALLEL
Parallel is one of the largest privately-held, vertically integrated, multi-state cannabis companies in the United States with a mission to pioneer well-being and improve the quality of life through cannabinoids. Parallel has ongoing operations in five medical and adult-use markets under the retail brands of Surterra Wellness in Florida; goodblend in Texas and in Pennsylvania; New England Treatment Access (NETA) in Massachusetts, and a joint venture with Cookies retail brand in Nevada. It will add a sixth market upon the pending regulatory approval of the planned acquisition of six Windy City Cannabis licenses in Illinois. Parallel has a diverse portfolio of high quality, proprietary and licensed consumer brands and products including Surterra Wellness, Coral Reefer (collaboration with Jimmy Buffett), Float and Heights offered through its retail wholesale business. Parallel operates approximately 50 locations nationwide, including 47 retail stores, and cultivation and manufacturing sites. Through its wholly-owned Parallel Biosciences subsidiary, it conducts advanced cannabis science and R&D for new product development in its facilities in Massachusetts, Florida, Texas and a facility in Budapest, Hungary through an exclusive license and partnership. Parallel follows rigorous operations and business practices to ensure the quality, safety, consistency, and efficacy of its products and is building its business by following strong values and putting the well-being of its customers and employees first. Find more information at www.liveparallel.com, or on Instagram and LinkedIn.
View original content to download multimedia:
SOURCE Parallel
|
https://www.whsv.com/prnewswire/2022/04/11/parallel-announces-opening-surterra-wellness-dispensary-clermont-central-florida/
| 2022-04-11T12:31:01Z
|
Acquisition extends the Perforce portfolio with a solution to automate, scale, and integrate security and compliance across hybrid infrastructures
MINNEAPOLIS, April 11, 2022 /PRNewswire/ -- Perforce Software ("Perforce"), a provider of solutions to enterprise teams requiring productivity, visibility, and scale along the development lifecycle, backed by Francisco Partners and Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake"), announced today that it has signed a definitive agreement to acquire Puppet (or "the Company"), an infrastructure automation software platform which enables users to deliver, update, monitor, and secure software across physical and virtual machines. Financial terms of the transaction were not disclosed.
By increasing productivity, eliminating mistakes, enhancing security, and accelerating software delivery for DevOps teams, Puppet's solutions support customers on their digital transformation journeys. Puppet was an early developer of what is now referred to as "infrastructure-as-code." More than 40,000 organizations have benefited from Puppet's open source and commercial solutions as the Company's infrastructure automation technology provides solutions to strengthen its customers' security posture, compliance, and business resiliency beyond the data center to the cloud. Additionally, Puppet's annual State of DevOps Report is regarded as the informative source for updates on DevOps adoption and advancement across organizations by over 35,000 technical and managerial professionals polled via ten separate surveys since 2011.
"This acquisition expands our product offering by adding new capabilities for enterprise DevOps teams to manage and secure their critical infrastructure," said Mark Ties, CEO of Perforce. "With Puppet, we will be providing our customers with access to a product portfolio that enables them to drive innovation on a global scale. We look forward to welcoming the Puppet team and continuing to offer the level of customer support, services, and community Puppet has established in the market."
"Puppet has been in the DevOps space for over 15 years with a focus on infrastructure-as-code and operators. Going forward, however, we believe enterprise customers are looking for strategic partners who can provide more breadth and depth across the entire DevOps lifecycle. Integrating Puppet into Perforce does just that," said Yvonne Wassenaar, CEO of Puppet. "As part of Perforce, we believe we will be better positioned to service the breadth of DevOps needs our customers have while accelerating our own innovation to ensure customers can deliver, operate and automate their infrastructures at scale in the data center, across clouds, and out to the edge."
The addition of Puppet builds on Perforce's existing DevOps portfolio, allowing Perforce to continue its focus on DevOps at scale and solve some of the most difficult automation challenges in the world's largest enterprises. Like Perforce, Puppet delivers solutions to some of the biggest companies in the world, including, as of year-end 2021, 85 percent of the world's largest banks and 80 percent of the world's top technology organizations. Together, the combined company will be helping to drive innovation at its combined customer base, which includes 40 companies of the Fortune 50.
"With this strategic acquisition, Perforce is positioned to capitalize on market tailwinds driving demand for IT infrastructure automation," said Evan Daar, Partner at Francisco Partners, and Sean Courtney, Senior Vice President at Clearlake, in a joint statement. "The addition of Puppet further enhances the capabilities Perforce can offer to its valued customers, and we look forward to catalyzing this opportunity to drive continued momentum for the platform."
The acquisition is subject to customary closing conditions and is expected to close in the second quarter of 2022.
To learn more about Puppet and its product offering, visit www.puppet.com
Jefferies LLC acted as exclusive financial advisor to Puppet in connection with the transaction. Lincoln International acted as the exclusive financial advisor to Perforce Software in connection with the transaction.
About Puppet
Puppet empowers people to innovate through infrastructure automation. For more than a dozen years, Puppet has pioneered the way in which infrastructure and operations teams scale infrastructure in the largest and fastest growing organizations in the world. More than 40,000 organizations — including over 80 percent of the Global 5000 — have benefited from Puppet's open source and commercial solutions to strengthen customers' security posture, compliance and business resiliency beyond the data center to the cloud. Headquartered in Portland, Oregon, Puppet is a privately held company with offices in London, Belfast, Singapore, and Sydney. For more information on Puppet, please visit www.puppet.com.
About Perforce
Perforce powers innovation at unrivaled scale. Perforce solutions future-proof competitive advantage by driving quality, security, compliance, collaboration, and speed – across the technology lifecycle. We bring deep domain and vertical expertise to every customer, so nothing stands in the way of success. Privately held and funded by Clearlake Capital and Francisco Partners, our global footprint spans more than 80 countries and includes over 75% of the Fortune 100. Perforce is trusted by the world's leading brands to deliver solutions to even the toughest challenges. Accelerate technology delivery, with no shortcuts. Get the Power of Perforce.
About Francisco Partners
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch over 20 years ago, Francisco Partners has invested in more than 400 technology companies, making it one of the most active and longstanding investors in the technology industry. With approximately $38 billion in assets under management, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential. For more information on Francisco Partners, please visit www.franciscopartners.com.
About Clearlake Capital
Clearlake Capital Group, L.P. is an investment firm founded in 2006 operating integrated businesses across private equity, credit and other related strategies. With a sector-focused approach, the firm seeks to partner with management teams by providing patient, long-term capital to businesses that can benefit from Clearlake's operational improvement approach, O.P.S.® The firm's core target sectors are technology, industrials, and consumer. Clearlake currently has over $72 billion of assets under management, and its senior investment principals have led or co-led over 300 investments. The firm is headquartered in Santa Monica, CA with affiliates in Dallas, TX, London, UK and Dublin, Ireland. More information is available at www.clearlake.com and on Twitter @Clearlake.
Media Contacts
PERFORCE U.S.
Grace Bonacum
PAN Communications
Ph: +1 617 502 4300
perforce@pancomm.com
PERFORCE UK/EMEA
Maxine Ambrose
Ambrose Communications
Ph: +44 118 328 0180
perforcepr@ambrosecomms.com
View original content to download multimedia:
SOURCE Perforce Software
|
https://www.whsv.com/prnewswire/2022/04/11/perforce-acquire-devops-pioneer-puppet/
| 2022-04-11T12:31:09Z
|
SOUTHFIELD, Mich., April 11, 2022 /PRNewswire/ -- Plante Moran has been named to FORTUNE magazine's list of "100 Best Companies to Work For" for the 24th consecutive year. The firm ranked 30 on the list.
One of the nation's largest certified public accounting and business advisory firms, Plante Moran is known for its people-first environment that prioritizes work-life balance, mental health and diversity, equity and inclusion – a formula that has been especially important in attracting and retaining top talent in the current job market.
"We continue to see the benefits of investing in programs and policies that can be tailored to each staff member and give people the ability to grow personally and professionally," Managing Partner Jim Proppe said. "We want to maintain and enhance our 'whole person comes to work' culture, especially during challenging times, to attract and retain best-in-class professionals who provide excellent service to our clients."
To attract and retain talent in a job market where workers are increasingly calling for more flexibility and a supportive company culture, Plante Moran created and enhanced programs that reaffirmed its commitment to its staff's well-being and performance.
While the firm has had workplace flexibility programs in place for decades, it enhanced these offerings last year to accommodate the changing needs of its staff, most notably through its Flexible Time Off and Workplace for Your Day policies. These policies allow staff to take time off as needed without having to "bank" time or worry about paid-time-off availability and choose the optimal working environment for the day based on their daily objectives and goals.
Plante Moran's workplace culture is often its top recruiting and retention tool, and the firm understands that little things make a big difference. From picking up the tab on food service delivery fees and shipping ice cream to staff members across the globe, to providing "thank you" bonuses to team members for their extraordinary efforts during the pandemic, the firm is constantly finding new ways to show staff they're appreciated and valued.
"In this job market, we know giving our team flexibility, independence and recognition for all the great work they do maximizes career satisfaction," Proppe said. "Being recognized by FORTUNE as one of the top companies to work for affirms we're doing right by our team and their families, which in turn, benefits our clients."
Plante Moran has more than 3,300 professionals based in Colorado, Illinois, Michigan and Ohio, as well as international offices in China, Mexico, India and Japan.
About Plante Moran
Plante Moran is among the nation's largest accounting, tax, consulting and wealth management firms and provides a full line of business analytics and data management services to private and public sector organizations. Plante Moran has a staff of more than 3,300 professionals throughout the United States with international offices in Shanghai, China; Monterrey, Mexico; Mumbai, India; and Tokyo, Japan. Plante Moran has been recognized by a number of organizations, including FORTUNE magazine, as one of the country's best places to work. For more information, visit plantemoran.com.
View original content:
SOURCE Plante Moran
|
https://www.whsv.com/prnewswire/2022/04/11/plante-moran-named-fortunes-100-best-companies-work-list/
| 2022-04-11T12:31:15Z
|
The Snapshot Offers Advisors the Capability to Summarize Key Financial Planning Charts into a Single Page
SHELTON, Conn., April 11, 2022 /PRNewswire/ -- RightCapital, the fastest-growing financial planning solution* that provides modern, interactive features for today's financial advisors, announced the Snapshot feature for creating personalized plan summaries. The Snapshot feature enables advisors to dynamically organize key charts and highlights from each client's plan in one place to make it easy to understand and share with the client.
The Snapshot feature offers advisors the capability to summarize key financial planning charts into a single page, along with these key benefits:
- Simple: Organize key charts and highlights from each client's plan into a single- or multi-page layout by adding, removing or rearranging the content widgets.
- Personalized: Add personalized notes or comments using a free-form text box.
- Easy to share: Share the Snapshot from the secure Client Portal or as a PDF.
"Many financial advisors told us they were spending too many hours cobbling together a one-page plan for each client using tools like Excel, PowerPoint or Canva," said Shuang Chen, co-founder and CEO of RightCapital. "We came up with the Snapshot feature to solve this problem for our advisor community. RightCapital is all about simplifying the complexity behind financial planning and this is one of many ways we try to accomplish that."
"My clients don't want an 80-page planning document they will never look at once they leave my office. So I've been creating one-page summary plans for them using Excel. But creating these plans manually has been time-consuming and complex," said Kirk Sheby, financial advisor at Sheby Financial Group. "RightCapital's Snapshot feature empowers me to create a personalized plan for each client by simply adding, subtracting and rearranging charts. These Snapshot reports will not only save me a lot of time but also keep my clients engaged in their financial planning process over the years."
"I will use RightCapital Snapshots as a financial dashboard for my clients – it will start as a tool to guide our discussion and finish as a tangible takeaway," said Jonny West, CFP®, Better Planning Better Life. "Snapshot reports succinctly communicate where clients are, where they want to be and the actions we will take to help them achieve their financial goals. These personalized Snapshots will have a big impact for my clients and RightCapital makes it so easy to create them."
"I've been using a proprietary report template that I create manually to share key metrics and stats with each client for a couple of years. RightCapital's new Snapshot feature will now save roughly 20 minutes per each report I create," said Travis Gatzemeier, CFP®, founder and financial planner at Kinetix Financial Planning. "Snapshot is a game-changer for financial advisors who want to share customized reports with clients in a simple, focused way."
The Snapshot feature is available to all RightCapital subscribers. To learn more, schedule your personalized RightCapital demo at https://www.rightcapital.com/book-demo or visit https://www.rightcapital.com/snapshot.
About RightCapital
RightCapital's mission is to create Right Plans for Real People™. RightCapital is used by thousands of financial advisors to grow their practices and set their clients on the path to financial success. Founded in 2015, RightCapital is the fastest-growing financial planning software with the highest user satisfaction among advisors*. Our modern, intuitive features make the financial planning process a breeze. From interactive retirement scenarios and tax-efficient distributions to insurance evaluation, student loan management and estate planning, we simplify the complexity of financial planning so anyone can understand how to plan for their future. For more information visit www.RightCapital.com.
*Source: The Kitces Report Volume 1, 2021 and Volume 1, 2020
View original content to download multimedia:
SOURCE RightCapital Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/rightcapital-introduces-snapshot-feature-creating-personalized-plan-summaries/
| 2022-04-11T12:31:22Z
|
Ex-NYPD Detective Explains How to Avoid Being a Victim—and a Perpetrator
NEW YORK, April 11, 2022 /PRNewswire/ -- Road-rage shootings in the US have doubled compared to pre-pandemic levels, according to a report in the Wall Street Journal. Citing data from a gun safety group, the paper said road-rage shootings averaged 44 per month in 2021, compared to 22 per month in 2019.
According to former NYPD Detective Mike Sapraicone, founder and president of Squad Security, Inc., it is quite likely a variety of factors are contributing to the increase. These include stress associated with COVID, high prices due to inflation, and a laxer criminal justice system, whereby many criminals believe there will be little or no consequences for their actions.
Sapraicone says the first step in avoiding road-rage begins before you even get in your in your car. "If some things in life haven't been going well and you're under some degree of stress, recognize it could affect your driving," said Sapraicone. "Take a deep breath and remind yourself you want to get from point A to point B in the most uneventful way possible. Turn on some music that will help you stay calm.
"If you encounter an aggressive driver on the road, let it go and don't engage," adds Sapraicone. "Avoid confrontations in common trouble spots, such as where lanes merge. If someone violates the 'alternate feed' credo, just let them in and back off. Responding with your own aggressive act will only escalate the situation."
Sapraicone says riding in left lanes on highways could anger someone who wants to pass you and go faster. "Remember you're not the highway patrol," he says. "Just move to the right and let the vehicle behind you pass."
It is important to have access to your phone in case you need to call authorities, so keep it on and make sure its voice commands are activated. Know where the nearest police station and hospital is in the event you're being followed by another driver, especially one who has displayed or fired a gun.
While the report centers on incidents where guns were fired, Sapraicone says it's reasonable to conclude overall occurrences of road-rage have risen significantly. These include situations where vehicles are damaged and noses are bloodied. He adds that road-rage incidents are often easily avoidable. "In many cases, it takes two to tango. Swallow your pride and move on."
About Squad Security, Inc. (squadsecurity.com)
Established in 1992, Squad Security, Inc. began operating in New York and expanded operations opening full-service offices in Los Angeles, Chicago, Toronto, and London. Since its inception the company has developed into a progressive, well-structured organization, offering a wide range of security and investigative solutions to multinational clients. Based in Uniondale, NY, the agency was founded by Michael D. Sapraicone, a retired first-grade NYPD detective and frequent commentator on security issues for major news media outlets. He also hosts "Street Smart" on Long Island News Radio.
Media Contact:
Joe Carella
Joseph J. Carella Associates Inc.
Public Relations—212-262-8800
mail@jjcpr.com
View original content to download multimedia:
SOURCE Squad Security, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/road-rage-shootings-have-doubled-during-pandemic/
| 2022-04-11T12:31:29Z
|
Smart partners with Firstlight Media to establish the best OTT Video Platform for the PLDT Group
MAKATI, The Philippines and TORONTO, April 11, 2022 /PRNewswire/ - PLDT's wireless subsidiary Smart Communications, Inc. (Smart) is breaking new ground in OTT (over-the-top) video experience for its customers, with the deployment of Firstlight Media's cloud native OTT platform.
Firstlight Media will provide a seamless, cross-platform video infrastructure. This enables differentiated video experiences and a whole new suite of cutting-edge capabilities, without the cost or complexity of maintaining separate, distinct systems. The new platform offers the elasticity, scalability, and innovation of the cloud, while combining cloud-based innovation and in-country service delivery to optimize consumer experience.
The new video infrastructure will improve the delivery of services like Smart GigaPlay, which currently features exclusive or premium premieres of content resulting from studio and production partnerships. These include live sports and music events, top shows, and first-run films. The new platform will provide subscribers with access to TV channels, on-demand content, pay-per-view, and subscriptions to exclusive live streams.
"This team-up with Firstlight Media is part of PLDT and Smart's commitment to continuously elevate the experience of our customers," said PLDT Inc and Smart Communications President and CEO Alfredo S. Panlilio, who recently signed the partnership agreement with Firstlight Media CEO and Co-Founder André Christensen. "Video is one of the primary drivers of data usage in the country. We at PLDT and Smart always strive to deliver world-class video experience for our subscribers, whether they watch at home using their fiber connections, or on their mobile phones using LTE or 5G."
"Compelling interfaces and responsive, reliable delivery of high-quality content to any subscriber anywhere have become table stakes for the best OTT providers," said Christensen. "Our fast, flexible platform has made it possible for PLDT/Smart quickly to create a total experience that is second to none today, and that is future-proofed to enable rapid expansion to new engagement and monetization opportunities that lie over the horizon."
Joining Christensen in the signing ceremonies for Firstlight Media were Goutham Vinjamuri, Chief Operating Officer; Prabu Chelladurai, Vice President, Product & Customer Success; and Jim Vinh, Sales Lead for APAC; as well as Jake Mendoza, Customer Success Manager for PLDT.
"More and more, viewers are consuming content on mobile devices and in out-of-home environments," said Arvin L. Siena, Vice President and Head of Technology Strategy and Transformation Office for PLDT and Smart. "Using the scalability and the agility of the Firstlight Media platform, we are harnessing the efficiencies of the cloud to create a service that gives our subscribers greater control over the viewing experience, increasing their levels of engagement and improving consumer loyalty and satisfaction."
The new GigaPlay app was launched on March 26, at the start of the new University Athletic Association of the Philippines (UAAP) season.
Firstlight Media's OTT architecture uses a sophisticated, cloud-native technology stack to power the PLDT and Smart platform from end-to-end. This is expected to deliver significant improvements in performance, flexibility, agility, and scale, and offering best-in-class user engagement.
Firstlight Media has also partnered with various companies and apps with global audiences, including Struum, Rogers Sports & Media's Sportsnet in Canada, Arha Media & Broadcasting Private Limited's aha 2.0, and others.
About Firstlight Media
Firstlight Media is expediting OTT's transformation to ultra-scalable, cloud-based platforms that use artificial intelligence to drive true engagement and monetization for Tier 1 operators. Founded by a team with deep OTT video expertise and a strong track record of building successful B2B businesses, Firstlight Media is poised to capture the next wave of growth in premium OTT entertainment services. The company is headquartered in Toronto and has additional locations in Los Angeles, San Diego and Chennai, India. For more information, visit firstlight.ai.
View original content to download multimedia:
SOURCE Firstlight Media
|
https://www.whsv.com/prnewswire/2022/04/11/smart-revolutionizes-video-services-elevate-customer-experience/
| 2022-04-11T12:31:36Z
|
Designed in partnership with group of world-renowned artists, "NFTickets" will give access to a business class seat on a Miami-bound flight this November
MIAMI, April 11, 2022 /PRNewswire/ -- TravelX, the company building the travel industry's first blockchain-based distribution protocol, today announced that it has joined forces with Air Europa, the third-largest Spanish airline flying to over 60 destinations around the world, to release the world's first NFT (non-fungible token) flight ticket series, or "NFTickets."
With purchase, owners will receive access to a special Air Europa flight to Miami Beach this November 29th, 2022, as well as perks and events ahead of the premier art show of the Americas taking place in Miami Beach this December. A series of NFTickets (10) in partnership with acclaimed artists will be released every 14 days via auction platform travelxchange.com/, with the first-ever available during a live auction on April 11 at 4 p.m. EST.
"Innovation is in our DNA, we have been pioneers in applying new technologies within our industry and it can not be different with NFTs, which could be the next step in the travel industry," said Bernardo Botella, Global Sales Director at Air Europa. "We are proud to be the first airline to adopt blockchain technology for inventory management and distribution. We're excited to see where this could take travel as a whole and how it could improve customer experience."
NFTickets function as traditional NFTs and are individually rare. When traded, transactions are recorded safely and securely on the blockchain. When ready to use, the owner can present the NFT and a matching flight ticket will be issued. The TravelX and Air Europa NFTickets will offer buyers an opportunity to hold a piece of travel industry history and participate in the first-ever blockchain-backed flight.
The NFTicket series titled, "The Art as the Destination," is being curated by Ximena Caminos, who commissioned acclaimed multi-disciplinary artist Carlos Betancourt for the first piece. His artworks explore issues of memory, and his own experiences, while also dwelling in issues of nature, the environment and matters of beauty, identity and communication. Carlos Betancourt artworks are included in the permanent collections of the Metropolitan Museum of Art NY, Smithsonian National Portrait Gallery DC, amongst others.
"Artists are intrigued by discovery, exploration," said Betancourt. " The same is with technology. With this piece, I'm experimenting with the boundaries of art and technology. The animated artwork is inspired by concepts of space, magical realms and travel experiences, as well as by the memories and feelings these experiences evoke."
"It's very exciting to give birth to a new kind of NFT, minted on Algorands carbon-negative blockchain," said Facundo Diaz, Co-Founder of TravelX. "We will blend the best of the traditional NFT, but add real-world application and experience. This provides a better flight ticket that travelers can easily manage and trade from their blockchain wallet, combined with a new kind of collectible art piece. We believe NFTickets will be the perfect fusion of art, travel, and technology."
To celebrate, TravelX is hosting an invite-only event at the Eiffel Tower, amid Paris NFT Day (April 12) and Paris Blockchain Week (April 13-14), where the final bid for the first-ever NFTicket will be revealed.
For more information about TravelX, visit https://www.travelx.io. For more information about the Paris, Eiffel Tower event, visit: https://nfticket.travelx.io/
Led by a team of tech and industry veterans with a track record of pioneering change, TravelX is building a blockchain-based distribution protocol designed to create a more secure, decentralized, frictionless, transparent, and efficient travel industry. The company's technology allows travel suppliers to more efficiently manage their inventory, tokenize their inventory into NFTs, unleashing use cases that enhance both travelers' flexibility and suppliers' profitability.
Air Europa is a member of the SkyTeam alliance, made up of 19 airlines that, for 19 years, have worked together as a large global network providing services to more than 630 million passengers a year. Air Europa's fleet is one of the most modern on the continent. In 2018, the German environmental organization Atmosfair rated Air Europa as the most efficient European network airline.
.
View original content:
SOURCE TravelX
|
https://www.whsv.com/prnewswire/2022/04/11/travelx-air-europa-launch-worlds-first-nft-flight/
| 2022-04-11T12:31:43Z
|
BERWYN, Pa., April 11, 2022 /PRNewswire/ -- Triumph Group [NYSE:TGI] announced that it was awarded a multi-year contract from Raytheon Intelligence & Space, a Raytheon Technologies business, to deliver air inlet and exhaust electro-mechanical door actuators and an advanced electronic control system for the Next Generation Jammer Mid-Band (NGJ-MB) pod. The contract covers production demand for LRIP lots I and II as well as non-recurring engineering for product and producibility enhancement. The work will be performed at Triumph's Actuation Products & Services facility located in Redmond, Washington.
The Next Generation Jammer is the Navy's advanced electronic attack system that offensively denies, disrupts, and degrades enemy technology, including air-defense systems and communications. NGJ-MB uses the latest digital, software-based and Active Electronically Scanned Array technologies. This allows operators to non-kinetically attack significantly more targets and at greater distances.
"Knowing that we play a key part in the success of the Next Generation Jammer Mid-Band program is exciting and aligns with our mission to partner with our customers to solve their hardest challenges with industry-leading technologies and innovation," said Mike Boland, President of Triumph Actuation Products & Services. "Our experience in designing and manufacturing actuators and controls will enhance the performance, reliability and affordability of the Next Generation Jammer Mid-Band."
Triumph Actuation Products & Services is a leader in design, development, manufacture and support of complex electro-hydraulic and mechanical systems and equipment for the aerospace and defense industry. Products include actuators, pumps, motors, reservoirs, control valves and a wide range of mechanical controls for commercial and military aircraft. Our Actuation Products & Services business services customers around the world with ten manufacturing sites across North America and Europe.
Triumph Group, Inc., headquartered in Berwyn, Pennsylvania, designs, engineers, manufactures, repairs, and overhauls a broad portfolio of aerospace and defense systems, components, and structures. The company serves the global aviation industry, including original equipment manufacturers and the full spectrum of military and commercial aircraft operators.
More information about Triumph can be found on the company's website at www.triumphgroup.com.
View original content:
SOURCE Triumph Group
|
https://www.whsv.com/prnewswire/2022/04/11/triumph-awarded-next-generation-jammer-production-contracts-raytheon-technologies/
| 2022-04-11T12:31:50Z
|
WASHINGTON, April 11, 2022 /PRNewswire/ -- Choice Home Warranty has been recognized as a Best Home Warranty of 2022 by U.S. News & World Report's 360 Reviews team.
U.S. News' online guide features in-depth information on choosing a home warranty company and covers a range of topics, including coverages, plan options and discounts.
"We are honored to be recognized as a Best Home Warranty Company for the third year in a row," said James Mostofi, CEO of Choice Home Warranty. "It is gratifying to see our commitment to excellence recognized yet again as Choice Home Warranty continues striving to be the largest and most respected home warranty company in the United States."
U.S. News evaluated home warranty companies based on cost, appliances and systems covered, and unique warranty features. U.S. News' 360 Reviews team applied an unbiased methodology that includes professional ratings and reviews, consumer ratings and reviews, and research comparing various features across home warranty companies.
Media Relations: media@choicehomewarranty.com
ABOUT CHOICE HOME WARRANTY
Choice Home Warranty is a technology-first home warranty provider headquartered in Edison, NJ. Choice provides service contracts to consumers for the repair or replacement of major home systems and appliances that break down due to normal wear and tear. Choice services its customers through a network of over 25,000 independent contractors. Choice is the fastest growing home warranty provider in the US and has covered more than 1.6 million homes across the country and handled more than 4.5 million service requests. ChoiceHomeWarranty.com is an industry leader, with proprietary automated dispatching and claim tracking technology.
ABOUT U.S. NEWS & WORLD REPORT
U.S. News & World Report is the global leader in quality rankings that empower people to make better, more informed decisions about important issues affecting their lives. A digital news and information company focused on Education, Health, Money, Travel, Cars and News, USNews.com provides consumer advice, rankings and analysis to serve people making complex decisions throughout all stages of life. The 360 Reviews team brings the U.S. News approach to consumer guidance into a broad set of consumer product and service categories. More than 40 million people visit USNews.com each month for research and guidance. Founded in 1933, U.S. News is headquartered in Washington, D.C.
View original content to download multimedia:
SOURCE Choice Home Warranty
|
https://www.whsv.com/prnewswire/2022/04/11/us-news-amp-world-reports-360-reviews-names-choice-home-warranty-among-best-home-warranty-companies-2022/
| 2022-04-11T12:31:57Z
|
Combination Treatment Demonstrates Enhanced Efficacy and Delayed Tumor Growth as Compared to Osimertinib Alone in EGFR Mutant Non-Small Cell Lung Cancer Models
VT3989, a First-in-Class TEAD Autopalmitoylation Inhibitor, Currently Being Evaluated in Phase 1 Clinical Trials
SAN MATEO, Calif. , April 11, 2022 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, today announced that new preclinical data on the company's transcriptional enhanced associate domain (TEAD) autopalmitoylation inhibitor, VT3989, were reported at the American Association for Cancer Research (AACR) Annual Meeting 2022. Presented findings demonstrated that the combination of VT3989 and osimertinib (Tagrisso®), an epidermal growth factor receptor (EGFR) inhibitor, possessed enhanced anti-tumor activity and delayed tumor growth as compared to osimertinib alone in preclinical EGFR mutant tumor models. The AACR conference is being held April 8-13, 2022, in New Orleans, Louisiana.
Data reported in the poster presentation demonstrated that VT3989 exhibits strong synergistic activity with osimertinib. This was highlighted by the ability of the combination to enhance the blocking of tumor growth in EGFR mutant, non-small cell lung cancer (NSCLC) cell-line derived xenograft models, including the HCC827 model that is already known to be particularly sensitive to osimertinib. Furthermore, the combination of VT3989 and osimertinib significantly increased the life span of mice in an NCI-H1975 NSCLC CDX model as compared to osimertinib monotherapy.
Additionally, researchers showed similar synergistic activity in blocking tumor regrowth in human patient-derived xenograft models of EGFR mutant NSCLC. Of note, data demonstrated that TEAD inhibition achieved with VT3989 significantly delayed the re-emergence of tumor mass after osimertinib treatment resulted in non-palpable tumors. This finding offers evidence that EGFR mutant NSCLC relies upon dysfunction in the Hippo pathway to survive treatment with osimertinib, and can thus be targeted with TEAD inhibition.
"The exciting new data presented at AACR not only support previous research highlighting the potency and selectivity of VT3989 as a TEAD inhibitor and its single agent anti-tumor activity in mesothelioma models, the findings also begin to build a compelling strategy around a synergistic combination treatment approach featuring VT3989 and EGFR inhibitors such as osimertinib," said Tracy Tang, Ph.D., vice president of biology at Vivace Therapeutics and lead author on the AACR poster presentation. "We are eager to continue our pioneering research into the Hippo pathway and how addressing dysfunction in that pathway may pave the way for first-in-class cancer therapies capable of addressing the unmet needs of patients."
Vivace's proprietary compounds inhibit palmitoylation of members of the TEAD protein family, including both covalent and non-covalent inhibitors. The company's clinical candidate, VT3989, is currently in Phase 1 clinical trials. Pre-clinical research and development activities have demonstrated that the clinical candidate is active as a monotherapy against tumors that rely upon dysfunction of the Hippo pathway, and in combination with other anti-cancer therapies in additional tumor types.
The poster presented is available at the company's website www.vivacetherapeutics.com.
About Vivace Therapeutics, Inc.
Vivace Therapeutics is a small molecule drug discovery and development company focused on targeting the Hippo pathway. The company is pursuing a first-in-class approach to treat human carcinomas of high unmet medical need. Based in San Francisco Bay Area, the company has raised $70 million to date, and is funded by leading biotechnology investors, including Canaan Partners, WuXi Healthcare Ventures, Cenova Capital, Sequoia Capital China, Boxer Capital and RA Capital Mangement. For more information, please visit www.vivacetherapeutics.com.
Tagrisso® is a registered trademark of the AstraZeneca group of companies.
Contact information
Sofie Qiao, Ph.D.
President and CEO
info@vivacetherapeutics.com
650.666.2753
Tim Brons
Vida Strategic Partners (media)
646-319-8981
tbrons@vidasp.com
View original content:
SOURCE Vivace Therapeutics, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/vivace-therapeutics-presents-new-preclinical-data-highlighting-strong-synergistic-activity-combination-vt3989-osimertinib-american-association-cancer-research-aacr-annual-meeting-2022/
| 2022-04-11T12:32:06Z
|
HANGZHOU, China, April 11, 2022 /PRNewswire/ -- Weidai Ltd. ("Weidai" or the "Company") (NYSE: WEI), a leading auto-backed financing solution provider in China, today announced its financial results for the year ended December 31, 2021, which have not been audited or reviewed by the Company's independent registered accounting firm.
Full Year 2021 Operational Results
Loan balance
Total loan balance as of December 31, 2021 was RMB853.0 million (US$133.9 million).
Full Year 2021 Financial Results
Net revenues in 2021 were RMB707.5 million (US$111.0 million). Among net revenues, loan service fee was RMB698.8 million (US$109.7 million), other revenues were RMB10.2 million (US$1.6 million) and net financing income was RMB1.2 million (US$183 thousand).
Provision for loans and advances in 2021 was RMB807.3 million (US$126.7 million).
Operating costs and expenses in 2021 were RMB644.3 million (US$101.1 million). Among operating costs and expenses, provision for financial guarantee liabilities was RMB76.1 million (US$11.9 million), origination and servicing expenses were RMB380.6 million (US$59.7 million), sales and marketing expenses were RMB3.4 million (US$0.5 million), general and administrative expenses were RMB162.0 million (US$25.4 million), and research and development expenses were RMB22.2 million (US$3.5 million). Share-based compensation expense in 2021 were RMB10.3 million (US$1.6 million).
Loss from operations in 2021 was RMB744.1 million (US$116.8 million).
Income tax expenses in 2021 were RMB403.9 million (US$63.4 million).
Net loss in 2021 was RMB1,144.0 million (US$179.5 million).
Comprehensive loss attributable to Weidai Ltd.'s ordinary shareholders in 2021 was RMB1,140.7 million (US$179.0 million).
Adjusted net loss in 2021 was RMB1,133.8 million (US$177.9 million).
Regulatory Developments
The Company commenced the process to exit the peer-to-peer lending business in May 2020. From July 2020 to December 2021, the Company closely cooperated with government authorities to promote a smooth exit of peer-to-peer investments. In July 2021, the Company, in cooperation with the relevant governmental authorities, repaid all outstanding net principal balances (the aggregate principal invested by a certain investor minus the aggregate amount that has been withdrawn by such investor) to investors on its platform. From December 2021 to date, the Company continues to cooperate with government authorities to complete its exit of the peer-to-peer lending industry.
Use of Non-GAAP Financial Measures
The Company uses adjusted net loss, a non-GAAP financial measure, in evaluating its operating results and for financial and operational decision-making purposes. The Company believes that adjusted net loss helps identify underlying trends in its business by excluding the impact of share-based compensation expenses. The Company believes that adjusted net loss provides useful information about its operating results, enhances the overall understanding of its past performance and future prospects and allows for greater visibility with respect to key metrics used by the Company's management in its financial and operational decision-making.
Adjusted net loss is not defined under U.S. GAAP and is not presented in accordance with U.S. GAAP. This non-GAAP financial measure has limitations as an analytical tool, and when assessing the Company's operating performance, cash flows or liquidity, investors should not consider it in isolation, or as a substitute for net loss, cash flows provided by operating activities or other consolidated statements of operation and cash flow data prepared in accordance with U.S. GAAP. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure.
For more information on this non-GAAP financial measure, please see the table captioned "Reconciliations of GAAP and Non-GAAP results" set forth at the end of this press release.
About Weidai Ltd.
Weidai Ltd. is a pioneer and leading auto-backed financing solution provider in China supported by sophisticated and effective risk management system and technology. The Company transforms used automobiles, a type of "non-standard" collateral, into investable assets, to provide accessible credit for China's small and micro enterprises, and connects the borrowers with institutional funding partners through its platform.
For more information, please visit http://weidai.investorroom.com/.
Exchange Rate Information
This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars are made at a rate of RMB6.3726 to US$1.00, the noon buying rate on December 30, 2021 set forth in the H.10 statistical release of the U.S. Federal Reserve Board.
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Weidai may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Weidai's beliefs and expectations, are forward-looking statements. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited the following: Weidai's goal and strategies; Weidai's expansion plans; Weidai's future business development, financial condition and results of operations; Weidai's expectations regarding demand for, and market acceptance of, its solutions and services; Weidai's expectations regarding keeping and strengthening its relationships with borrowers, investors and financial institutions and other platform participants; general economic and business conditions; Weidai's assumptions underlying or related to any of the foregoing regulations and governmental policies relating to the online consumer finance industry in China; its ability to comply with existing or future laws and regulations related to data protection or data security; and Weidai's ability to meet the standards necessary to maintain listing of its ADSs on the NYSE, including its ability to cure any non-compliance with the NYSE's continued listing criteria; litigation and negative publicity surroundings China -based companies listed in the U.S.; and the duration of the COVID-19 outbreak, including the emergence of COVID variants, and its potential impact on the Company's business and financial performance. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Weidai does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
For investor and media inquiries, please contact:
In China:
Christensen
Mr. Rene Vanguestaine
Tel: +86-10-5900-1548
E-mail: rvanguestaine@christensenir.com
In US:
Christensen
Ms. Linda Bergkamp
Tel: +1-480-614-3004
E-mail: lbergkamp@christensenir.com
View original content:
SOURCE Weidai Ltd.
|
https://www.whsv.com/prnewswire/2022/04/11/weidai-ltd-announces-full-year-2021-financial-results/
| 2022-04-11T12:32:12Z
|
VANCOUVER, BC, April 11, 2022 /PRNewswire/ - Wishpond Technologies Ltd. (TSXV: WISH) (OTCQX: WPNDF) (the "Company" or "Wishpond"), a provider of marketing-focused online business solutions, is pleased to announce that it expects to release its Audited Annual Financial Statements for the fiscal year ended December 31, 2021 on Wednesday, April 27th, 2022.
The Company will also host a conference call to discuss the results on the same day at 10:00 am PT (1:00 pm ET). The call will be hosted by: Ali Tajskandar, Chairman and Chief Executive Officer; David Pais, Chief Financial Officer, and Pardeep S. Sangha, Head of Investor Relations.
Please connect 5 minutes prior to the conference call to ensure time for any software download that may be required.
Per: "Ali Tajskandar"
Ali Tajskandar, Chairman and Chief Executive Officer
Based out of Vancouver, British Columbia, Wishpond is a provider of marketing-focused online business solutions. Wishpond's vision is to become the leading provider of digital marketing solutions that empower entrepreneurs to achieve success online. The Company offers an "all-in-one" marketing suite that provides companies with marketing, promotion, lead generation, and sales conversion capabilities on one integrated platform. Wishpond replaces disparate marketing solutions with an easy-to-use product, for a fraction of the cost. Wishpond serves over 3,700 customers who are primarily small and medium-sized businesses (SMBs) in a wide variety of industries. The Company has developed cutting-edge marketing technology solutions and continues to add new features and applications with great velocity. The Company employs a Software-as-a-Service (SaaS) business model where substantially all the Company's revenue is subscription-based recurring revenue which provides excellent revenue predictability and cash flow visibility. Wishpond is listed on the TSX Venture Exchange under the ticker "WISH", and on the OTCQX Best Market under the ticker "WPNDF". For further information, visit: www.wishpond.com.
While the Company expects to release its financial results for the fiscal year ended December 31, 2021 on April 27, 2022 and host a conference call on the same day, such statements may represent forward-looking information within the meaning of applicable Canadian securities legislation. The Company will use commercially reasonable efforts to meet such disclosed timelines, however, extenuating circumstances such as delays in auditor review, requests for additional information from auditors, the availability of employees and consultants, other pressing business or regulatory requirements which may divert management attention from the audit and other factors may cause the Company to not be able to meet such deadlines. Readers are cautioned to not place undue reliance on forward-looking information. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE Wishpond Technologies Ltd.
|
https://www.whsv.com/prnewswire/2022/04/11/wishpond-announces-conference-call-its-fourth-quarter-fiscal-year-end-2021-financial-results/
| 2022-04-11T12:32:19Z
|
The day marks a celebration of the hard-working individuals who keep marketing teams running smoothly. Nominate yourself or others for the 2022 Marketing Ops Awards.
SAN FRANCISCO, April 11, 2022 /PRNewswire/ -- Today Zapier—the leader in no-code automation—announced the launch of the first-ever Marketing Operations Appreciation Day — an annual celebration on April 11 to recognize the people who keep marketing teams running smoothly. As part of the day, Zapier has launched the Marketing Ops Awards—a nomination-based contest to recognize the top professionals in the industry. The award application is open to professionals working in marketing operations, CRM operations, email operations, revenue operations, or those who have similar roles or responsibilities.
"With an ever increasing dependency on data, and as the number of tools that marketing teams use grow every day, there's a clear need to have a marketing ops team at every business," said Moody Glasgow, Chief Marketing Officer at Zapier. "Marketing ops is the backbone of any well-run marketing team, but they don't often get the recognition they deserve. That's why we're so excited to celebrate these hard-working professionals with their own designated day."
According to the HubSpot and MO Pros 2021 Marketing Operations report, 65% of companies report having a dedicated Marketing Operations individual or team. Marketing operations teams are responsible for building systems and sourcing the best tech tools that support marketing efforts.
A great example of this is the marketing team at ServiceTitan. They use Zapier to test new Google Ads formats that may not be fully integrated into the platform, without sacrificing reporting fidelity and while keeping audience lists fresh and up to date. This enables the team to easily send the right data, to the right place, at the right time—all with the highest security standards in place, so they can focus their efforts on strategic planning and customer success.
To enter Zapier's Marketing Ops Awards, complete this short entry form by May 11, 2022. To learn more about Zapier, visit www.zapier.com
About
Founded in 2011, Zapier is the global leader in automation software. By connecting over 4,000 of the most popular work apps, Zapier empowers its users to make the most of the tools they already use—and to focus on what matters most. For more information, visit www.zapier.com.
View original content to download multimedia:
SOURCE Zapier
|
https://www.whsv.com/prnewswire/2022/04/11/zapier-announces-marketing-operations-appreciation-day/
| 2022-04-11T12:32:31Z
|
Average US gas price drops 10 cents to $4.27 per gallon
CAMARILLO, Calif. (AP) — The average U.S. price of a gallon of regular-grade gasoline dropped 10 cents over the past two weeks to $4.27 per gallon as oil prices continue to “yo-yo,” industry analyst Trilby Lundberg said Sunday.
The price at the pump was $1.32 above what it was one year ago, according to the Lundberg Survey taken Friday.
Nationwide, the highest average price for regular-grade gas was in Los Angeles, at $5.85 per gallon. The lowest average was in Tulsa, Oklahoma, at $3.52 per gallon.
According to the survey, the average price of diesel was $5.13 per gallon, down 2 cents over two weeks.
Lundberg said prices dropped dramatically in the past two weeks, in part because higher prices reduced demand during the second half of March.
However, the drop isn’t predictive of further declines because among other things, the global oil supply is tight due to a dip in output last month by OPEC, Lundberg said.
The war in Ukraine also has sparked global uncertainty. The U.S. has banned all Russian energy supplies but Lundberg said sanctioned Russian oil is still finding “big buyers like India and China happy to pay discount prices.”
In a bid to reduce spiking energy prices, President Joe Biden last month ordered the release of 1 million barrels of oil per day from the nation’s strategic petroleum reserve for six months.
On Thursday, the International Energy Agency said that its member countries are releasing 60 million barrels of oil from their emergency reserves on top of previous United States pledges.
The Paris-based organization says the new commitments made by its 31 member nations, which include the U.S. and much of Europe, amount to a total of 120 million barrels over six months, the largest release in the group’s history.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.wvva.com/2022/04/11/average-us-gas-price-drops-10-cents-427-per-gallon/
| 2022-04-11T12:36:54Z
|
Biden to nominate new ATF chief, release ghost gun rule
WASHINGTON (AP) — President Joe Biden is nominating an Obama-era U.S. attorney to run the Bureau of Alcohol, Tobacco, Firearms and Explosives, as his administration unveils its formal rule to rein in ghost guns, privately made firearms without serial numbers that are increasingly cropping up at crime scenes.
The White House confirmed that Biden is announcing the nomination of Steve Dettlebach, who served as a U.S. attorney in Ohio from 2009 to 2016, in a Monday afternoon event. The administration is also releasing the finalized version of its ghost gun rule, which comes as the White House and the Justice Department have been under growing pressure to crack down on gun deaths and violent crime in the U.S.
Dettlebach’s confirmation is likely to be an uphill battle for the Biden administration. Biden had to withdraw the nomination of his first ATF nominee, gun-control advocate David Chipman, after the nomination stalled for months because of opposition from Republicans and some Democrats in the Senate.
Both Republican and Democratic administrations have failed to get nominees for the ATF position through the politically fraught process since the director’s position was made confirmable in 2006. Since then, only one nominee, former U.S. Attorney B. Todd Jones, has been confirmed. Jones made it through the Senate in 2013 but only after a six-month struggle. Jones was acting director when President Barack Obama nominated him in January 2013.
The Biden administration’s plan was first reported by Politico.
For nearly a year, the ghost gun rule has been making its way through the federal regulation process. Gun safety groups and Democrats in Congress have been pushing for the Justice Department to finish the rule for months. It will probably be met with heavy resistance from gun groups and draw litigation in the coming weeks.
Gun Owners of America vowed that it would immediately fight the rule.
“Just as we opposed the Trump Administration’s arbitrary ban on bump stocks, GOA will also sue Biden’s ATF to halt the implementation of this rule,” Aidan Johnston, the group’s director of federal affairs said in a statement. The group believes the rule violates the U.S. Constitution and several federal laws.
But gun safety advocacy groups, like Everytown for Gun Safety, which pushed the federal government for years to take action on ghost guns, applauded Biden’s moves and insisted that both Dettlebach’s appointment and the finalized rule will help combat gun violence.
“Ghost guns look like a gun, they shoot like a gun, and they kill like a gun, but up until now they haven’t been regulated like a gun,” said John Feinblatt, Everytown’s president.
Christian Heyne, the vice president of policy at Brady, another gun control group, said Dettlebach was “an unimpeachable public servant who has spent a career using the levers of government to hold negligent or nefarious actors accountable.”
Justice Department statistics show that nearly 24,000 ghost guns were recovered by law enforcement at crime scenes and reported to the government from 2016 to 2020. It is hard to say how many are circulating on the streets, in part because in many cases police departments don’t contact the government about the guns because they can’t be traced.
The new rule changes the current definition of a firearm under federal law to include unfinished parts, like the frame of a handgun or the receiver of a long gun. It says those parts must be licensed and include serial numbers. Manufacturers must also run background checks before a sale — as they do with other commercially made firearms. The requirement applies regardless of how the firearm was made, meaning it includes ghost guns made from individual parts, kits or by 3D printers.
Federally licensed firearms dealers must retain key records until they shut down their business or licensed activity and then transfer the records to ATF as they are currently required to do at the end of licensed activity. Previously, these dealers were permitted to destroy most records after 20 years, making it harder for law enforcement to trace firearms found at crime scenes.
For years, federal officials have been sounding the alarm about an increasing black market for homemade, military-style semi-automatic rifles and handguns. As well as turning up more frequently at crime scenes, ghost guns have been increasingly encountered when federal agents buy guns in undercover operations from gang members and other criminals.
Some states, like California, have enacted laws in recent years to require serial numbers to be stamped on ghost guns.
The critical component in building an untraceable gun is what is known as the lower receiver, a part typically made of metal or polymer. An unfinished receiver — sometimes referred to as an “80-percent receiver” — can be legally bought online with no serial numbers or other markings on it, no license required.
Police across the country have been reporting spikes in ghost guns being recovered by officers. The New York Police Department, for example, said officers found 131 firearms without serial numbers since January.
A gunman who killed his wife and four others in Northern California in 2017 had been prohibited from owning firearms, but he built his own to skirt the court order before his rampage. And in 2019, a teenager used a homemade handgun to fatally shoot two classmates and wound three others at a school in suburban Los Angeles.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.wvva.com/2022/04/11/biden-nominate-new-atf-chief-release-ghost-gun-rule/
| 2022-04-11T12:37:01Z
|
Once a retail giant, Kmart will be down to 3 stores after NJ closing
AVENEL, N.J. (AP) — The familiar sights and sounds are still there: the scuffed and faded floor tiles, the relentless beige-on-beige color scheme, the toddlers’ clothes and refrigerators and pretty much everything in between.
There’s even a canned recording that begins, “Attention, Kmart shoppers” — except it’s to remind folks about COVID-19 precautions, not to alert them to a flash sale over in ladies’ lingerie like days of old.
Many of the shelves are bare, though, at the Kmart in Avenel, New Jersey, picked over by bargain hunters as the store prepares to close its doors for good April 16.
Once it shutters, the number of Kmarts in the U.S. – once well over 2,000 – will be down to three last holdouts, according to multiple reports, in a retail world now dominated by Walmart, Target and Amazon.
The demise of the the store in the middle-class suburb, 15 miles south of New York City, is the tale of the death of the discount department store writ small.
“You’re always thinking about it because stores are closing all over, but it’s still sad,” said cashier Michelle Yavorsky, who said she has worked at the Avenel store for 2 ½ years. “I’ll miss the place. A lot of people shopped here.”
In its heyday, Kmart sold product lines endorsed by celebrities Martha Stewart and Jaclyn Smith, sponsored NASCAR auto races and was mentioned in movies including “Rain Man” and “Beetlejuice.” It was name-dropped in songs by artists from Eminem to the Beastie Boys to Hall and Oates; in 2003, Eminem bought a 29-room, suburban Detroit mansion once owned by former Kmart chairman Chuck Conaway.
The chain cemented a place in American culture with its Blue Light Specials, a flashing blue orb affixed to a pole that would beckon shoppers to a flash sale in progress. Part of its success was due to its early adoption of layaway programs, which allowed customers who lacked credit to reserve items and pay for them in installments.
For a time, Kmart had a little bit of everything: You could shop for your kids’ back-to-school supplies, get your car tuned up and grab a meal without leaving the premises.
“Kmart was part of America,” said Michael Lisicky, a Baltimore-based author who has written several books on U.S. retail history. “Everybody went to Kmart, whether you liked it or not. They had everything. You had toys. You had sporting goods. You had candy. You had stationery. It was something for everybody. This was almost as much of a social visit as it was a shopping visit. You could spend hours here. And these just dotted the American landscape over the years.”
Kmart’s decline has been slow but steady, brought about by years of falling sales, changes in shopping habits and the looming shadow of Walmart, which coincidentally began its life within months of Kmart’s founding in 1962.
Struggling to compete with Walmart’s low prices and Target’s trendier offerings, Kmart filed for Chapter 11 bankruptcy protection in early 2002 — becoming the largest U.S. retailer to take that step — and announced it would close more than 250 stores.
A few years later, hedge fund executive Edward Lampert combined Sears and Kmart and pledged to return them to their former greatness, but the recession and the rising dominance of Amazon contributed in derailing those goals. Sears filed for Chapter 11 in 2018 and currently has a handful of stores left in the U.S. where it once had thousands.
Kmarts continue to operate in Westwood, New Jersey; Bridgehampton, on New York’s Long Island, and Miami.
It didn’t have to end this way, according to Mark Cohen, director of retail studies at Columbia University in New York and former CEO of Sears Canada. Trying to compete with Walmart on price was a foolish strategy, he said, and Lampert was criticized for not having a retail background and appearing more interested in stripping off the assets of the two chains for their cash value.
“It’s a study in greed, avarice and incompetence,” Cohen said. “Sears should have never gone away; Kmart was in worse shape, but not fatally so. And now they’re both gone.
“Retailers fall by the wayside sometimes because they’re selling things people don’t want to buy,” he continued. “In the case of Kmart, everything they used to sell, people are buying but they’re buying it from Walmart and Target.”
Transformco, which owns Kmart and Sears, did not respond to an email seeking comment and a phone number listed for the company was not taking messages.
Nationwide, some former Kmarts remain vacant while others have been replaced by other big-box stores, fitness centers, self-storage facilities, even churches. One former site in Colorado Springs, Colorado, is now a popular dine-in movie theater.
Employees at the Kmart in Avenel found out last month that the store would close.
Unlike 20 years ago, when news of impending Kmart closures around the country prompted an outpouring of support from loyal shoppers and a Detroit radio station even mounted a campaign to try and save a local store, the closing of the Avenel location was met mostly with an air of resignation.
“It’s maybe a little nostalgic because I’ve lived my whole life in this area, but it’s just another retail store closing,” said Jim Schaber, a resident of nearby Iselin who said his brother worked in the shoe department at Kmart for years. “It’s just another sign of people doing online shopping and not going out to the retail stores.”
The closing packed a little more of an emotional punch for Mike Jerdonek, a truck driver who recalled shopping at Kmart in Brooklyn and Queens in his younger days.
“It’s like history passing right in front of our eyes,” he said as he sat in his car outside the Avenel store. “When I was younger I didn’t have any money, so it was a good place to shop because the prices were cheap. And to see it gone right now, it’s kind of sad.”
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.wvva.com/2022/04/11/once-retail-giant-kmart-will-be-down-3-stores-after-nj-closing/
| 2022-04-11T12:37:08Z
|
Toddler dies after going down waterfall in North Carolina
JACKSON COUNTY, N.C. (WHNS/Gray News) - A 3-year-old child has died after falling down a waterfall Sunday evening, according to the Jackson County Sheriff’s Office.
Deputies said they received reports at 5:50 p.m. that the child, who was visiting Whitewater Falls with her family, had been swept away in the water at the top of the falls and had been carried by the current.
Emergency responders from Jackson, Transylvania, Haywood, Henderson,and Oconee counties were dispatched to the falls to rescue the child, WHNS reported.
Just before nightfall, the 3-year-old little girl was found dead and entrapped in an area of the waterfall. Her body was recovered around 1 a.m. Monday.
The child has been identified as Nevaeh Jade Newswanger, 3, of Pennsylvania. Her family had been living in Oconee County while working in the area.
“First and foremost our prayers are with the Newswanger family as they grieve the loss of this precious young child,” said Jackson County Sheriff Chip Hall. “With the onset of spring weather, we need to be reminded of the dangers associated with many scenic areas of the region such as waterfalls.”
Hall reminded people to view the falls from a safe distance from a designated viewing area, following safety precautions.
Copyright 2022 WHNS via Gray Media Group, Inc. All rights reserved.
|
https://www.wvva.com/2022/04/11/toddler-dies-after-going-down-waterfall-north-carolina/
| 2022-04-11T12:37:15Z
|
Manhole cover explosion caused some to panic in New York’s Times Square
NEW YORK (WCBS) - An Earthcam video shows the moment people began scrambling out of the area just before 7 p.m. Sunday.
Con Ed said a power cable failure led to an explosion and fire in a manhole.
As firefighters worked to put out the fire, dark gray smoke came from a manhole and two others, filling the air.
“Once I’m seeing the fire, the cops are telling me to back up and start backing up. But still I started like proceeding to the fire‚ and then it’s actually exploded right in front of me. And that’s when I was just like I started running,” Lavier Pounds said.
Marivic Jaks said she is visiting from California and was running late to catch her tour bus when she heard the boom.
“We just missed it. We missed the bus. Five minutes of walking and then a loud, loud … I’m still nervous and shaking,” she said.
Firefighters evacuated people in the area as a precaution.
Officials said there were elevated carbon monoxide levels in an office building, and firefighters assisted Con Ed crews in ventilating the cellar and subcellar of that building.
On Sunday, Con Ed says there have been no power outages because of the fire.
Copyright 2022 WCBS via CNN Newsource. All rights reserved.
|
https://www.whsv.com/2022/04/11/manhole-cover-explosion-caused-some-panic-new-yorks-times-square/
| 2022-04-11T13:55:06Z
|
Mimi Reinhard, who typed up Schindler’s list, dies at 107
JERUSALEM (AP) — Mimi Reinhard, a secretary in Oskar Schindler’s office who typed up the list of Jews he saved from extermination by Nazi Germany, has died in Israel at the age of 107.
Reinhard died early Friday and was laid to rest Sunday in Herzliya, near Tel Aviv, her son Sasha Weitman confirmed.
She was one of 1,200 Jews saved by German businessman Schindler after he bribed Nazi authorities to let him keep them as workers in his factories. The account was made into the acclaimed 1993 film “Schindler’s List” by director Steven Spielberg.
Reinhard was born Carmen Koppel in Vienna, Austria, in 1915, and moved to Krakow, Poland, before the outbreak of World War II. After Nazi Germany invaded Poland in 1939, she was confined to the Krakow ghetto before being sent to the nearby Plaszow concentration camp in 1942.
Reinhard’s knowledge of shorthand got her work in the camp’s administrative office, where, two years later, she was ordered to type up the handwritten list of Jews that were to be transferred to Schindler’s ammunition factory.
“I didn’t know it was such an important thing, that list,” she told an interviewer with Yad Vashem, the World Holocaust Remembrance Center, in 2008. “First of all, I got the list of those who were with Schindler already in Krakow, in his factory. I had to put them on the list.” Later she put her own name, and the names of two friends.
At the Brünnlitz labor camp, where Schindler’s ammunition factory was housed, she was put to work in Schindler’s office.
She said that although she worked in Schindler’s office toward the end of the war, she had little personal contact with him.
“He was a very charming man, very outgoing,” she recalled, decades after the war. “He didn’t treat us like scum.”
After the war, she made her way to the United States, where she lived until immigrating to Israel in 2007 at the age of 92.
Weitman, Reinhard’s son, said that after coming to Israel she “became a kind of a celebrity” because of the Schindler’s List film’s popularity, something he said “pumped another 15 years into her life.”
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.whsv.com/2022/04/11/mimi-reinhard-who-typed-up-schindlers-list-dies-107/
| 2022-04-11T13:55:14Z
|
NEW YORK, April 11, 2022 /PRNewswire/ -- 5WPR, one of the largest independently-owned PR firms in the U.S., announces today the continued expansion of its specialty Israel PR practice area, providing PR and digital services for Israel-based businesses looking to launch or extend their international reach.
In the past year, 5W has welcomed several Israel-based brands to their continuously growing client roster, including AI-powered web accessibility solutions, innovators in digital advertising, global publishing groups, and more.
"5W has developed tried-and-true practices, as well as fostering key relationships with media, that ensure our client's work is being showcased in an overwhelmed and competitive landscape," said 5WPR CEO, Matthew Caiola. "Our work continues to garner international attention, and as a result, we are expanding out roster of Israel-based clients and recruiting more top talent to help lead impactful campaigns for these high growth brands."
5W's team of experts have developed a specialty in high-growth tech communications campaigns. The teams handle major milestones, from launching products, developing strategic campaigns around mergers and acquisitions, fundraising and IPOs, through to building layered programs and social media strategies that bring clients into mainstream conversations.
About 5WPR
5W Public Relations is a full-service PR agency in NYC known for cutting-edge programs that engage with businesses, issues and ideas. With more than 250 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications and Reputation Management), Public Affairs, Crisis Communications and Digital Marketing (Social Media, Influencer, Paid Media, SEO). 5W was awarded 2020 PR Agency of The Year and brings leading businesses a resourceful, bold and results-driven approach to communication.
View original content to download multimedia:
SOURCE 5W Public Relations
|
https://www.whsv.com/prnewswire/2022/04/11/5wpr-continues-expansion-israel-pr-practice-area/
| 2022-04-11T13:55:20Z
|
$28,000 grant to support corporate and military spouse fellowship programs on behalf of Transurban North America
MELVILLE, N.Y., April 11, 2022 /PRNewswire/ -- American Veterans Group (AVG), a social impact investment bank and Wall Street's first and only public benefit corporation, has provided a grant to the U.S. Chamber of Commerce Foundation's Hiring Our Heroes Fellowship Program. Hiring Our Heroes (HOH) connects military service members, military spouses, and veterans with American businesses to help them find meaningful employment.
The $28,000 gift from American Veterans Group will be used to support the non-profit's corporate and military spouse fellowship programs. The funds will be used to support the operating costs of facilitating learning opportunities for five active-duty service members and four military spouses in the National Capital Region. The fellowships will be awarded to populations with the greatest need, including enlisted service members, women, and persons of color.
American Veterans Group is a service-disabled, veteran-owned investment bank that dedicates 25% of its earnings to support veterans' causes. The gift to Hiring Our Heroes was made possible by Transurban North America's appointment of AVG as a co-manager on a recent Commonwealth of Virginia bond issue. The global transportation company is developing and operating a growing network of dynamically-tolled Express Lanes in the Greater Washington Area in partnership with government – including along I-95, I-395, and I-495. AVG was co-manager for a $638 million series 2022 senior lien revenue refunding bond issuance by the Commonwealth of Virginia Small Business Financing Authority on behalf of 95 Express Lanes, LLC, operated by Transurban.
"Supporting Hiring Our Heroes aligns perfectly with our corporate social mission to help veterans make the often-difficult transition from military to civilian life," said Ben Biles, co-founder and chief executive officer of American Veterans Group. "Fellowship programs like Hiring Our Heroes forge strong relationships between veterans and military spouses and key business decision makers who are invested in fostering their success. We wholeheartedly support the U.S. Chamber of Commerce Foundation in this important work and share Transurban's commitment to making a difference for veterans in the D.C. area."
Hiring Our Heroes fellowships are designed to provide workforce development programs that place highly skilled and educated service members, veterans, military spouses, and military caregivers with employers who are committed to hiring them. Service members receive experiential work opportunities prior to their departure from the military, creating direct pathways to employment.
"It's support from partners such as American Veterans Group that makes our work possible," said Eric Eversole, president of Hiring Our Heroes and vice president at the U.S. Chamber of Commerce Foundation. "Thanks to their generosity and belief in our mission, we're able to deliver best-in-class solutions to connect diverse military talent with American businesses regardless of their location in the world. Through our engagement of the business community, we have worked with our partners to help more than 600,000 veterans and military spouses find meaningful careers."
"At Transurban, our mission is to strengthen communities through transport and that means investing in the communities we serve," said Michael Discenza, chief financial officer of Transurban North America. "We thank American Veterans Group for their partnership and dedication to the meaningful investments they bring forward to serve communities. We are honored Hiring our Heroes is using this donation to support our military and their spouses who have made invaluable contributions to serve and defend our country."
About American Veterans Group
American Veterans Group, PBC, is a military veteran-owned, social impact-focused broker dealer that delivers value to institutional clients while providing meaningful philanthropic support to the military veteran community. The company reinvests 25% of its earnings in national and local military veteran non-profit organizations that provide worthy services and support to one of America's most vulnerable, at-risk populations. As Wall Street's only public benefit corporation, American Veterans Group empowers institutional clients to partner in its social mission while enabling them to remain focused on key business objectives and goals. To learn more about American Veterans Group, visit their website at www.americanvetsgroup.com.
About the U.S. Chamber of Commerce Foundation (USCCF)
The U.S. Chamber of Commerce Foundation (USCCF) is a 501(c)(3) nonprofit affiliate of the U.S. Chamber of Commerce dedicated to strengthening America's long-term competitiveness by addressing developments that affect our nation, our economy and the global business environment.
About Hiring Our Heroes
Hiring Our Heroes (HOH) is a 501(c)(3) organization under the U.S. Chamber of Commerce Foundation. The non-profit launched in March 2011 as a nationwide initiative to help veterans, transitioning service members, and military spouses find meaningful employment. Working with the U.S. Chamber of Commerce's vast network of state and local chambers and other strategic partners from the public, private and nonprofit sectors, Hiring Our Heroes has helped hundreds of thousands of veterans and military spouses find meaningful employment through its comprehensive training and hiring events, fellowship programs, and online tools. HOH programs and services are available in all 50 states, Puerto Rico, the District of Columbia, and on military installations around the world. For more information on programming and initiatives: HiringOurHeroes.org; @HiringOurHeroes on LinkedIn, Facebook, Twitter and Instagram.
About Transurban North America
Transurban is one of the world's largest toll-road operators and developers, working to get people where they want to go, as quickly and safely as possible. By embracing collaboration with government, our public-private partnerships are delivering transformative infrastructure solutions across five markets. In fiscal year 2021, our global customers saved 376,000 hours on average each workday across two million trips on our roads with faster, more predictable travel options. With a leading market share of transportation P3 investment in North America, we are pioneering travel solutions like dynamically tolled Express Lanes and are partnering with government to think about the policies, technology and infrastructure that will get you home today and 10 years from now. Learn more about Transurban North America at: Transurban.com | Expresslanes.com | A25.com
Media Contacts:
For American Veterans Group
Mark Kroeger
The Boldsquare Group
(513) 236-3109
mark@boldsquare.com
For Hiring Our Heroes
Alice Massimi
(202) 961-5748
amassimi@uschamber.com
For Transurban North America
Tanya Sheres
(571) 335-3511
tsheres@transurban.com
View original content:
SOURCE American Veterans Group
|
https://www.whsv.com/prnewswire/2022/04/11/american-veterans-group-provides-grant-us-chamber-commerce-foundations-hiring-our-heroes-fellowship-program/
| 2022-04-11T13:55:26Z
|
SANTA CLARA, Calif., April 11, 2022 /PRNewswire/ -- Ampere® Computing announced that it has submitted a draft registration statement on a confidential basis to the U.S. Securities and Exchange Commission (the "SEC") for a proposed initial public offering of common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Ampere expects to complete the public offering following the SEC review process, subject to market and other conditions.
This announcement is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933, as amended (the "Securities Act"). As required by Rule 135, this press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.
Contact:
Brooke Wells
bwells@amperecomputing.com
View original content to download multimedia:
SOURCE Ampere
|
https://www.whsv.com/prnewswire/2022/04/11/ampere-announces-confidential-submission-draft-registration-statement-proposed-initial-public-offering/
| 2022-04-11T13:55:32Z
|
Shadow High™ Sweeps Retail Shelves With Its Grayscale Glory
CHATSWORTH, Calif., April 11, 2022 /PRNewswire/ -- There is a new school in town ready to disrupt the Rainbow and demand a double take. Rainbow High™, NPD's #1 Doll and #1 Fashion Doll, has officially met its match. Introducing… Shadow High™! Feelings of a nostalgic high school rivalry, anyone?
The students of Shadow High, who embody the other half of the Rainbow, are available for pre-order beginning today, April 11, 2022 at online retailers including Amazon, Walmart, and Target and are hitting store shelves on April 25. The Shadow High™ collection features an assortment of six dolls distinguished by bold, grayscale tones with a touch of iridescent shine and classic rainbow accents. The line introduces fans and collectors to all-new characters whose personalities are just as unique and enigmatic as their style. The Shadow High students remain true to the values of their colorful Rainbow High counterparts including creativity and inclusivity, but are aesthetically different, proudly expressing their personalities through their fashions.
With the launch of Shadow High™, the Rainbow High™ brand officially expands into untapped territory, introducing fans to its most creative and unexpected collection to date. After much anticipation, a few thrilling social stunts and some press worthy leaks, the Shadow High™ characters have generated buzz across both the collector and fan community. For over a week, Rainbow High™ fans were left in the dark as they excitedly debated whether the newly launched Shadow High™ social accounts were official, building up even more anticipation in advance of the reveal. When the dolls were finally revealed, fans went wild in the comments.
"Our Rainbow High fans are loyal and passionate and there has been noise and demand for the new collection since word got out, said Isaac Larian, Founder and CEO of MGA Entertainment. "The Shadow High collection was a secret kept under wraps for many months and fans couldn't get enough while we played along via social media seeing takeovers, leaks and mysterious Shadow High accounts popping up in advance of its debut. The collection has already disrupted the industry even before its launch!"
At Shadow High, the talent is unwavering, and creativity is unmatched. Unlike their impeccable rivals, the students of Shadow High take an avant-garde approach to their creative expression. These students may thrive in the shadows, but they always let their true colors shine. The collection takes full command of the other side of the Rainbow with a bold, polished, and luxe feel that is woven throughout packaging and design. Meet the passionate students of Shadow High:
- Natasha Zima, Cosmetic Chemistry Focus
- Heather Grayson, Special Effects Makeup Focus
- Ash Silverstone, Audio & Visual Effects Focus
- Nicole Steel, Installation Focus
- Luna Madison, Film Focus
- Shanelle Onyx, Couture Fashion Design Focus
The dolls are fully articulated, including their arms and legs, and they feature unique sculpts. Like their predecessors, the Shadow High™ dolls themselves inspire fans to "be creative now" and embody themes of confidence and self-expression that resonate with kids, parents, and collectors alike. The new collection's packaging will mirror that of Rainbow High™ with a twist, as though Shadow High hacked Rainbow High's brand block on shelves. The fashions sported by the dolls feature trendy fabrics and aspirational designs that kids see in the real world. Each doll features two edgy outfits for extended playability and endless imaginative play.
Fans of the collection can also catch the students of Shadow High in season three of the hit animated Rainbow High series, which aired April 1 on YouTube. Fans can catch up on previous seasons on Netflix and check out all of the latest episodes on YouTube. In the series, Shadow High students are tired of Rainbow High winning everything, and they are determined to no longer be the arts school hidden in the shadows.
Head to the Rainbow High page and follow along @officialrainbowhigh @officialshadowhigh and hashtag #LETYOURTRUECOLORSSHINE for more information.
About MGA Entertainment
MGA Entertainment is the fastest growing and largest privately held toy company in the U.S. and is headquartered in Chatsworth, California. The company creates innovative, proprietary, and licensed consumer products and entertainment, including toys, games, dolls, apparel, consumer electronics, home décor, stationery, and sporting goods. The MGA family includes award-winning brands such as L.O.L. Surprise!™, Little Tikes®, Rainbow High™, Bratz®, Na! Na! Na! Surprise™, Baby Born® Surprise and Zapf Creation®. Visit us at www.mgae.com.
View original content to download multimedia:
SOURCE MGA Entertainment
|
https://www.whsv.com/prnewswire/2022/04/11/an-eclipse-is-coming-toy-aisle-will-never-be-same/
| 2022-04-11T13:55:41Z
|
Life Science and Data Science Industry Veteran Joins Anju's Executive Suite; Sets Course for the Future
FT. LAUDERDALE, Fla., April 11, 2022 /PRNewswire/ -- Anju, a leading provider of comprehensive software solutions to the life sciences industry, announced that it has appointed Laurence (Larry) Birch as its Chief Executive Officer. Larry brings more than three decades of life sciences, software and global management experience to Anju, and is uniquely prepared to lead the Company through its next phase of growth.
"I joined Anju because it can be built into one of the leaders in the life sciences technology space," said Mr. Birch. "My goal is to empower our customers to help patients by applying our software in eClinical, Medical Affairs, Data and other technology-based services."
"We are extremely fortunate to have Larry lead Anju into the future," said James Scola, Partner, Abry Partners. "Larry's strong track record in healthcare, life sciences and software technology will enable Anju to drive innovation and success for our clients and partners as they seek to improve outcomes for patients in the healthcare value chain."
Larry has been on both sides of clinical research and data management, starting his career at Baxter, Inc. assuming positions of increasing responsibility in financial and management positions. Larry's career progressed into leadership roles serving as CEO of Aksys, (Home Hemodialysis) and NeoPharm (Oncology Biotech). Most relevant to Anju's core business, he led Datatrak (eClinical Enterprise Solutions) for nine years driving a significant increase in revenue backlog and transformed the business model introducing several new eClinical products and services.
"I enjoy being a part of an industry that helps people live longer and better lives—we must never forget our important role in this process," added Birch. "I believe that the health tech revolution has only just begun, and I want to do my part to drive and adopt the changes in digitization and artificial and machine learning as it continues to transform the life science industry."
About Anju
Anju provides an adaptive platform for clinical trials, medical affairs, and a newly designed, state-of-the-art clinical content and data repository. Anju provides a leading suite of solutions that leverage AI and data-driven analytics to provide a breadth of services to worldwide pharmaceutical, biotech and contract research Life Sciences customers & partners.
Media Contact:
John F. Kouten
JFK Communications, Inc.
(o) 1+609-241-7352 (c) 1+908-227-4714
jfkouten@jfkhealth.com
View original content:
SOURCE Anju Life Sciences Software
|
https://www.whsv.com/prnewswire/2022/04/11/anju-appoints-laurence-birch-chief-executive-officer/
| 2022-04-11T13:55:46Z
|
Appian takes customers from process discovery to workflow design and automation, delivering a total experience in one unified platform
MCLEAN, Va., April 11, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced that it has been recognized again as a 2022 Gartner Peer Insights Customers' Choice for Enterprise Low-Code Application Platforms (LCAP). Appian is one of only four vendors to receive the "Customers' Choice" distinction, and the only vendor to receive the distinction across the four categories for Large Enterprise ($1-10B), Midsize Enterprise ($50M-$1B), North America, and Europe, the Middle East and Africa.
Gartner Peer Insights is a free peer review and ratings platform designed for enterprise software and services decision makers. Reviews go through a strict validation and moderation process in an effort to ensure they are authentic.
According to Gartner®, "To qualify for the Customers' Choice distinction, vendors must have a product that is listed in this market on Gartner Peer Insights, have their overall rating (out of 5 stars) above or equal to the mean rating for that market, and receive 50 or more eligible published customer reviews during the one-year submission period."
As of December 31, 2021, Appian had the highest number of reviews within Gartner Peer Insights for the LCAP market: 141 reviews with an Overall rating of 4.6 out of 5. To learn more, read the new March 2022 "Gartner Peer Insights 'Voice of the Customer': Enterprise Low-Code Application Platforms" report.
A sample of Appian end-user reviews submitted over the last 12 months includes:
"Crush your ROI with Rapid Development and Deployment of Complex Business Solutions."
— Senior Data Architect in the Transportation industry [read review]
"Appian Helps Us Reimagine Our Business."
— Chief Technology Officer in the Media industry [read review]
"'Go-To' Platform For All Your Enterprise Needs!"
— Senior Program Manager in the Life Sciences industry [read review]
"Delight Your Users, Customers, and Developers With Appian!"
— IT Developer in the Manufacturing Industry [read review]
Pavel Zamudio-Ramirez, Chief Customer Officer at Appian, said, "We believe that this new report is evidence of our focus on customer success and the quality of experience our customers get from our software and our people."
To try the latest version of Appian for yourself, sign up for free at www.appian.com/platform/free-trial/.
Disclaimer
Gartner® and Peer Insights™ are trademarks of Gartner, Inc. and/or its affiliates. All rights reserved. Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
Gartner, Gartner Peer Insights 'Voice of the Customer': Enterprise Low-Code Application Platforms, 31st March 2022.
About Appian
Appian is the unified platform for change. We accelerate customers' businesses by discovering, designing, and automating their most important processes. The Appian Low-Code Platform combines the key capabilities needed to get work done faster, Process Mining + Workflow + Automation, in a unified low-code platform. Appian is open, enterprise-grade and trusted by industry leaders. For more information, visit www.appian.com.
View original content to download multimedia:
SOURCE Appian
|
https://www.whsv.com/prnewswire/2022/04/11/appian-named-customers-choice-again-2022-gartner-peer-insights-voice-customer-enterprise-low-code-application-platforms/
| 2022-04-11T13:55:52Z
|
DANVERS, Mass., April 11, 2022 /PRNewswire/ -- The National Scleroderma Foundation announced today that recording artist Ashley Barron has been named their official Celebrity Ambassador. A new star on the country music scene, Barron was diagnosed with scleroderma at age five. At that time, her family had never heard of the disease, a common experience with the rare disease, which only affects 300,000 Americans. Now as Celebrity Ambassador, Barron is working to represent the organization and increase awareness and understanding of scleroderma as she travels the country for performances. Tragically, Ashley lost her mother, Carol Lee Barron, to scleroderma in October 2020. Her mother's diagnosis of systemic sclerosis occurred only four months before her death.
"I am so honored to have the opportunity to work alongside the National Scleroderma Foundation to bring awareness to this disease," says Barron. "I never thought when I was diagnosed at 5 years old, that I'd one day get the opportunity to bring support and community to others that I did not have. I'm very excited for the future and what is to come."
"Ashley is uniquely positioned to help others affected by scleroderma find their best path forward," said National Scleroderma Foundation CEO Mary J. Wheatley. "As a talented recording artist, as a person who has scleroderma herself, and as someone who lost her mother to this disease, Ashley's compelling story can touch people in her audience who need to know about the disease and the work the National Scleroderma Foundation is doing to address it."
Barron's latest single, "The Wind," from her debut album is a hope filled anthem that captures the imagination and embodies the spirit of a powerful, independent woman who finds a positive way to move forward no matter what life throws her way.
The Foundation and Barron's recording label, SSM Nashville Records, have plans for future appearances, both virtual and in-person, as health and safety restrictions allow. Barron will be on tour this spring and summer sharing her story, and her songs, with an audience for the first time in years. In the scleroderma rare disease community, connecting with others on the same path makes a difference. To learn more about scleroderma and the National Scleroderma Foundation, visit www.scleroderma.org.
ABOUT ASHLEY BARRON
Ashley Barron is country music artist who embraces the independent and powerful country woman aura in her writing and music. Influenced by the country greats such as Johnny Cash and other modern stars like Miranda Lambert, she now incorporates her life experiences and stories into her writing, creating passionate, home-grown, and relatable music. Her past single, "Beer in a Bar," received critical acclaim and topped in Billboard at #37. Her next release, "Let Me Go," showed her strength both lyrically and vocally. Ashley's newest single, "The Wind," is an encouraging anthem to stay strong and keep going when life gets difficult. Her self-titled, debut album is available now! ashleybarronofficial.com
ABOUT SSM NASHVILLE RECORDS
SSM Nashville Records is an established Music Row company with proven success for over 15 years. Their artist roster and team have more than 40 years of experience in the music business that account for breaking many artists and for millions of records sold. SSM Nashville Records is a song-driven company that strives to establish a family atmosphere. ssmnashville.com
ABOUT SCLERODERMA
Scleroderma is a rare rheumatic disease that affects connective tissue and the vascular system causing an overproduction of collagen (fibrosis) in the skin (localized scleroderma), and the internal organs (systemic sclerosis), which can be life-threatening. Anyone can have scleroderma. The cause is not yet known and there is no cure.
ABOUT NATIONAL SCLERODERMA FOUNDATION
The National Scleroderma Foundation is a relentless force for people who have scleroderma as it advances medical research, promotes disease awareness, and provides support and education to people with scleroderma, their families and support networks. Its highly regarded peer-reviewed research grant program aims to discover the cause, understand the mechanisms, and overcome scleroderma forever. scleroderma.org
Media Contact:
Steve Sookikian
ssookikian@scleroderma.org
(978) 624-1243
View original content to download multimedia:
SOURCE National Scleroderma Foundation
|
https://www.whsv.com/prnewswire/2022/04/11/ashley-barron-named-celebrity-ambassador-by-national-scleroderma-foundation/
| 2022-04-11T13:55:59Z
|
SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its new service offering for high throughput Antibody Characterization Services.
Aviva Systems Biology's Antibody Characterization Services provides drug discovery researchers in small to mid-size biotechs with an affordable and easily accessible solution for rapid screening of therapeutic antibodies, kinetic analysis, and epitope mapping and binning. By leveraging the advanced Carterra® LSA™ platform, Aviva can provide high throughput SPR analysis for biotherapeutic antibody development at a scale other screening providers can't match.
"The addition of our antibody characterization services to our current offering of custom protein, ELISA, and antibody development will enable our clients to reduce the cost and time it takes to bring a novel biotherapeutic molecule to the clinic. We are excited to offer this unique solution to biotherapeutic antibody researchers," said Kevin Harvey, President of Aviva Systems Biology.
Learn more about Aviva's Antibody Characterization Services at the AACR Annual Meeting 2022 in New Orleans at booth #1951, April 10-13, 2022, or by visiting avivasysbio.com.
About Aviva Systems Biology
Aviva Systems Biology, founded in 2002, is a global market leader in proteomics research offering a broad portfolio of polyclonal and monoclonal antibodies, immunoassay kits, recombinant proteins, and custom protein expression and antibody characterization services for academic and biopharma researchers. Headquartered in San Diego, California, the Aviva offering supports multiple applications such as western blotting, IHC, ELISA, and immunoprecipitation along with providing researchers one of the largest catalogs of targets and species to choose from.
Contact
Wendy Parenteau
Director of Marketing
wparenteau@avivasysbio.com
View original content:
SOURCE Aviva Systems Biology
|
https://www.whsv.com/prnewswire/2022/04/11/aviva-systems-biology-announces-launch-high-throughput-antibody-characterization-services/
| 2022-04-11T13:56:05Z
|
SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its AvivaBlot™ product line of ECL reagents for western blot application. This new portfolio supports picogram to low femtogram detection of proteins via enhanced and stabilized chemiluminescent detection.
Western blotting is a foundational research application for the separation and identification of proteins. To ensure researchers achieve the best from their western blots, the AvivaBlot ECL reagents are easy-to-use, high quality, and affordable for a variety of western blot detection needs. The portfolio offers products in three sensitivity ranges:
- AvivaBlot Pico One ECL Reagent – One pre-mixed component that is ideal for general detection needs.
- AvivaBlot Femto ECL Reagent – Offers high range flexibility with mid-femtogram detection.
- AvivaBlot Ultra Femto ECL Reagent – Support low femtogram detection for rare and precious samples.
"For nearly 20 years Aviva Systems Biology has supported customers with thousands of antibodies validated in Western Blot, the primary workhorse application for protein analysis in most research settings. We are excited to now provide best-in-class ECL detection reagents that will support Aviva customers complete Western Blot workflow needs," said Kevin Harvey, Ph.D., President.
Learn more about AvivaBlot ECL Reagents at the AACR Annual Meeting 2022 in New Orleans at booth #1951, April 10-13, 2022, or by visiting avivasysbio.com.
About Aviva Systems Biology
Aviva Systems Biology, founded in 2002, is a global market leader in proteomics research offering a broad portfolio of polyclonal and monoclonal antibodies, immunoassay kits, recombinant proteins, and custom protein expression and antibody characterization services for academic and biopharma researchers. Headquartered in San Diego, California, the Aviva offering supports multiple applications such as western blotting, IHC, ELISA, and immunoprecipitation along with providing researchers one of the largest catalogs of targets and species to choose from.
Contact
Wendy Parenteau
Director of Marketing
wparenteau@avivasysbio.com
View original content to download multimedia:
SOURCE Aviva Systems Biology
|
https://www.whsv.com/prnewswire/2022/04/11/aviva-systems-biology-launches-avivablot-ecl-reagents-western-blot/
| 2022-04-11T13:56:11Z
|
CHARLOTTE, N.C., April 11, 2022 /PRNewswire/ -- As previously announced, Bank of America will report its first-quarter 2022 financial results on Monday, April 18. The results will be released at approximately 6:45 a.m. ET, followed by an investor presentation at 8:30 a.m. ET.
The news release, supplemental filing and investor presentation can be accessed at Bank of America's Investor Relations website at https://investor.bankofamerica.com/quarterly-earnings.
Investor Conference Call Information
For a listen-only connection to the investor presentation, dial 1.877.200.4456 (U.S.) or 1.785.424.1732 (international). The conference ID is 79795. Please dial in 10 minutes prior to the start of the call. Investors can also listen to a live audio of the conference call and view the presentation slides by visiting the "Events & Presentations" section of the company's Investor Relations website.
Bank of America
Bank of America is one of the world's leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 67 million consumer and small business clients with approximately 4,200 retail financial centers, approximately 16,000 ATMs, and award-winning digital banking with more than 54 million verified digital users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 3 million small business households through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and approximately 35 countries. Bank of America Corporation stock (NYSE: BAC) is listed on the New York Stock Exchange.
For more Bank of America news, including dividend announcements and other important information, visit the Bank of America newsroom and register for news email alerts.
Investors May Contact:
Lee McEntire, Bank of America
Phone: 1.980.388.6780
lee.mcentire@bofa.com
Jonathan G. Blum, Bank of America (Fixed Income)
Phone: 1.212.449.3112
jonathan.blum@bofa.com
Reporters May Contact:
Christopher P. Feeney, Bank of America
Phone: 1.980.386.6794
christopher.feeney@bofa.com
View original content to download multimedia:
SOURCE Bank of America Corporation
|
https://www.whsv.com/prnewswire/2022/04/11/bank-america-report-first-quarter-2022-financial-results-april-18/
| 2022-04-11T13:56:17Z
|
BOSTON and NEW YORK, April 11, 2022 /PRNewswire/ -- A new partnership unites Best In Class MD, the leading orthopedic telehealth platform with access to the nation's top orthopedic physicians, and FIGUR8, the digital health company that's developed the most advanced wearable musculoskeletal health decision support technology on the market. Building on the two companies' shared mission in forging a new standard of care in advancing musculoskeletal health, the partnership creates the first offering of its kind on the market that combines precision musculoskeletal analytics with world-class orthopedic care.
To date, the lack of codified, accurate and objective data for musculoskeletal conditions has been one of the industry's biggest challenges. FIGUR8's breakthrough technology delivers data on key musculoskeletal biomarkers — including range of motion, movement quality, strength and functional mobility — and accurately pinpoints the source and severity of an injury while showing real-time recovery visibility.
"We're excited to be charting a new course in the delivery of musculoskeletal health management together with Best In Class MD, which has built the deepest roster of world-class musculoskeletal clinicians," said Nan-Wei Gong, co-founder and CEO of FIGUR8. "With this partnership, FIGUR8 and Best In Class MD are combining the best musculoskeletal data available with the best orthopedic physicians in the country to deliver best in class orthopedic care and optimal patient outcomes."
Best In Class MD brings an unmatched network of the nation's foremost orthopedic physicians — accepting only the top 1% of the nation's orthopedic specialists — and a scalable, HIPAA-compliant and URAC-accredited telehealth platform, providing on-demand access to patients seeking musculoskeletal consultations with leading orthopedic physicians across the country.
"We founded Best In Class MD with the mission to enable direct access to world-class experts and personalized treatment plans," said Dr. Benedict Nwachukwu, CEO and cofounder of Best In Class MD and an orthopedic surgeon at the Hospital for Special Surgery. "FIGUR8 brings objective and meaningful data to the standard musculoskeletal clinical assessment in a way that's never been done before, equipping Best In Class MD's physicians with precision analytics to support diagnostic and treatment decisions for musculoskeletal conditions. Patients look to Best In Class MD for trusted and individualized plans of care for their musculoskeletal health, and our partnership with FIGUR8 further delivers on Best In Class MD's mission."
More than 1.7 billion people suffer from musculoskeletal conditions, according to the World Health Organization. Musculoskeletal disorders account for one of the largest categories of workplace injuries, accounting for over 50 percent of workers' compensation costs according to the Bureau of Labor Statistics. FIGUR8's advanced musculoskeletal assessment solution — developed over years of R&D by MIT engineers in collaboration with Mass General Brigham clinicians — enables a full musculoskeletal and orthopedic assessment to be conducted in less than 15 minutes.
BICMD is an integrated telehealth platform built to provide consumers and enterprises with immediate and direct access to a national network of leading medical doctors for personalized expert medical opinions. By increasing access to the country's top providers, BICMD is on a mission to solve the well-defined challenge of obtaining medical certainty. To learn more, visit www.bicmd.com.
FIGUR8 is creating the most advanced wearable musculoskeletal (MSK) technology on the market. Its powerful, lightweight system combines clinically smart biosensors, intuitive software and AI to improve musculoskeletal health at every point of care — from injury through full recovery. FIGUR8 has developed the first musculoskeletal diagnostics decision support system of its kind that can accurately pinpoint the source and severity of an injury while showing real-time recovery visibility. Powering FIGUR8's solution is breakthrough technology developed over years by MIT engineers in collaboration with Mass General Brigham clinicians. For more info, visit www.figur8tech.com.
View original content to download multimedia:
SOURCE FIGUR8
|
https://www.whsv.com/prnewswire/2022/04/11/best-class-md-figur8-partner-advance-patient-access-precision-musculoskeletal-health-management/
| 2022-04-11T13:56:24Z
|
-- Black Knight's Optimal Blue Mortgage Market Indices tracked conforming 30-year rates daily throughout March as they topped 4.9% before pulling back and finishing the month at 4.79%
-- The spread between mortgage rates and 10-year Treasuries climbed another 20 basis points as the rise in mortgage rates outpaced the ~50 basis point rise in Treasury yields
-- Overall rate lock activity rose 19% from January, driven by a 31% increase in purchase volume, which is now up nearly 70% over the past three months
-- Cash-out locks were mostly flat (+1.6%) while rate/term refinance volumes continued to contract, falling another 15.4% in March for an 81% year-over-year decline
-- The continued decline in rate/term refinance locks pushed the refi share of the market down to just 28%, the lowest point since November 2018
-- With home price growth continuing to set records, non-conforming products captured additional market share in March and now account for 18% of lock activity
-- Likewise, upward pressure on home prices pushed the average loan amount up another $8,000 to just under $362,000
JACKSONVILLE, Fla., April 11, 2022 /PRNewswire/ -- Today, Black Knight, Inc. (NYSE: BKI) announced the release of its latest Originations Market Monitor report, looking at mortgage origination data through March month-end. Leveraging daily rate lock data from the Black Knight Optimal Blue PPE – mortgage lending's most widely used pricing engine -- the Originations Market Monitor provides the industry's earliest and most comprehensive view of origination activity.
"Mortgage interest rates spiked in March, with 30-year offerings climbing 70 basis points over the course of the month," said Scott Happ, president, Optimal Blue, a division of Black Knight. "In fact, our OBMMI daily interest rate tracker showed the average 30-year conforming rate reach as high as 4.93% late in the month before pulling back slightly to close out March at 4.79%. And yet, despite seeing the fastest one-month rise in rates in nearly 13 years, we saw purchase lock volumes increase by 31% from February -- likely as prospective buyers moved to lock in their loans before rates climbed any higher."
The month's pipeline data showed overall rate locks up 19.1% from February, driven by a 31.5% surge in purchase lending activity. While cash-out refinance locks remained relatively flat (+1.6%), rate/term refinance activity continued to slide, with March marking the sixth consecutive monthly decline. The continued decline in rate/term refinance locks pushed the refi share of the market down to just 28%, the lowest point since November 2018. Non-conforming loan products continued to gain market share at the expense of agency volumes as the pace of home price growth has reached new record highs. Pull-through rates -- the share of locks that result in funded loans -- fell on both purchase and refinance locks, with refi pull-through falling to just 65.7%.
"As home prices continue to climb -- even in the face of sharply rising interest rates -- we've seen the average loan amount rise as well," Happ continued. "The average loan rose by $8,000 to just under $362,000 in March, representing a more than 23% increase over February's rise. In turn, non-conforming products -- including both jumbos and loans with expanded guidelines -- continued to take market share from conforming loans and accounted for a full 18% of the month's lock activity. The FHA share of lock activity also rose on strong purchase lending demand."
Each month's Originations Market Monitor provides high-level origination metrics for the U.S. and the top 20 metropolitan statistical areas by share of total origination volume. Much more detail on March's origination activity can be found in the full Black Knight Originations Market Monitor report.
About Black Knight
Black Knight, Inc. (NYSE: BKI) is an award-winning software, data and analytics company that drives innovation in the mortgage lending and servicing and real estate industries, as well as the capital and secondary markets. Businesses leverage our robust, integrated solutions across the entire homeownership life cycle to help retain existing customers, gain new customers, mitigate risk and operate more effectively.
Our clients rely on our proven, comprehensive, scalable products and our unwavering commitment to delivering superior client support to achieve their strategic goals and better serving their customers. For more information on Black Knight, please visit www.blackknightinc.com/.
For more information:
Michelle Kersch
904.854.5043
michelle.kersch@bkfs.com
Mitch Cohen
704.890.8158
mitch.cohen@bkfs.com
View original content to download multimedia:
SOURCE Black Knight, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/black-knight-originations-market-monitor-driven-by-rise-purchase-loans-overall-rate-locks-up-19-march-despite-70-basis-point-rate-jump-month/
| 2022-04-11T13:56:32Z
|
- BORA 2.0 Governance Council, Tokenomics, and Community Channel Contents Disclosed
- Airdrop event will be held from April 11th
SEOUL, South Korea, April 11, 2022 /PRNewswire/ -- BORANETWORK (CEO Gyehan Song) announced on April 11 that it releases the BORA 2.0 white paper and brand site (borachain.io).
BORANETWORK, which had announced the BORA 2.0 renewal blueprint through the BORA 2.0 Partners Day in February, introduced specific details such as the BORA 2.0 Governance Council, Tokenomics, and community channels through the white paper and brand site released this day.
About 20 companies participate in the Governance Council, including Sandbox Network, Collab ASIA, Kakao Entertainment, Legendaries, Kakao VX, Lion Heart Studio, Kakao Games, Wemade, XL Games, Neowiz, Mobirix, Neptune, Metabora, Haegin, Burke O'Sully, Hyperithm, Krosslab, Krust Universe, and Kakao Enterprise.
The Governance Council operates each of the BORA 2.0 nodes and actively participates in decision-making for the benefit of the BORA ecosystem. Metabora was appointed as the first chairperson, and the Governance Council has 4 committees according to each business areas: Token, Content, Technology, and Marketing.
Meanwhile, BORA Tokenomics for issuance of service tokens and NFTs by various entities, strengthening the distribution environment, smooth liquidity supply management, security of token economy sustainability in the ecosystem, and aggressive investment for growth development 2.0, was released.
According to this, inflation and permanent lockup mechanisms are introduced, and all tokens are distributed to five pools: Liquidity pool, Ecosystem pool, Community pool, Governance Council pool, and Reserve pool, which is to be used for expansion & growth of the BORA 2.0 platform. It was decided at the GC General Assembly on April 8 that inflation is to be introduced at a competitive level and decreasing every year in consideration of the market competition.
In addition, in order to alleviate the one-way communication that was previously conducted, a window has been prepared for the community to come together, and Medium, Twitter, Telegram, and Discord will be operated as the main channels.
Vincent Lim (CBO of BORANETWORK) said, "The Bora platform plans to create a healthy environment where high-quality content for users and NFT projects can be showcased within the Bora ecosystem, together with growth of Governance Council."
On the other hand, BORANETWORK will conduct an airdrop event to revitalize the community from April 11, and conduct various events based on social referrals and through a lottery among BORA social channel followers.
Should you have any inquiries, please do not hesitate to contact us.
BORANETWORK PTE. LTD.
View original content to download multimedia:
SOURCE BORANETWORK
|
https://www.whsv.com/prnewswire/2022/04/11/boranetwork-bora-20-white-paper-brand-site-released/
| 2022-04-11T13:56:38Z
|
Strengthens Brother's existing commitments and programs dedicated to sustainability
BRIDGEWATER, N.J., April 11, 2022 /PRNewswire/ -- Today, in advance of Earth Day, Brother International Corporation (Brother) is announcing this new partnership along with a series of Corporate Social Responsibility activities and Environmental Action across the organization – thus strengthening local and global efforts to fight climate change.
Brother is announcing a new partnership with Clean Ocean Action, a leading national and regional voice working to protect waterways using science, as a sponsor of the 37th Annual Beach Sweeps Event. This includes sponsorship of two Covid-compliant beach sweeps events open to the public of New Jersey and a Virtual Lunch and Learn hosted by a Clean Ocean Action representative on Earth Day available to all Brother employees to learn more about protecting our oceans.
In addition, on Earth Day, Brother employees will be making their annual 'Brother Earth Promise,' an individual commitment to help protect the environment, such as addressing pollution by recycling and cutting their use of single-use plastics, amongst other efforts.
"I am proud to see Brother employees rally around our environmental activities and Brother Earth Promise, and I am thrilled to see a collective effort to address the urgent global climate change crisis across our organization," said Don Cummins, President, Brother International Corporation. "While we think globally, we must also act locally, and our sponsorship of Clean Ocean Action activities in New Jersey will help ensure that our own shores are free from ocean plastics and pollution."
Brother's partnership with Clean Ocean Action builds on Brother's existing flagship environmental programs such as their Recycling Program for printers and ink cartridges, employee volunteer activities supporting the Friends of the Great Swamp National Wildlife Refuge in New Jersey for the past ten years, a long-standing sponsorship of the Wolf River Conservancy Restoration Series that includes lectures and volunteer events to restore the Wolf River in West Tennessee, and an annual $25,000 donation to the Arbor Day Foundation in support of their mission to plant, nurture, and celebrate trees.
These activities complement Brother's ongoing sustainability commitments, which include A Commitment to Meeting EPEAT Requirements, Brother Product Recycling Program, Brother Toner & Ink Cartridge Recycling Program, Brother's Environmental Management System, ENERGY STAR®-Compliant Products.
Brother considers the environment at all stages of a product's life cycle, from development, design, and manufacturing to use, disposal, and reuse, as the social responsibility of a manufacturing company. In fact, over the past 5 years (2016-2020), carbon emissions across Brother Americas have been reduced by 9.7% and over 30% since 2012. Brother has remanufactured more than 5.5 million toner cartridges (2017-2021) and recycles more than 99% of its waste, with less than 1% of waste going to landfills. Brother has also supported biodiversity conservation and restoration activities across the Americas with $650,000 donated, 159,369 trees planted (US/CAN), and 26,843,750 sq. ft. of rainforest protected in Guatemala through a partnership with the Arbor Day Foundation.
"Brother strives to positively and continuously act to decrease the environmental impact and increase the sustainability of our business operations in alignment with the Brother Group globally," says Vickie Berry, Manager of Environmental, Health and Safety. "The Brother Group aims to achieve carbon neutrality in all business operations and minimize CO2 emissions from the entire value chain by 2050 so as to contribute toward creating a carbon-free society."
About Brother International Corporation
Brother International Corporation has earned its reputation as a premier provider of home office and business products, products for the sewing and crafting enthusiast as well as industrial solutions that revolutionize the way we live and work. Brother International Corporation is a wholly-owned subsidiary of Brother Industries Ltd. With worldwide sales exceeding $6 billion, this global manufacturer was started more than 100 years ago. Bridgewater, New Jersey is the corporate headquarters for Brother in the Americas. It has fully integrated sales, marketing services, manufacturing, research and development capabilities located in the U.S. In addition to its headquarters, Brother has facilities in California, Illinois and Tennessee, as well as subsidiaries in Canada, Brazil, Chile, Argentina, Peru and Mexico. For more information, visit www.brother.com.
Contact
Brother International Corporation USA
Loren Waldron
loren.waldron@brother.com
View original content to download multimedia:
SOURCE Brother International Corporation
|
https://www.whsv.com/prnewswire/2022/04/11/brother-expands-sustainability-efforts-with-new-partnership-with-clean-ocean-action/
| 2022-04-11T13:56:45Z
|
LUND, Sweden, April 11, 2022 /PRNewswire/ -- During the period April 4 - April 8, 2022, Alfa Laval AB (publ) (LEI code: 549300UCKT2UK88AG251) has repurchased in total 116,000 own shares (ISIN: SE0000695876) as part of the share buyback program initiated by the Board of Directors in order to secure optimized capital structure.
The share buybacks form part of the SEK 2 billion share buyback program, which Alfa Laval announced on April 27, 2021. The share buy-back program, which runs between April 28, 2021 and April 25, 2022, is being carried out in accordance with the EU Market Abuse Regulation (MAR) and the Commission Delegated Regulation 2016/1052 (the so-called Safe Harbour Regulation).
Shares in Alfa Laval have been repurchased as follows:
All acquisitions have been carried out on Nasdaq Stockholm by Nordea on behalf of Alfa Laval. Following the above acquisitions, Alfa Laval's holding of own shares amounts to 5,923,992 shares as of April 8, 2022.
The total number of shares in Alfa Laval, including the own shares, is 419,456,315, and the number of outstanding shares, excluding the own shares, is 413,532,323.
A full breakdown of the transactions is attached to this announcement.
For more information please contact:
Johan Lundin
Head of Investor Relations
Alfa Laval
Tel: +46 46 36 65 10
Mobile: +46 730 46 30 90
Henrik G. Welch
Head of Group Treasury
Alfa Laval
Tel: +46 46 36 65 10
Mobile: +46 70 2638399
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Alfa Laval
|
https://www.whsv.com/prnewswire/2022/04/11/buybacks-shares-alfa-laval-during-week-14-2022/
| 2022-04-11T13:56:52Z
|
Trailblazing executive brings deep sector experience to fast-growing, innovative cannabis tech firm
WILMINGTON, Del., April 11, 2022 /PRNewswire/ -- TrueGreen, a leading provider of smart packaging technology solutions for the cannabis industry, announced today the appointment of Katherine Lagow as President.
Lagow joins TrueGreen from Standard Wellness Company, a vertically integrated multi-state cannabis operator (MSO) with licenses in Ohio, Utah, Maryland and Missouri, where she most recently led all marketing and business development. Lagow was VP of Operations prior to launching their marketing department, where she was responsible for overseeing operations across all states and entities. Lagow joined Standard Wellness in 2018 prior to the company launching operations, and played a key role in expanding the company from one operational facility in Ohio to eight facilities across four states. She helped grow the company from 10 employees to 150 employees, and the company now boasts annual revenue expectation of 29M in 2022, and 76M in 2023 once the additional facilities in Utah and Missouri are fully operational.
Working closely with TrueGreen's senior executive team, Lagow will head TrueGreen's rapidly expanding new business efforts, integrating the company's product development, marketing, communications, and strategic partnerships.
"Katherine is recognized as one of the industry's most effective and far-sighted new leaders, and we are delighted to have her join our growing team," said Chris Quinlan, founder and CEO of TrueGreen. "Her experience building and scaling a top MSO and her deep relationships at every level will further accelerate our ability to deliver transformational solutions for customers across the country."
"In a short timeframe, TrueGreen has established itself as a clear trailblazer in cannabis technology solutions and I am excited by the opportunity to help seize the tremendous opportunity for their business and the entire industry," said Lagow. "The industry is moving incredibly quickly and TrueGreen's smart packaging technology is uniquely positioned to deliver immense value for customers, consumers and government."
An industry leader, Lagow has deep experience across every facet of the cannabis business from fundraising, to operations, to government affairs. Prior to joining Standard, she was an executive at The Team8 sports marketing and investment firm founded by tennis legend Roger Federer and his longtime agent Tony Godsick where she spearheaded strategic initiatives and new partnerships.
Lagow earned multiple degrees from Louisiana State University (LSU) including a BA in Politics and Government, a JD and an MBA. She is a member of the Louisiana Bar and earlier in her career clerked in the Louisiana courts.
TrueGreen also announced the appointment of Juliet Albin as director of strategic operations. Juliet works closely with COO Mark Donovan on the deployment and integration of TrueGreen's smart packaging technologies for customers.
These key appointments come as the company prepares to roll out its smart packaging platform with a leading MSO.
In the fall of 2021, Clearfield announced a capital raise led by Merida Capital Holdings, the leading private equity fund targeting key growth drivers in the development of the cannabis industry.
About TrueGreen
TrueGreen is the world's first smart packaging technology addressing the diverse needs of cannabis industry regulators, growers and consumers. From farm to fingertip, TrueGreen automates product and consumer data in real-time to enhance convenience and deliver insights that drive growth and brand loyalty while ensuring product safety and control. The Clearfield team has unmatched experience in technology, finance, consumer marketing and regulatory and government affairs. TrueGreen: Your Cannabis, Made Smarter™. For more go to: www.TrueGreenglobal.com
For more on Katherine Legow go to: (99+) Katherine Lagow | LinkedIn
Media contact:
Marc Sampogna,
marc@truegreenglobal.com
View original content to download multimedia:
SOURCE TrueGreen
|
https://www.whsv.com/prnewswire/2022/04/11/cannabis-industry-leader-katherine-lagow-named-president-truegreen/
| 2022-04-11T13:56:59Z
|
Canon publishes guide to assist in managing and protecting important information for printers and multifunction devices
MELVILLE, N.Y., April 11, 2022 /PRNewswire/ -- To assist companies in taking appropriate steps in managing and protecting important information on printers and multifunction devices, Canon U.S.A., Inc., a leader in digital imaging solutions, has announced that Canon Inc. has published a white paper that covers cybersecurity guidelines for organizations and their systems that manage important information. Canon multifunctional printer covered by the whitepaper support each control within both National Institute of Standards and Technology (NIST) standards and provides specific guidance for how to configure the devices in support of the NIST controls.
The white paper, created by Canon Inc. and verified by Trellix (former McAfee Enterprise), can serve as a guide to organizations' security administrators who are responsible for the configuration and maintenance of Canon imageRUNNER ADVANCE DX devices.1 It covers cybersecurity guidelines for NIST SP 800-171, which is required for organizations that conduct business with government bodies (such as the United States Department of Defense and the Japanese Ministry of Defense). The white paper also includes information on NIST SP 800-172, which defines Advanced Persistent Threat countermeasuresto help companies take appropriate steps so that they can protect important information.
Among the topics the white paper addresses are access control, which details how to verify and control connection to – and use of – external systems while limiting the use or portable storage devices on external systems. Awareness and training, which emphasizes an organization's responsibility to provide security training on insider threats and reporting, as well as audit and accountability components, are examples of important steps the white paper details that can be taken to help a company bolster their own security measures.
Details that relate device functions and settings to specific cybersecurity controls are also part of the white paper, emphasizing the importance of actively and assertively detecting, tracking and responding to threats via analyzing audit logs and utilizing threat intelligence to search for indicators of compromise.
The white paper was supported by Trellix in Musarubra, Japan, as the cybersecurity company reviewed the document's descriptions and ensured its accuracy regarding the description on how to fulfill minimum security requirements for implementation and operation of information-technology equipment.
The guidance also extends to color printers, such as the imageRUNNER ADVANCE DX series as well as the imagePRESS C170 / C165 models and the imagePRESS Lite C170/C165, as well as imageRUNNER ADVANCE DX models that print black and white. A list of printers and multifunction devices in support of NIST SP 800-171 and 172 target models can be found here.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean markets. With approximately $30.6 billion in global revenue, its parent company, Canon Inc. (NYSE:CAJ), as of 2021 has ranked in the top-five overall in U.S. patents granted for 36 consecutive years† and was one of Fortune Magazine's World's Most Admired Companies in 2022. Canon U.S.A. was featured in Newsweek's Most Loved Workplaces list for 2021, ranking among the top 100 companies for employee happiness and satisfaction at work. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss and follow us on Twitter @CanonUSA.
† Number of patents for 2021 are based on figures released by IFI CLAIMS Patent Services. Figures for 2005 to 2020 are based on information issued by the United States Patent and Trademark Office.
1 Canon Inc. does not guarantee that the use of the information in this white paper will prevent malicious attacks or the misuse of Canon devices. Furthermore, Canon Inc. does not guarantee that your environment and Canon devices meet the requirements of the security guidelines described in this white paper.
View original content to download multimedia:
SOURCE Canon U.S.A., Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/canon-publishes-guide-help-customers-protect-environment-against-cybersecurity-threats/
| 2022-04-11T13:57:06Z
|
ADDISON, Texas, April 11, 2022 /PRNewswire/ -- CarOffer, the fast-growing inventory acquisition innovator and part of the CarGurus network (Nasdaq: CARG), proudly announced Kim Jenkins has been named Vice President of Consumer Operations. In this newly created role, Jenkins oversees the Consumer Operations department, which was formed in August of last year to support CarGurus™ Instant Max Cash Offer, the only platform of its kind that brings automotive wholesale and retail together, leveraging the synergies of the CarGurus and CarOffer partnership.
Jenkins has been with the organization for approximately five years and previously served as Senior Director of Training and Implementation. In her new role, she is responsible for all aspects of consumer operations including: strategic planning to support quick and seamless scalable growth of the department; optimizing efficiencies through improved processes and integrating best-in-class systems; and ensuring delivery of superior customer service and a world class experience.
The Consumer Operations team at CarOffer is the fastest growing department within the company due to the immediate success of CarGurus Instant Max Cash Offer, the first consumer-facing product for CarOffer. Consumer Operations handles the lifecycle of the purchase of vehicles sold by consumers via the CarGurus Sell My Car site as it relates to the consumer experience. For example, Jenkins's team ensures the consumer is guided through the sale process with transparency and ease, while also coordinating critical details including identify verification, titling and registration documents, lien payoffs and scheduling the 'white glove service' of convenient at-home vehicle pick up. For a closer look at how it works, click here.
"Kim has been a tremendous contributor to the growth and success of CarOffer since she joined our company almost five years ago," says Bruce Thompson, founder and CEO of CarOffer. "Her dedication to leading a high performing team along with her passion for an unparalleled customer experience make her the perfect executive to lead our Consumer Operations team."
Prior to joining CarOffer, Jenkins served as a Senior Client Services Manager for nearly four years at Tail Light, an enterprise automotive retail software provider, where she oversaw the support team and streamlined processes for the optimization of people, services and technology. Before that, she led Guest Relations at Carlson Restaurants Worldwide for four years, and Cadbury Adams for more than eight years.
"CarOffer is an exceptional company and I'm proud to be a part of the journey," says Jenkins. "I'm looking forward to leading our exceptional team and seeing the growth of the consumer business in the months and years ahead."
About CarOffer
CarOffer is the automotive industry's leading inventory management platform for modern day wholesaling that allows dealers and dealer groups to buy, sell, and trade with automation and ease. Leveraging the power of data, national scale, and the company's proprietary Buying Matrix™ technology, the platform helps dealers acquire and exchange used inventory more efficiently. CarOffer is part of the CarGurus network (Nasdaq: CARG). For more information, visit www.caroffer.com.
About CarGurus
CarGurus (Nasdaq: CARG) is a multinational, online automotive platform for buying and selling vehicles that is building upon its industry-leading listings marketplace with both digital retail solutions and the CarOffer online wholesale platform. The CarGurus marketplace gives consumers the confidence to purchase or sell a vehicle either online or in-person, and it gives dealerships the power to accurately price, effectively market, instantly acquire and quickly sell vehicles, all with a nationwide reach. The company uses proprietary technology, search algorithms and data analytics to bring trust, transparency, and competitive pricing to the automotive shopping experience. CarGurus is the most visited automotive shopping site in the U.S. (source: Comscore Media Metrix® Multi-Platform, Automotive – Information/Resources, Total Visits, Q4 2021, U.S.).
CarGurus also operates online marketplaces under the CarGurus brand in Canada and the United Kingdom. In the United States and the United Kingdom, CarGurus also operates the Autolist and PistonHeads online marketplaces, respectively, as independent brands.
To learn more about CarGurus, visit www.cargurus.com and for more information about CarOffer, visit www.caroffer.com.
CarGurus® is a registered trademark of CarGurus, Inc., and CarOffer® is a registered trademark of CarOffer, LLC. All other product names, trademarks and registered trademarks are property of their respective owners.
© 2022 CarGurus, Inc., All Rights Reserved.
View original content to download multimedia:
SOURCE CarOffer
|
https://www.whsv.com/prnewswire/2022/04/11/caroffers-kim-jenkins-named-vice-president-consumer-operations/
| 2022-04-11T13:57:12Z
|
DALIAN, China, April 11, 2022 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it will report its unaudited financial results for the fourth quarter and full year ended December 31, 2021 on Thursday, April 14, 2022, before the U.S. market opens.
CBAK's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Thursday, April 14, 2022 (8:00 PM Beijing/Hong Kong Time on April 14, 2022).
For participants who wish to join the call, please register in advance for the conference using the link provided below at least 15 minutes prior to the scheduled call start time. Upon registration, participants will receive the conference call access information, including dial-in numbers, Direct Event passcode, a unique registrant ID and an email with detailed instructions to join the conference call.
Participant Online Registration:
Once completing the registration, please dial-in at least 10 minutes before the scheduled start time of the earnings call and enter the Direct Event passcode and registrant ID as instructed to connect to the call.
Additionally, a live and archived webcast of the conference call will be available at:
A replay of the conference call may be accessed by phone approximately two hours after the conclusion of the live call at the following numbers until April 22, 2022. To access the replay, please reference the conference ID 1846656.
About CBAK Energy
CBAK Energy Technology, Inc. is a leading high-tech enterprise engaged in the development, manufacturing, and sales of new energy high power lithium batteries. The applications of the Company's products and solutions include electric vehicles, light electric vehicles, electric tools, energy storage, uninterruptible power supply (UPS), and other high-power applications. In January 2006, CBAK Energy became the first lithium battery manufacturer in China listed on the Nasdaq Stock Market. CBAK Energy has multiple operating subsidiaries in Dalian and Nanjing, as well as a large-scale R&D and production base in Dalian.
For more information, please visit www.cbak.com.cn.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, strategy and plans, and our expectations for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements.
Any forward-looking statements contained in this press release are only estimates or predictions of future events based on information currently available to our management and management's current beliefs about the potential outcome of future events. Whether these future events will occur as management anticipates, whether we will achieve our business objectives, and whether our revenues, operating results, or financial condition will improve in future periods are subject to numerous risks. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: significant legal and operational risks associated with having substantially all of our business operations in China, the Chinese government may exercise significant oversight and discretion over the conduct of our business and may intervene in or influence our operations at any time, which could result in a material change in our operations and/or the value of our securities or could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and could cause the value of such securities to significantly decline or be worthless, trading in our securities may be prohibited under the Holding Foreign Companies Accountable Act if the PCAOB subsequently determines our audit work is performed by auditors that the PCAOB is unable to inspect or investigate completely, the effects of the global Covid-19 pandemic, changes in domestic and foreign laws, regulations and taxes, uncertainties related to China's legal system and economic, political and social events in China, the volatility of the securities markets; and other risks including, but not limited to, the ability of the Company to meet its contractual obligations, the uncertain market for the Company's lithium battery cells and business, macroeconomic, technological, regulatory, or other factors affecting the profitability of battery cells designed for energy storage that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 10-K as well as in our other reports filed or furnished from time to time with the SEC. You should read these factors and the other cautionary statements made in this press release. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
For investor and media inquiries, please contact:
In China:
CBAK Energy Technology, Inc.
Investor Relations Department
Thierry Jiewei Li
Phone: 86-18675423231
Email: ir@cbak.com.cn
The Blueshirt Group
Ms. Feifei Shen
Phone: +86 13466566136
Email: feifei@blueshirtgroup.com
The Blueshirt Group
Ms. Suwen Feng
Phone: +86 13917110134
Email: suwen@blueshirtgroup.com
In the United States:
The Blueshirt Group
Ms. Julia Qian
Phone: +1 973-619-3227
Email: Julia@blueshirtgroup.com
View original content:
SOURCE CBAK Energy Technology, Inc.
|
https://www.whsv.com/prnewswire/2022/04/11/cbak-energy-report-fourth-quarter-amp-full-year-2021-unaudited-financial-results-thursday-april-14-2022/
| 2022-04-11T13:57:18Z
|
Ultimate Pet Nutrition Nutra Complete for Dogs is a Premium Beef Blend Freeze-Dried Raw Dog Food That Supports Energy and Longevity
LOS ANGELES, April 11, 2022 /PRNewswire/ -- April 11th is National Pet Day, and there is no better way to celebrate than for pet owners to tend to the health and diet of their furry family. Ultimate Pet Nutrition® and their founder Dr. Gary Richter recommends that all pet parents make sure that their furry loved ones are getting their proper nutrition and are up to date with their regularly scheduled veterinary exams.
Ultimate Pet Nutrition Nutra Complete™ for Dogs is the complete pet food to support overall canine health for National Pet Day. Nutra Complete is a premium blend of dog food that is 100% freeze-dried raw. Containing zero fillers or artificial preservatives, Ultimate Pet Nutrition Nutra Complete supports optimal canine health by helping boost your dog's diet, healthy digestion, and energy levels.*
Ultimate Pet Nutrition Nutra Complete for Dogs is an advanced formula containing 40 veterinarian-approved ingredients. These ingredients are also freeze-dried raw which preserves nutrient content in every bite. Most dog food companies strip the nutritional value out of their dog food by using high cooking temperatures. Ultimate Pet Nutrition's freeze-drying process is designed to help every dog get maximum nutrition with Nutra Complete. Filled with healthy, nutritious beef, Nutra Complete provides quality protein that helps to support your dog's organs, muscles, and digestion. Other ingredients include antioxidant-packed berries, seeds full of fatty acids, and high fiber vegetables that support your dog's health, from eyesight to mobility. To further ensure optimal nutrition, Ultimate Pet Nutrition Nutra Complete is packed with essential vitamins and minerals to support your dog's energy, healthy coat, and immune system for a happier life.*
How to Purchase Ultimate Pet Nutrition Nutra Complete
Pet owners can purchase Ultimate Pet Nutrition Nutra Complete for Dogs on the Ultimate Pet Nutrition site for $59.95 with a 90-day money-back guarantee (minus shipping and handling).
About Ultimate Pet Nutrition
Founded by Dr. Gary Richter, Ultimate Pet Nutrition provides pets with the nutrition they need to live their happiest and healthiest lives. Ultimate Pet Nutrition® combines both holistic and conventional methods to craft products with maximum health benefits all dogs and cats can appreciate. Best-selling products include Nutra Thrive for Cats, the popular Nutra Bites line of freeze-dried raw treats for cats and dogs, and Nutra Thrive for dogs. Follow Ultimate Pet Nutrition on Instagram @ultimatepetnutrition, and Twitter @ultpetnutrition. For retail opportunities, contact retail@ultimatepetnutrition.com.
About Dr. Gary Richter
Gary Richter, DVM, is an award-winning veterinarian, international bestselling author of The Ultimate Pet Health Guide, and founder of Ultimate Pet Nutrition which combines both holistic and conventional methods to craft products with maximum health benefits for all dogs and cats can appreciate. Dr. Richter has been the recipient of over 20 local and national awards including "Best Veterinarian" and "Best Alternative Medicine Provider." Dr. Richter has been the Medical Director of Holistic Veterinary Care since 2009. Currently, Dr. Richter's public TV special based on his bestselling book, The Ultimate Pet Health Guide is airing nationwide. To learn more, visit www.drgaryrichter.com and follow on Instagram @petvetexpert.
*All pets are unique. Your pet's results can and will vary.
Media Contact:
Ashley Patterson
ashley@stanton-company.com
View original content to download multimedia:
SOURCE Ultimate Pet Nutrition
|
https://www.whsv.com/prnewswire/2022/04/11/celebrate-national-pet-day-with-dr-gary-richters-ultimate-pet-nutrition-nutra-complete-dogs/
| 2022-04-11T13:57:26Z
|
STUTTGART, Germany, April 11, 2022 /PRNewswire/ -- René Ziegler, 41, will join Exyte as Head of Corporate Communications & Investor Relations on May 1, 2022. He will report to the Stuttgart-based company's CEO Dr. Wolfgang Büchele. After seven years with Exyte, his predecessor Adriana Williams is moving on to join a leading global manufacturer of semi-finished copper and copper alloy products.
Exyte is a global leader in designing, developing and building high-tech facilities, particularly semiconductor fabs, battery factories and biopharmaceuticals manufacturing plants. The company also constructs specialized buildings to house data centers. Ziegler's responsibilities will include corporate communications, investor relations, and marketing communications.
"Exyte is gaining an acknowledged communications professional and a strong leader in René Ziegler. He will continue to advance Exyte's communications in terms of content, organization, and processes. Drawing on many years' experience in reputation management, he will provide communications support for Exyte's growth strategy," says Büchele. Ziegler adds, "Current and future stakeholders are sure to be drawn to Exyte as it continues to professionalize and internationalize its communications. I look forward to charting the strategic course for the further development of communications and, by extension, the transformation of Exyte."
Ziegler brings to the table many years' experience with technology, innovation, and business and financial communications. He is joining Exyte from Brose, an automotive supplier based in the German region of Franconia. Ziegler was responsible for communications, marketing, and public affairs at this family-owned company. Prior to that, he had held various communications positions at the technology and services company Bosch. Most recently, he was responsible for strategy and thought leadership. He had also long been in charge of the Bosch Group's external communications and media relations.
About Exyte
Exyte is a global leader in the design, engineering, and delivery of ultra-clean and sustainable facilities for high-tech industries. With cutting-edge expertise developed over more than a century, we serve clients in the sophisticated markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centers. Exyte offers a full range of services from consulting to managing the implementation of turnkey solutions with the highest standards in safety and quality to our customers worldwide. We create a better future by enabling key industries to enhance the quality of modern life. In 2021, Exyte generated sales of EUR 4.9 billion with around 7,400 employees worldwide.
Logo - https://mma.prnewswire.com/media/1487100/Exyte_Logo.jpg
Photo - https://mma.prnewswire.com/media/1783690/Exyte_Ziegler.jpg
Contact
Adriana Williams
Vice President CorporateCommunications & Investor Relations
+49 711 8804 1489
adriana.williams@exyte.net
www.exyte.net
René Ziegler
+49 172 5838786
Twitter: @rene_ziegler
View original content to download multimedia:
SOURCE Exyte
|
https://www.whsv.com/prnewswire/2022/04/11/change-communications-ren-ziegler-joins-exyte-new-head-corporate-communications-amp-investor-relations/
| 2022-04-11T13:57:32Z
|
BLOOMFIELD, Conn., April 11, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) will be hosting its Investor Day on Friday, June 3, 2022 in New York City.
The event will feature in-depth presentations on corporate strategy and financial targets. It will begin at 8:30 a.m. ET and conclude by 1:30 p.m. ET. A live webcast of the presentation will be available at https://investors.cigna.com/events-and-presentations/default.aspx in the Investor Relations section of Cigna's website.
To listen to this presentation live on the Internet, visit https://investors.cigna.com/events-and-presentations/default.aspx at least 15 minutes prior to the presentation to download and install any necessary audio software. Following the event, a replay will be available on the website for four weeks.
About Cigna
Cigna Corporation is a global health services company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products.
Cigna maintains sales capability in over 30 countries and jurisdictions, and has over 185 million customer relationships around the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.
Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
Ralph.Giacobbe@cigna.com
Media Contact
Justine Sessions
1 (860) 810-6523
Justine.Sessions@cigna.com
View original content to download multimedia:
SOURCE Cigna
|
https://www.whsv.com/prnewswire/2022/04/11/cigna-corporation-host-investor-day-new-york-city-june-3/
| 2022-04-11T13:57:39Z
|
Company launches suite of pre-care digital front door solutions powered by CipherConnect to drive appointment volume and reduce no-shows
NEW YORK, April 11, 2022 /PRNewswire/ -- CipherHealth, a recognized leader and innovator in patient-centered communications, engagement, and insights for the nation's leading healthcare systems, today announced CipherConnect, a new conversational engagement solution that automates the many manual scheduling, intake, and virtual waiting room tasks that consume precious frontline resources. CipherConnect manages patient-provider communication via a frictionless, conversational, web-based chat interface that captures relevant conversational patient data and seamlessly integrates with EMRs, delivering a more comprehensive and up-to-date view of patients' health and wellness.
Healthcare is facing an existential threat: Overextended nurses and physicians are abandoning their jobs at unprecedented levels, while consumers have growing expectations for more seamless, convenient, and personalized experiences from their healthcare providers. According to Adam Cherrington, Senior Research Director at KLAS Research, "Recent research of ours has shown that digital front door solutions —particularly those focused on pre-care activation and preparation—not only improve patient convenience and satisfaction, but also reduce the administrative burden on a nursing community that is increasingly burned out and leaving the profession at unprecedented levels."1
"Removing friction in pre-care workflows has never been more important for both providers and patients," said Jake Pyles, CipherHealth CEO. "CipherConnect does just that by automating many of the critical interactions that patients have with their providers as they prepare for their appointments. But CipherConnect goes far beyond the capabilities of a mere chatbot, allowing providers to capture and leverage conversational context and data for richer and more informed interactions later in the patient journey, from point-of-care to post-care through preventative care. As data gathered at one point along the care continuum can be applied to any other part, providers can truly deliver personalized care at scale."
CipherConnect is interoperable with over 85 Electronic Health Record (EHR) systems, including Epic and Cerner. By interconnecting dynamic, conversational data from CipherConnect with clinical information held in the EHRs, providers have a more complete and up-to-date picture of their patients, enabling them to be better prepared and agile to resolve issues that impact the patient journey and result in better outcomes downstream. Later this year, CipherHealth will augment CipherConnect with additional "virtual waiting room" capabilities and more advanced scheduling and referral management solutions that keep patients interacting with providers between visits.
In addition to its current pre-care solutions, including Appointment Reminders, Procedure Preparation, and Patient Screening solutions, CipherHealth is using the conversational engagement capabilities of CipherConnect to roll out a new set of digital front door solutions:
- Booking Confirmation: Share booking details for newly scheduled appointments including time, provider name, and location.
- Appointment Prep: Inform patients on next steps for arrival, such as safety instructions, remote registration, and check-in.
- Data Intake: Collect data for consent, forms, screeners, and other paperwork before arrival; upload images of insurance cards and identification as well as documents for billing or from a previous provider.
"We're operating in a different world than we were two years ago on so many different levels. Notably, we have a patient base that places an ever-growing value on convenience, personalization, and compassionate care," said Shawn R. Smith, MBA, CPXP, Assistant Vice President: Clinical Enterprise, Patient Experience at Inova. "CipherHealth's vision for the future of patient engagement tightly aligns with ours: Patients should feel known and welcomed from the very first interaction they have with us, and that experience should be carried through every time, every touch—to each person in every community we have the privilege to serve. CipherHealth's tools and solutions for engagement, and particularly their new set of pre-care engagement tools, allow us to execute on that vision in new and comprehensive ways."
CipherConnect is available immediately. To learn more, visit cipherhealth.com/cipherconnect.
About CipherHealth
CipherHealth is an award-winning digital patient engagement company committed to enhancing communication and coordination throughout the care continuum. Since 2009, CipherHealth has helped define the patient engagement category, delivering groundbreaking tools and superior services to help health systems deliver patient-centric, quality care that improves clinical outcomes, drives operational efficiency, and creates sustainable financial value through a full suite of communications solutions. CipherHealth's automated, scalable platform empowers healthcare organizations to drive meaningful conversations among patients, provider staff and caregivers, regardless of care setting, thereby achieving new standards for patient care and accelerating the digital transformation of the industry.
View original content to download multimedia:
SOURCE CipherHealth
|
https://www.whsv.com/prnewswire/2022/04/11/cipherhealth-announces-cipherconnect-conversational-engagement-solution-that-leverages-patient-data-personalize-engagement-keep-patients-network/
| 2022-04-11T13:57:46Z
|
New agreement becomes effective Jan. 1, 2023
EAGAN, Minn., April 11, 2022 /PRNewswire/ -- Prime Therapeutics LLC (Prime) announced today that they will begin administering Medicare Part D business pharmacy benefits for ClearStone Solutions (ClearStone), effective Jan. 1, 2023. ClearStone manages pharmacy services for the Northern Plains Alliance (NPA). The NPA serves 130,000 Medicare members in seven states: Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota and Wyoming.
Prime is offering different network and formulary designs to meet ClearStone's clients' need for differentiation in the marketplace. With the addition of ClearStone pharmacy services for NPA, Prime will serve nearly 1.8 million Medicare members.
"We are extremely excited that ClearStone has chosen Prime as their trusted pharmacy benefits provider. We are proud of the work our organization has done to advance its leadership position as the pharmacy benefit manager of choice for government health plans," said Kip Haffner, vice president of government programs at Prime. "Prime continues to offer government programs offerings to clients like ClearStone that delivers financial savings for the plans, grows their membership and implements programs to help keep their members healthy. We look forward to being a strategic partner alongside ClearStone, the Northern Plains Alliance plans and their members."
About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves nearly 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. For more information visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.
Contact:
Denise Lecher
Public Relations Manager
612.777.5763
denise.lecher@primetherapeutics.com
View original content:
SOURCE Prime Therapeutics LLC
|
https://www.whsv.com/prnewswire/2022/04/11/clearstone-solutions-selects-prime-therapeutics-pharmacy-benefit-manager/
| 2022-04-11T13:57:53Z
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.